Archive for February, 2010
Feb. 26, 2010 (Business Wire) — Acme United Corporation (NYSE AMEX:ACU) today announced that net sales for the quarter ended December 31, 2009, were $13.4 million compared to $12.6 million in the same period in 2008, an increase of 7% (4% in local currency). Net sales for the year ended December 31, 2009 were $59.1 million, compared to $68.7 million in the same period in 2008, a decrease of 14% (17% in local currency).
Net income for the fourth quarter ended December 31, 2009 was $731,000, or $.22 per diluted share, compared to $634,000, or $.18 per diluted share, for the comparable period last year, an increase of 22%. Net income for the year ended December 31, 2009 was $2,842,000, or $.85 per diluted share, compared to $4,467,000, or $1.24 per diluted share, in the comparable period last year.
Net sales for the year ended December 31, 2009, in the U.S. segment decreased 16% compared to 2008. Net sales in Canada for the year ended December 31, 2009 decreased 13% in U.S. dollars compared to 2008, and 6% in local currency. The decline in net sales for the twelve months ended December 31, 2009 in the U.S. and Canadian segment was principally due to the economic downturn. European net sales for the year ended December 31, 2009 increased 3% in U.S. dollars and 8% in local currency compared to 2008.
Gross margins were 39% for the fourth quarter ended December 31, 2009 and 2008, respectively. Gross margins were 37% for 2009 compared to 40% in 2008. The gross margin decline for the year was primarily due to fixed costs spread over lower sales, the weaker Canadian dollar which raised the cost of products in our Canadian segment, and product mix.
Operating income in the fourth quarter ended December 31, 2009 was $293,000, compared to $795,000 in the fourth quarter of 2008. Operating income in the fourth quarter of 2009 included a $210,000 write-off of medical products donated for relief efforts. The fourth quarter of 2008 included a benefit of $400,000 from the reversal of incentive compensation liabilities. Excluding these items, operating income was $503,000 in the fourth quarter of 2009 compared to $395,000 in 2008.
Pretax income in the fourth quarter ended December 31, 2009 was $266,000 compared to $875,000 in the fourth quarter of 2008. Included in pretax income in the fourth quarter of 2008 was $265,000 in other income related to the Company’s gain on the sale of its former facility in Bridgeport, CT, which had ceased manufacturing in 1996. Excluding the $210,000 charge associated with the donation of medical products and the exceptional items in the fourth quarter of 2008, pretax income was $476,000 in the fourth quarter of 2009 compared to $210,000 in same period in 2008.
In the fourth quarter of 2009, the Company recorded an income tax benefit of approximately $464,000, which was primarily due to $500,000 of tax savings related to the Company’s donation of medical products to AmeriCares and the donation of land to the City of Bridgeport, CT. This donation, which occurred in December 2009, consisted of waterfront property adjacent to the property the Company sold in December 2008.
The full year effective tax rate in 2009 was 18%, compared to 33% in 2008. The decrease in the effective tax rate in 2009 was primarily the result of the $500,000 of tax savings resulting from the donations. Without these credits, the effective tax rate would have been approximately 32% for 2009.
Walter C. Johnsen, Chairman and CEO said, “We completed 2009 with momentum. Our award-winning iPoint pencil sharpeners are gaining wide distribution, the Speed Pak utility knives are building sales, and the Camillus knife sales are growing. Our new proprietary non-stick coatings are broadening our product applications for cutting in the craft, office, industrial, hardware and other markets.”
Mr. Johnsen added that he was pleased with the Company’s substantial reduction in debt during the year, and its new bank facility obtained in January 2010. He emphasized that Acme United enters 2010 with a stronger balance sheet than a year ago, and is well positioned for growth.
The Company’s bank debt less cash on December 31, 2009 was $2.7 million compared to $6.5 million on December 31, 2008. During fiscal year 2009, the Company repurchased 206,000 shares of its common stock for approximately $1.7 million and paid $700,000 in dividends on its common stock; the expenditures were offset by cash flow from operations of $6.6 million.
ACME UNITED CORPORATION is an innovative supplier of cutting devices, measuring instruments and safety products for school, home, office, industrial and hardware use. Its leading brands include Westcott®, Clauss®, Camillus® and PhysiciansCare ®.
Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, the following: (i) the Company’s plans, strategies, objectives, expectations and intentions are subject to change at any time at the discretion of the Company; (ii) the impact of current uncertainties in global economic conditions and the ongoing financial crisis affecting the domestic and foreign banking system and financial markets, including the impact on the Company’s suppliers and customers (iii) the Company’s plans and results of operations will be affected by the Company’s ability to manage its growth, and (iv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.
|
ACME UNITED CORPORATION |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
YEAR END REPORT 2009 |
(Unaudited) |
|
|
|
|
|
|
Quarter Ended |
|
|
|
|
Quarter Ended |
Amounts in $000’s except per share data |
|
|
|
|
December 31, 2009 |
|
|
|
|
December 31, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
|
$ |
13,422 |
|
|
|
|
$ |
12,584 |
|
Cost of goods sold |
|
|
|
|
8,248 |
|
|
|
|
|
7,701 |
|
Gross profit |
|
|
|
|
5,174 |
|
|
|
|
|
4,883 |
|
Selling, general, and administrative expenses |
|
|
|
|
4,881 |
|
|
|
|
|
4,088 |
|
Income from operations |
|
|
|
|
293 |
|
|
|
|
|
795 |
|
Interest expense |
|
|
|
|
(32 |
) |
|
|
|
|
(89 |
) |
Interest income |
|
|
|
|
33 |
|
|
|
|
|
– |
|
Net interest expense |
|
|
|
|
2 |
|
|
|
|
|
(89 |
) |
Other (expense) income |
|
|
|
|
(29 |
) |
|
|
|
|
169 |
|
Total other (expense) income net |
|
|
|
|
(27 |
) |
|
|
|
|
80 |
|
Pre-tax income |
|
|
|
|
266 |
|
|
|
|
|
875 |
|
Income tax (benefit) expense |
|
|
|
|
(464 |
) |
|
|
|
|
241 |
|
Net income |
|
|
|
$ |
731 |
|
|
|
|
$ |
634 |
|
|
|
|
|
|
|
|
|
|
|
|
Shares outstanding – Basic |
|
|
|
|
3,208 |
|
|
|
|
|
3,415 |
|
Shares outstanding – Diluted |
|
|
|
|
3,305 |
|
|
|
|
|
3,511 |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share basic |
|
|
|
$ |
0.23 |
|
|
|
|
$ |
0.19 |
|
Earnings per share diluted |
|
|
|
|
0.22 |
|
|
|
|
|
0.18 |
|
|
ACME UNITED CORPORATION |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
YEAR END REPORT 2009 (cont.) |
(Unaudited) |
|
|
|
|
|
|
|
Year Ended |
|
|
|
|
Year Ended |
Amounts in $000’s except per share data |
|
|
|
|
December 31, 2009 |
|
|
|
|
December 31, 2008 |
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
|
$ |
59,149 |
|
|
|
|
$ |
68,719 |
|
Cost of goods sold |
|
|
|
|
37,075 |
|
|
|
|
|
41,062 |
|
Gross profit |
|
|
|
|
22,073 |
|
|
|
|
|
27,657 |
|
Selling, general, and administrative expenses |
|
|
|
|
19,047 |
|
|
|
|
|
20,778 |
|
Income from operations |
|
|
|
|
3,027 |
|
|
|
|
|
6,879 |
|
Interest expense |
|
|
|
|
(155 |
) |
|
|
|
|
(396 |
) |
Interest income |
|
|
|
|
129 |
|
|
|
|
|
– |
|
Net interest expense |
|
|
|
|
(26 |
) |
|
|
|
|
(396 |
) |
Other (expense) income |
|
|
|
|
452 |
|
|
|
|
|
193 |
|
Total other income (expense) net |
|
|
|
|
426 |
|
|
|
|
|
(203 |
) |
Pre-tax income |
|
|
|
|
3,453 |
|
|
|
|
|
6,676 |
|
Income tax expense |
|
|
|
|
611 |
|
|
|
|
|
2,209 |
|
Net income |
|
|
|
$ |
2,842 |
|
|
|
|
$ |
4,467 |
|
|
|
|
|
|
|
|
|
|
|
|
Shares outstanding – Basic |
|
|
|
|
3,289 |
|
|
|
|
|
3,486 |
|
Shares outstanding – Diluted |
|
|
|
|
3,353 |
|
|
|
|
|
3,612 |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share basic |
|
|
|
$ |
0.86 |
|
|
|
|
$ |
1.28 |
|
Earnings per share diluted |
|
|
|
|
0.85 |
|
|
|
|
|
1.24 |
|
|
ACME UNITED CORPORATION |
CONDENSED CONSOLIDATED BALANCE SHEETS |
YEAR END REPORT 2009 |
(Unaudited) |
|
Amounts in $000’s |
|
|
|
|
|
|
December 31, 2009 |
|
|
|
|
December 31, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
|
|
|
|
$ |
6,519 |
|
|
|
$ |
5,225 |
Accounts receivable, net |
|
|
|
|
|
|
10,703 |
|
|
|
|
10,564 |
Inventories |
|
|
|
|
|
|
17,400 |
|
|
|
|
21,769 |
Prepaid and other current assets |
|
|
|
|
|
|
1,133 |
|
|
|
|
1,088 |
Total current assets |
|
|
|
|
|
|
35,755 |
|
|
|
|
38,646 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
|
2,088 |
|
|
|
|
2,269 |
Long term receivable |
|
|
|
|
|
|
1,892 |
|
|
|
|
2,000 |
Other assets |
|
|
|
|
|
|
2,574 |
|
|
|
|
2,509 |
Total assets |
|
|
|
|
|
$ |
42,309 |
|
|
|
$ |
45,424 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and stockholders’ equity: |
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
|
|
|
$ |
3,546 |
|
|
|
$ |
3,669 |
Other current liabilities |
|
|
|
|
|
|
3,257 |
|
|
|
|
5,157 |
Total current liabilities |
|
|
|
|
|
|
6,803 |
|
|
|
|
8,826 |
Non-current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Long term debt |
|
|
|
|
|
|
9,154 |
|
|
|
|
11,750 |
Other non current liabilities |
|
|
|
|
|
|
1,811 |
|
|
|
|
1,960 |
Total liabilities |
|
|
|
|
|
|
17,768 |
|
|
|
|
22,536 |
Total stockholders’ equity |
|
|
|
|
|
|
24,541 |
|
|
|
|
22,888 |
Total liabilities and stockholders’ equity |
|
|
|
|
|
$ |
42,309 |
|
|
|
$ |
45,424 |
Feb. 26, 2010 (Business Wire) — DTS, Inc. (Nasdaq:DTSI) today announced significant news in the Digital TV space by entering into a partnership with Samsung Electronics Co., Ltd to integrate DTS audio decoding (or DTS Digital Surround) technology into virtually all Samsung digital televisions worldwide. This global partnership teams the global market leader in televisions with the leading audio technology provider for HD entertainment. Most importantly, it will further enhance the consumer entertainment experience by matching DTS best-in-class audio technology with Samsung’s industry-leading HDTV products.
“DTS is thrilled to partner with an industry leader such as Samsung as we continue our efforts to bring the finest audio experience possible to consumers,” said Brian Towne, Executive Vice President and General Manager, DTS, Inc. “Further, we remain focused on the future as we continue our expansion into new segments of home and portable entertainment.”
The integration of DTS technology in Samsung digital televisions is the latest milestone in the growth of DTS, a company that is quickly becoming a household name in the home entertainment arena. Recognition of DTS’ expansion is evident by the growing popularity of its DTS-HD Master Audio technology in the Blu-ray disc format and its emergence into the PC space with DTS Premium Suite, a new and compelling, high performance technology offering.
About DTS
DTS, Inc. (NASDAQ: DTSI) is a digital technology company dedicated to delivering the ultimate entertainment experience. DTS branded decoders are in virtually every major brand of multi-channel surround sound processors, and there are hundreds of millions of DTS-licensed consumer electronics products available worldwide. A pioneer in multi-channel audio, DTS technology is in home theatre, car audio, PC and game console products, as well as DVD-Video, Blu-ray Disc and surround music software. Founded in 1993, DTS’ corporate headquarters are located in Calabasas, California with its licensing operations headquartered in Limerick, Ireland. DTS also has offices in Northern California, Washington, Canada, China, France, Hong Kong, Japan, South Korea, Taiwan and the United Kingdom. For further information, please visit www.dts.com. DTS and the DTS Symbol are registered trademarks of DTS, Inc. DTS Neural Surround is a trademark of DTS, Inc. All other trademarks are the properties of their respective owners.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause DTS’ results to differ materially from historical results or those expressed or implied by such forward-looking statements. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements containing the words “planned,” “expects,” “believes,” “strategy,” “opportunity,” “anticipates” and similar words. These statements may include, among others, plans, strategies and objectives of management for future operations; any statements regarding proposed new products, services or developments; any statements regarding future economic conditions or financial or operating performance; statements of belief and any statements of assumptions underlying any of the foregoing. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to, the transition to the next generation optical drives and consumer adoption of such technology, the rapidly changing and competitive nature of the digital audio, consumer electronics and entertainment markets, the Company’s inclusion in or exclusion from governmental and industry standards, continued customer acceptance of the Company’s technology, products, services and pricing, risks related to ownership and enforcement of intellectual property, the continued release and availability of entertainment content containing DTS audio soundtracks, success of the Company’s research and development efforts, risks related to integrating acquisitions, greater than expected costs, the departure of key employees, the current financial crisis and global economic downturn, a loss of one or more of the Company’s key customers or licensees, changes in domestic and international market and political conditions, and other risks and uncertainties more fully described in DTS’ public filings with the Securities and Exchange Commission, available at www.sec.gov. DTS does not intend to update any forward-looking statement contained in this press release to reflect events or circumstances arising after the date hereof.
Feb. 25, 2010 (Business Wire) — Orckit Communications Ltd. (NASDAQ:ORCT), the leading Carrier Ethernet + Transport (CE+T) networking vendor, today announced that Mr. VK Aggarwal has joined the company as Managing Director India. Bringing more than 35 years of sales, business development, marketing and R&D expertise in the telecommunication market, Mr. Aggarwal will be leading the Indian headquarter, based in Gurgaon.
“VK Aggarwal joins Orckit-Corrigent from one of the world’s largest telecommunication vendors, Nokia Siemens Networks, where he served as Account Director for public operators and defense. Prior to this, he served as Executive Vice President, Siemens Communications for public & private operators and defense. His decision to join Orckit-Corrigent is evidence to our success and potential as a company,” said Mr. Oren Tepper, Vice President, corporate sales. “We recently announced the selection of our solutions by a Tier-1 service provider in India, and with the newly extended team we are looking forward to taking an active role in building the next generation transport for India’s networking infrastructure.”
The telecommunication market in India continues to present exceptional growth. For example, analyst firm OVUM has predicted 135 million new mobile connections in India in 2010. Cost optimized solutions are mandatory for building networks on a very large scale, and Orckit-Corrigent was able to introduce a Carrier Ethernet platform that is both scalable and cost efficient.
“Orckit-Corrigent has an excellent track record with innovative technologies. I look forward to joining the company’s talented team and fulfilling our potential in this growing market,” said Mr. VK Aggarwal, Managing Director, India at Orckit-Corrigent. “The company has already gained a significant footprint by building the next generation triple play network that is based on GPON technologies, and upcoming phases of the deployment will rely on Carrier Ethernet + Transport solutions.”
Orckit-Corrigent has also brought on additional employees to its headquarters in Gurgaon, India, to better serve the existing customers and develop new business opportunities.
About Orckit Communications Ltd.
Orckit facilitates telecommunication providers’ delivery of high capacity broadband residential, business and mobile services over wireline or wireless networks with its Orckit-Corrigent family of products. With 20 years of field experience with Tier-1 customers located around the world and sound leadership, Orckit has a firm foothold in the ever-developing world of telecommunication.
Orckit-Corrigent’s product lines include Carrier Ethernet + Transport (CE+T) switches – an MPLS based portfolio enabling advanced packet as well as legacy services over packet networks with a wide set of transport features, and Personalized Video Distribution systems – an advanced video distribution portfolio, optimized for IPTV, enabling multiple HD streams per home. Orckit-Corrigent markets its products directly and indirectly through strategic alliances as well as distribution and reseller partners worldwide.
Orckit was founded in 1990 and went public 1996. Orckit is dually listed on NasdaqGM (ORCT) and the Tel Aviv Stock Exchange and is headquartered in Tel-Aviv, Israel.
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s history of losses, dependence on a limited number of customers, risks in product development plans and schedules, rapid technological change, changes and delays in product approval and introduction, customer acceptance of new products, the impact of competitive products and pricing, market acceptance, the lengthy sales cycle, exchange rate fluctuations, fluctuation in order size, proprietary rights of the Company and its competitors, need for additional financing, the ability to repay the convertible notes, risk of operations in Israel, government regulation, dependence on third parties to manufacture products, the effect of current global economic conditions, as well as turmoil in the financial and credit markets, and other risk factors detailed in the Company’s United States Securities and Exchange Commission filings. Actual results may materially differ. Orckit assumes no obligation to update the information in this release.
Feb. 25, 2010 (Business Wire) — Deckers Outdoor Corporation (NASDAQGS: DECK) today announced record financial results for both the fourth quarter and fiscal year ended December 31, 2009.
Fourth Quarter Highlights
- Net sales increased 14.7% to $348.0 million versus $303.5 million for the same period last year
- Diluted EPS increased 28.9% to $5.22 versus non-GAAP diluted EPS of $4.05 a year ago, which excluded a pre-tax non-cash impairment of $20.9 million on intangible assets, or $0.98 per diluted share
- Gross margin increased 450 basis points to a record 49.8% compared to 45.3% for the same period last year
- UGG® brand sales increased 15.7% to $333.3 million compared to $288.0 million for the same period last year
- International sales increased 96.0% to $39.3 million compared to $20.1 million for the same period last year
- Retail sales increased 88.7% to $46.6 million versus $24.7 million for the same period last year
- eCommerce sales increased 27.0% to $45.9 million compared to $36. 1 million for the same period last year
Fiscal 2009 Highlights
- Net sales increased 17.9% to $813.2 million versus $689.4 million last year
- Diluted EPS was $8.89 on a GAAP basis, or $8.94 excluding a pre-tax non-cash impairment of $1.0 million on intangible assets in the second quarter of 2009. The non-GAAP diluted EPS of $8.94 represents an increase of 23.0% versus non-GAAP diluted EPS of $7.27 a year ago, which excluded a pre-tax non-cash impairment of $35.8 million on intangible assets, or $1.67 per diluted share
- UGG® brand sales increased 22.3% to $711.8 million compared to $582.0 million last year
- Domestic sales increased 11.1% to $646.0 million compared to $581.5 million last year
- International sales increased 54.9% to $167.2 million compared to $107.9 million last year
- Retail sales increased 105.3% to $79.0 million versus $38.5 million last year
- Cash and cash equivalents and short-term investments increased 75.6% to $342.0 million versus $194.8 million a year ago
Angel Martinez, President, Chief Executive Officer and Chairman of the Board of Directors, stated: “We are extremely pleased with our fourth quarter results and strong finish for the year. During the holiday season, we experienced robust demand for the entire UGG brand product line, with the performance of several new styles far exceeding expectations. Sell-through was particularly strong at our company-owned retail stores and on our eCommerce websites, which helped us increase earnings substantially during the fourth quarter. Our ability to successfully develop new and compelling footwear, penetrate additional categories, profitably grow our consumer direct division, and expand internationally is driving our current performance, while at the same time creating new growth opportunities for the future. 2009 was not without its challenges. The difficult retail environment negatively impacted our other brands as the majority of our accounts carried much less inventory and bought closer to season compared to prior years. That said, the Teva brand experienced better sell-through on the strength of new product introductions and was able to gain market share in a challenging year. In addition, improved inventory management led to lower closeout sales and increased margins. The Simple brand also performed well at retail, especially with major accounts like Nordstrom and Journeys. We are excited about several new product introductions for 2010 and believe a renewed emphasis on balancing style and sustainability will broaden our consumer base and enhance the brand’s market position.”
International Direct Distribution
On January 1, 2010, the Company commenced selling directly to wholesale customers for the Teva brand in the Benelux region and France. The Company also has announced that, in January 2011, following the expiration of existing distribution agreements, the Company will assume control of distributing the UGG, Teva and Simple brands in the United Kingdom and the UGG and Simple brands in the Benelux region and France. As part of the transition, the Company plans to incur incremental expenses in 2010 and will experience a shift in sales from 2010 to 2011. The net impact of this transition in 2010 on pre-tax earnings is estimated to be approximately $8.0 million, of which approximately 65% is a one-time impact. Most of the incremental sales and gross margin benefits resulting from this additional spend will not be realized until 2011. By selling directly to the retailers in the United Kingdom, Benelux and France, the Company expects to capture the additional sales and gross margin previously provided to its distributors.
Mr. Martinez commented, “The international markets represent a significant growth opportunity, and we are excited about the incremental sales and earnings potential by selling directly to our wholesale customers. Starting in 2011, we believe that the incremental sales and gross margin benefits from selling directly to our wholesale customers will more than offset the infrastructure investments in 2010 and drive higher earnings in the future. Furthermore, with control over sales and marketing, we look forward to building on the current momentum and expanding market share for each of the brands in their respective categories.”
Division Summary
UGG® Brand
UGG brand net sales for the fourth quarter increased 15.7% to a record $333.3 million compared to $288.0 million for the same period last year. The sales gain was primarily attributable to an increase in full price selling at company-owned retail stores and on the Company’s eCommerce websites coupled with higher shipments to international distributors versus the same period a year ago. For the full year, UGG brand sales increased 22.3% to a record $711.8 million versus $582.0 million in 2008.
Teva® Brand
Teva brand net sales decreased 14.8% to $10.5 million for the fourth quarter compared to $12.4 million for the same period last year. The decline in sales was primarily the result of lower closeout sales compared with the same period last year. For the full year, Teva brand sales decreased 10.2% to $77.7 million compared to $86.5 million in 2008.
Simple® Brand
Simple brand net sales for the fourth quarter increased 17.9% to $2.7 million compared to $2.3 million for the same period last year, primarily due to an increase in weighted-average selling prices. For the full year, Simple brand sales decreased 17.7% to $14.1 million versus $17.2 million in 2008.
Other Brands
Combined net sales of the Company’s other brands were $1.5 million and $9.6 million for the fourth quarter and full year, respectively.
eCommerce
Sales for the eCommerce business, which are included in the brand sales numbers above, increased 27.0% to $45.9 million for the fourth quarter compared to $36.1 million for the same period a year ago. The increase in sales resulted from higher demand for the fall line of the UGG brand, increased spend in advertising, and a favorable inventory position compared to the same period last year. For the full year, sales for the eCommerce business increased 10.0% to $75.7 million versus $68.8 million in 2008.
Retail Stores
Sales for the retail store business, which are included in the brand sales numbers above, increased 88.7% to $46.6 million for the fourth quarter compared to $24.7 million for the same period a year ago, driven by 5 new stores and a same store sales increase of 29.7%. For the full year, sales for the retail store business increased 105.3% to $79.0 million versus $38.5 million in 2008. For those stores that were open during the full year of 2008 and 2009, same store sales grew by 27.6%.
Balance Sheet
At December 31, 2009, cash and cash equivalents and short-term investments increased 75.6% to $342.0 million compared to $194.8 million at December 31, 2008. Inventories at December 31, 2009 decreased 8.0% to $85.4 million from $92.7 million at December 31, 2008.
Full-Year 2010 Outlook
- Based upon current visibility, the Company introduced a full year revenue growth target of approximately 11% over 2009.
- The Company expects full year diluted earnings per share to increase approximately 5% over the non-GAAP diluted EPS of $8.94 in 2009. This guidance assumes a gross profit margin of approximately 47% and SG&A as a percentage of sales of approximately 25%.
- Fiscal 2010 guidance includes estimates of incremental expenses in 2010 associated with the transition to wholesale sales for the Teva brand in the Benelux region and France and estimates of incremental expenses and a shift in sales from 2010 to 2011 associated with the upcoming transitions in January 2011 to wholesale sales in the United Kingdom, Benelux region and France of approximately $8.0 million, or approximately $0.38 per diluted share. Fiscal 2010 guidance also assumes an effective tax rate of approximately 37% compared to 36.2% in 2009 due to the impact on international income from the aforementioned incremental expenses and shift in profit.
First Quarter Outlook
- The Company currently expects first quarter 2010 revenue to increase approximately 7% over 2009, and expects first quarter 2010 diluted earnings per share to be down approximately 6% compared to 2009.
- First quarter guidance includes estimates of $2.0 million for incremental investments associated with the distribution transitions, which results in reducing diluted EPS by approximately $0.10. First quarter guidance also includes improved gross margins compared to 2009 due to a higher retail mix and improved brand margins. In addition, first quarter guidance includes higher levels of fixed overhead for new retail stores, international infrastructure and other general and administrative costs.
The Company’s conference call to review fourth quarter and fiscal 2009 results will be broadcast live over the internet today, Thursday, February 25, 2010 at 4:30 pm Eastern Time. The broadcast will be hosted at www.deckers.com and www.earnings.com.
Deckers Outdoor Corporation strives to be a premier lifestyle marketer that builds niche brands into global market leaders by designing and marketing innovative, functional and fashion-oriented footwear developed for both high performance outdoor activities and everyday casual lifestyle use. Teva®, Simple® Shoes, UGG® Australia, TSUBO®, and Ahnu® are registered trademarks of Deckers Outdoor Corporation.
This news release contains statements regarding our expectations, beliefs and views about our future financial performance which are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by the use of words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “project,” or future or conditional verbs such as “will,” “would,” “should,” “could,” or “may” or by the fact that such statements relate to future, and not just historical, events or circumstances, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for the Company’s markets and the demand for its products. The forward-looking statements in this news release regarding our future financial performance are based on currently available information as of the date of this release, and because our business is subject to a number of risks and uncertainties, some of which may be beyond our control, actual operating results in the future may differ materially from the future financial performance expected at the current time. Those risks and uncertainties include, among others: the continued decline of the global economy; our ability to anticipate fashion trends; consumer demand or inventory needs; whether the UGG brand will continue to grow at the same rate it has experienced in the past; impairment charges related to our brands’ intangible assets if our product sales or operating performance decline to a point that the fair value of our brands’ intangible assets do not exceed their carrying values; shortages or price fluctuations of raw materials that could interrupt product manufacturing and increase product costs; increased costs of manufacturing in China and actions by the Chinese government; currency fluctuations; our ability to implement our growth strategy; the success of our customers, their ability to perform and obtain credit in an adverse economic environment and the risk of losing one or more of our key customers; our ability to develop and protect our brands and intellectual property; the risk that counterfeiting can harm our sales or our brand image; our dependence on independent manufacturers to supply our products; the risk that retailers could postpone or cancel existing orders; unpredictable events and circumstances and currency risks related to our international operations; a downturn in key market economies; volatile credit markets; liquidity and market risks for our cash equivalents and short-term investments; the risk of losing key personnel; a delay or interruption in the delivery of merchandise to our customers; and the sensitivity of our sales to seasonal and weather conditions. Certain of these risks and uncertainties, as well as others, are more fully described under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, which the Company filed with the Securities and Exchange Commission on March 2, 2009, and under “Risk Factors” in any subsequent filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements contained in this news release, which speak only as of the date of this release. The Company undertakes no obligation to publicly release or update the results of any revisions to forward-looking statements, which may be made to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The risks and uncertainties highlighted herein should not be assumed to be the only items that could affect the future performance or valuation of the Company.
(Tables to follow)
|
DECKERS OUTDOOR CORPORATION |
AND SUBSIDIARIES |
Condensed Consolidated Balance Sheets |
(Unaudited) |
(Amounts in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
December 31, |
Assets |
|
|
|
2009 |
|
2008 |
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
315,862 |
|
176,804 |
Restricted cash |
|
|
|
300 |
|
300 |
Short-term investments |
|
|
|
26,120 |
|
17,976 |
Trade accounts receivable, net |
|
|
|
76,427 |
|
108,129 |
Inventories |
|
|
|
85,356 |
|
92,740 |
Prepaid expenses and other current assets |
|
|
|
7,210 |
|
3,691 |
Deferred tax assets |
|
|
|
9,712 |
|
13,324 |
Total current assets |
|
|
|
520,987 |
|
412,964 |
|
|
|
|
|
|
|
Restricted cash |
|
|
|
400 |
|
700 |
Property and equipment, at cost, net |
|
|
|
35,442 |
|
28,318 |
Intangible assets, net |
|
|
|
23,940 |
|
24,034 |
Deferred tax assets |
|
|
|
16,704 |
|
17,447 |
Other assets |
|
|
|
1,570 |
|
258 |
|
|
|
|
|
|
|
Total assets |
|
$ |
|
599,043 |
|
483,721 |
|
|
|
|
|
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Trade accounts payable |
|
$ |
|
47,331 |
|
42,960 |
Accrued expenses |
|
|
|
33,854 |
|
27,672 |
Income taxes payable |
|
|
|
19,685 |
|
24,577 |
Total current liabilities |
|
|
|
100,870 |
|
95,209 |
|
|
|
|
|
|
|
Long-term liabilities |
|
|
|
6,269 |
|
3,847 |
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
Deckers Outdoor Corporation stockholders’ equity: |
|
|
|
|
|
|
Common stock |
|
|
|
129 |
|
131 |
Additional paid-in capital |
|
|
|
125,431 |
|
115,214 |
Retained earnings |
|
|
|
365,304 |
|
268,515 |
Accumulated other comprehensive income |
|
|
|
494 |
|
392 |
Total Deckers Outdoor Corporation stockholders’ equity |
|
|
|
491,358 |
|
384,252 |
Noncontrolling interest |
|
|
|
546 |
|
413 |
Total equity |
|
|
|
491,904 |
|
384,665 |
|
|
|
|
|
|
|
Total liabilities and equity |
|
$ |
|
599,043 |
|
483,721 |
|
|
DECKERS OUTDOOR CORPORATION |
AND SUBSIDIARIES |
Condensed Consolidated Statements of Income |
(Unaudited) |
(Amounts in thousands, except for per share data) |
|
|
|
|
Three-month period ended |
|
Twelve-month period ended |
|
|
|
December 31, |
|
December 31, |
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
347,989 |
|
|
303,506 |
|
|
813,177 |
|
|
689,445 |
|
Cost of sales |
|
|
174,548 |
|
|
166,016 |
|
|
442,087 |
|
|
384,127 |
|
Gross profit |
|
|
173,441 |
|
|
137,490 |
|
|
371,090 |
|
|
305,318 |
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
67,825 |
|
|
52,843 |
|
|
188,843 |
|
|
152,574 |
|
Impairment loss |
|
|
— |
|
|
20,925 |
|
|
1,000 |
|
|
35,825 |
|
Income from operations |
|
|
105,616 |
|
|
63,722 |
|
|
181,247 |
|
|
116,919 |
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense, net: |
|
|
|
|
|
|
|
|
|
Interest income |
|
|
(37 |
) |
|
(683 |
) |
|
(1,010 |
) |
|
(3,190 |
) |
Interest expense |
|
|
40 |
|
|
(227 |
) |
|
(875 |
) |
|
(142 |
) |
Other, net |
|
|
(37 |
) |
|
(14 |
) |
|
(91 |
) |
|
(251 |
) |
Income before income taxes |
|
|
105,650 |
|
|
64,646 |
|
|
183,223 |
|
|
120,502 |
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
37,602 |
|
|
24,306 |
|
|
66,304 |
|
|
46,631 |
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
68,048 |
|
|
40,340 |
|
|
116,919 |
|
|
73,871 |
|
Less: Net (income) loss attributable to the noncontrolling interest |
|
|
(306 |
) |
|
120 |
|
|
(133 |
) |
|
77 |
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Deckers Outdoor Corporation |
|
$ |
67,742 |
|
|
40,460 |
|
|
116,786 |
|
|
73,948 |
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Deckers Outdoor Corporation common stockholders per share: |
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
5.27 |
|
|
3.10 |
|
|
8.98 |
|
|
5.67 |
|
Diluted |
|
$ |
5.22 |
|
|
3.07 |
|
|
8.89 |
|
|
5.60 |
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares: |
|
|
|
|
|
|
|
|
|
Basic |
|
|
12,851 |
|
|
13,072 |
|
|
13,008 |
|
|
13,042 |
|
Diluted |
|
|
12,987 |
|
|
13,198 |
|
|
13,131 |
|
|
13,195 |
|
|
|
DECKERS OUTDOOR CORPORATION |
AND SUBSIDIARIES |
Reconciliation of Non-GAAP Measures |
(Unaudited) |
(Amounts in thousands, except for per share data) |
|
|
|
|
Three-month period |
|
Twelve-month period |
|
|
|
ended December 31, |
|
ended December 31, |
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
105,650 |
|
|
64,646 |
|
183,223 |
|
|
120,502 |
Add back impairment charges |
|
|
—- |
|
|
20,925 |
|
1,000 |
|
|
35,825 |
|
|
|
|
|
|
|
|
|
|
Income before income taxes, excluding impairment charges |
|
|
105,650 |
|
|
85,571 |
|
184,223 |
|
|
156,327 |
|
|
|
|
|
|
|
|
|
|
Income tax expense (1) |
|
|
37,602 |
|
|
32,214 |
|
66,666 |
|
|
60,494 |
|
|
|
|
|
|
|
|
|
|
Net income excluding impairment charges |
|
|
68,048 |
|
|
53,357 |
|
117,557 |
|
|
95,833 |
|
|
|
|
|
|
|
|
|
|
Less: Net (income) loss attributable to the noncontrolling interest |
|
|
(306 |
) |
|
120 |
|
(133 |
) |
|
77 |
|
|
|
|
|
|
|
|
|
|
Net income excluding impairment charges attributable to Deckers Outdoor Corporation |
|
$ |
67,742 |
|
|
53,477 |
|
117,424 |
|
|
95,910 |
|
|
|
|
|
|
|
|
|
|
Net income excluding impairment charges attributable to Deckers Outdoor Corporation common stockholders per share: |
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
5.27 |
|
|
4.09 |
|
9.03 |
|
|
7.35 |
Diluted |
|
$ |
5.22 |
|
|
4.05 |
|
8.94 |
|
|
7.27 |
|
|
|
|
|
|
|
|
|
|
Weighted-average shares: |
|
|
|
|
|
|
|
|
|
Basic |
|
|
12,851 |
|
|
13,072 |
|
13,008 |
|
|
13,042 |
Diluted |
|
|
12,987 |
|
|
13,198 |
|
13,131 |
|
|
13,195 |
Feb. 25, 2010 (Business Wire) — Republic Airways Holdings Inc. (NASDAQ: RJET) announced today it has signed a purchase agreement for 40 CS300 jets, part of the next-generation CSeries aircraft being developed by Bombardier. Republic also has options for up to an additional 40 aircraft. The aircraft, which will be configured in a single-cabin, with two-by-three seating for 138 passengers, including 25 STRETCH seats, is scheduled for delivery beginning in the second quarter of 2015.
The aircraft are powered by Pratt & Whitney PW1000G engines. Republic has signed an exclusive 15-year PureSolution maintenance contract with Pratt & Whitney for the support of the engines.
“Republic is pleased to be the North American launch customer for the CSeries aircraft,” said Bryan Bedford, chairman, president and CEO of Republic Airways. “This aircraft will bring next-generation advantages to all phases of its mission, including passenger comfort, dependability, efficiency and economics.”
“The CS300 will help us dramatically reduce our fuel consumption and impact on the environment. Our customers will also appreciate the generous amount of personal space with wider aisles, increased shoulder room, improved storage bins and extra-large windows,” Bedford added.
“The CSeries aircraft program is a significant part of Bombardier’s future, and we’re delighted that Republic Airways will be part of it,” said Gary R. Scott, President, Bombardier Commercial Aircraft. “This major CSeries order from our first North American customer reflects the confidence Republic Airways has in Bombardier’s ability to deliver a game-changing aircraft and to service the airline’s requirements.”
Republic Airways Holdings, based in Indianapolis, Indiana is an airline holding company that owns Chautauqua Airlines, Frontier Airlines, Lynx Aviation, Midwest Airlines, Republic Airlines and Shuttle America, collectively “the airlines.” The airlines offer scheduled passenger service on approximately 1,600 flights daily to 118 cities in 44 states, Canada, Costa Rica, and Mexico under branded operations at Frontier, Midwest, and through fixed-fee airline services agreements with five major U.S. airlines. The fixed-fee flights are operated under an airline partner brand, such as AmericanConnection, Continental Express, Delta Connection, United Express, and US Airways Express. The airlines currently employ approximately 11,000 aviation professionals and operate 283 aircraft.
Additional Information
In addition to historical information, this release contains forward-looking statements. Republic Airways Holdings Inc. (the “Company”) may, from time-to-time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Republic Airways’ beliefs, expectations, hopes or intentions regarding future events. Words such as “expects,” “intends,” “believes,” “anticipates,” “may,” “will,” “should,” “plan,” “estimate,” “predict,” “potential,” “continue,” or “likely” and similar expressions as well as the negative of such expressions are used to identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to Republic Airways as of such date. Republic Airways assumes no obligation to update any forward-looking statement. Actual results may vary, and could differ materially, from those anticipated, estimated, projected or expected in these forward-looking statements for a number of many reasons, including, among others, the risk factors disclosed in the Company’s most recent filing with the Securities and Exchange Commission.
Feb. 25, 2010 (Business Wire) — CDC Software Corporation (NASDAQ: CDCS), a global provider of enterprise software applications and services, today announced that, based on preliminary financial projections and estimates, the company expects 2010 non-GAAP earnings per share(a) to be in the range of $1.50 to 1.55, an increase of 15-18 percent from $1.31 reported for 2009; and revenue for 2010 to be in the range of $220 million to $228 million an increase of 8-12 percent from $203.9 million reported in 2009.
“We are pleased that, according to our preliminary estimates, we forecast double digit improvement in our non-GAAP earnings per share,” said Peter Yip, CEO of CDC Software. “We believe we have strong momentum going into 2010 after reporting an excellent fourth quarter. For the fourth quarter of 2009, Adjusted EBITDA(a) nearly doubled to $14.8 million, from $7.8 million in the fourth quarter of 2008 and non-GAAP earnings per share nearly quadrupled to $0.40 compared to $0.11 in the fourth quarter of 2008. We also reported record operating cash flow of $53 million for the full year 2009.
“Even if the slow economic recovery continues throughout 2010, we are cautiously optimistic that we are well positioned, with improved operating metrics and net cash on hand, for organic growth through cross-sell opportunities and expansion in emerging markets such as China and India.”
About CDC Software
CDC Software (NASDAQ: CDCS), The Customer-Driven Company™, is a provider of enterprise software applications and a full range of services designed to help organizations deliver a superior customer experience, while increasing efficiencies and profitability. Leveraging a service-oriented architecture (SOA), CDC Software offers multiple delivery options for their solutions including on-premise, hosted, cloud-based Software as a Service (SaaS) or blended-hybrid deployment offerings. CDC Software’s solutions include enterprise requirements planning (ERP), manufacturing operations management, enterprise manufacturing intelligence, supply chain management (demand management, order management and warehouse and transportation management), e-Commerce, human capital management, customer relationship management (CRM), complaint management and aged care solutions.
CDC Software’s recent acquisitions are part of its “acquire, integrate, innovate and grow” strategy. Fueling the success of this strategy is the company’s global scalable business and technology infrastructure featuring multiple complementary applications and services, domain expertise in vertical markets, cost effective product engineering centers in India and China, a highly collaborative and fast product development process utilizing Agile methodologies, and a worldwide network of direct sales and channel operations. This strategy has helped CDC Software deliver innovative and industry-specific solutions to more than 6,000 customers worldwide within the manufacturing, distribution, transportation, retail, government, real estate, financial services, health care, and not-for-profit industries. For more information, please visit www.cdcsoftware.com.
About CDC Corporation
The CDC family of companies includes CDC Software (NASDAQ: CDCS) focused on enterprise software applications and services, CDC Global Services focused on IT consulting services, and outsourced R&D and application development, CDC Games focused on online games, and China.com, Inc. (HKGEM:8006) focused on portals for the greater China markets. For more information about CDC Corporation (NASDAQ: CHINA), please visit www.cdccorporation.net.
(a) Adjusted Financial Measures
This press release includes Adjusted EBITDA and non-GAAP earnings per share, which are not prepared in accordance with GAAP (“Non-GAAP Financial Measures”). Non-GAAP Financial Measures are not alternatives for measures such as net income, earnings per share and cash and cash equivalents prepared under generally accepted accounting principles in the United States (“GAAP”). These Non-GAAP Financial measures may also be different from non-GAAP measures used by other companies. Non-GAAP Financial Measures should not be used as a substitute for, or considered superior to, measures of financial performance prepared in accordance with GAAP.
Investors should be aware that these Non-GAAP Financial Measures have inherent limitations, including their variance from certain of the financial measurement principals underlying GAAP, should not be considered as a replacement for GAAP performance measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP. These supplemental Non-GAAP Financial Measures should not be construed as an inference that the Company’s future results will be unaffected by similar adjustments to net earnings determined in accordance with GAAP.
* Special Note Regarding CDC Software Financial Projections and Guidance
The financial estimates and guidance contained herein apply only to CDC Software Corporation, a subsidiary of CDC Corporation. These estimates and guidance amounts do not apply to, and are not indicative of, the expected consolidated financial performance of CDC Corporation, or the expected financial performance of CDC Games Corporation, China.com, Inc. or any of their respective subsidiaries. Investors are cautioned not to place reliance on the financial estimates and guidance set forth herein for purposes of any investment decision with respect to the shares of CDC Corporation, and should read the foregoing in conjunction with the reports and other materials filed with the United States Securities and Exchange Commission by CDC Corporation and CDC Software Corporation, from time to time.
Cautionary Note Regarding Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding our expectations for 2010 GAAP net income and non-GAAP earnings per share, our beliefs regarding momentum in our corporate performance, our beliefs regarding our sales pipeline and cross-selling opportunities, and other statements that are not historical fact, the achievement of which involve risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions proves incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make. These statements are based on management’s current expectations and are subject to risks and uncertainties and changes in circumstances. There are important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, including the following: (a) the ability to realize strategic objectives by taking advantage of market opportunities in targeted geographic markets; (b) the ability to make changes in business strategy, development plans and product offerings to respond to the needs of current, new and potential customers, suppliers and strategic partners; (c) the effects of restructurings and rationalization of operations; (d) the ability to address technological changes and developments including the development and enhancement of products; (e) the entry of new competitors and their technological advances; (f) the need to develop, integrate and deploy enterprise software applications to meet customer’s requirements; (g) the possibility of development or deployment difficulties or delays; (h) the dependence on customer satisfaction with the company’s software products and services; (i) continued commitment to the deployment of the enterprise software solutions; (j) risks involved in developing software solutions and integrating them with third-party software and services; (k) the continued ability of the company’s enterprise software solutions to address client-specific requirements; (l) demand for and market acceptance of new and existing enterprise software and services and the positioning of the company’s solutions; (m) the ability of staff to operate the enterprise software and extract and utilize information from the company’s enterprise software solutions; (n) the continued cooperation of our strategic and business partners; (o) risks relating to economic conditions and other matters beyond our control; and (p) the risk that the preliminary financial results provided herein could differ from our actual results. Further information on risks or other factors that could cause results to differ is detailed in our filings or submissions with the United States Securities and Exchange Commission, and those of our ultimate parent company, CDC Corporation, located at www.sec.gov. All forward-looking statements included in this press release are based upon information available to management as of the date of the press release, and you are cautioned not to place undue reliance on any forward looking statements which speak only as of the date of this press release. The company assumes no obligation to update or alter the forward looking statements whether as a result of new information, future events or otherwise. Historical results are not indicative of future performance.
Feb. 24, 2010 (Business Wire) — TowerJazz, the global specialty foundry leader, today announced financial results for the fourth quarter and fiscal year ended December 31, 2009.
Highlights
- Record revenue of $100.6 million in Q4 2009, growing 30 percent over last year and 26 percent sequentially
- Guiding for continued sequential growth into Q1 2010, expecting $110-115 million in revenues, 94 percent growth as compared to Q1 2009
- Gross profit of $38.7 million in Q4 2009 with margins of 39 percent on a non-GAAP basis, as compared to $15.6 million and 20 percent in Q4 2008.
- Operating profit of $23.3 million in Q4 2009 with margins of 23 percent on a non-GAAP basis, as compared to $1.7 million and 2 percent in Q4 2008.
- Full year revenues at $298.8 million, up 19 percent over last year, significantly higher than the industry.
- Strong year-end cash-balance of $81.8 million, as compared to $34.9 million as of December 2008
2009 fourth quarter and full year results summary
Fourth quarter 2009 revenue was $100.6 million, representing a 26 percent increase over third quarter 2009 revenue of $79.6 million and 30 percent over fourth quarter 2008 revenue of $77.5 million. Full year 2009 revenues were $298.8 million, 19 percent higher than $251.7 million recorded in 2008.
On a non-GAAP basis, as described and reconciled below, the gross profit for the fourth quarter 2009 was $38.7 million, a sequential growth 50 percent, and representing 39 percent margins. Comparing to the fourth quarter of 2008, non-GAAP gross margin increased from 20 to 39 percent. Non-GAAP operating profit in the fourth quarter 2009 was $23.3 million, substantially higher than $1.7 million and $13.0 million achieved in the fourth quarter of 2008 and third quarter 2009, respectively.
Calculated in accordance with GAAP, TowerJazz achieved in the fourth quarter 2009 gross profit for the first time since 2000 of $6.6 million, as compared to gross loss of $5.3 million and gross loss of $10.8 million in the third quarter 2009 and fourth quarter 2008, respectively. Net loss for the fourth quarter 2009 was $31.4 million as compared to $30.2 million for the previous quarter, or $0.16 and $0.18 per share, respectively, including for the fourth quarter of 2009 GAAP financing expenses of $18.7 million, resulting mainly from non-cash GAAP financing expenses due to the significant increase in market and fair value of the Company’s tradable securities.
EBITDA for the fourth quarter of 2009 was $23 million, an all time record, and up substantially from $2 million reported in the fourth quarter of 2008 and $15 million in third quarter 2009.
Company’s cash balance, as of December 31, 2009 was $81.8 million, as compared to $34.9 million as of December 2008 and $51.7 million as of September 2009.
“2009 demonstrated an inflection year for the Company, in realizing our strategy of becoming the worldwide specialty foundry leader. All of our business units achieved substantial tactical and strategic customer wins. Breaking the significant milestone of $100 million in quarterly revenue with record EBITDA and record annual design wins while expecting continued 2010 growth, despite foundry seasonality, is evidence of our continued strong positive trajectory,” commented Russell Ellwanger, Chief Executive Officer. “We have on hand many substantive opportunities targeting beyond a $500 million annual revenue run-rate.”
Amir Elstein, Chairman of the Board, commented, “The activities in 2009 and the company’s performance, culminating in 19 percent year-over-year revenue increase against a double-digit downturn for the industry, is confirmation of the vast capabilities of the TowerJazz management and the entire team, and is indicative of a customer-centric company with well-defined strategy and goals. I remain confident and boldly optimistic with regard to the coming quarters. In addition, these accomplishments are a great tribute to our CEO who was recognized and appreciated by fellow industry experts, as the Israeli Hi-Tech CEO of the year, for the TowerJazz business breakthrough.”
Financial Guidance
TowerJazz forecasts revenue in the first quarter of 2010 to range between $110 and $115 million, representing a sequential revenue growth of 9-14 percent and 89-98 percent year-over-year growth in revenues.
Conference Call and Web Cast Announcement
TowerJazz will host a conference call to discuss fourth quarter 2009 results today, February 24, 2010, at 10:00 a.m. Eastern Time (EST) / 5:00 p.m. Israel time.
To participate, please call: 1-888-407-2553 (U.S. toll-free number) or +972-3-918-0609 (international) and mention ID code: TOWER-JAZZ
Callers in Israel are invited to call locally by dialing 03-918-0609. The conference call will also be Web cast live at www.earnings.com and at www.towerjazz.com and will be available thereafter on both Web sites for replay for a period 90 days, starting a few hours following the call.
As previously announced, beginning with the fourth quarter of 2007, the Company has been presenting its financial statements in accordance with U.S. GAAP.
As applied in this release, the term Earnings Before Interest Tax Depreciation and Amortization (EBITDA) consists of loss, according to U.S. GAAP, excluding interest and financing expenses (net), tax, depreciation and amortization and stock based compensation expenses. EBITDA is not a required GAAP financial measure and may not be comparable to a similarly titled measure employed by other companies. EBITDA should not be considered in isolation or as a substitute for operating income, net income or loss, cash flows provided by operating, investing and financing activities, or other income or cash flow statement data prepared in accordance with GAAP.
This release, including the financial tables below, presents other financial information that may be considered “non-GAAP financial measures” under Regulation G and related reporting requirements promulgated by the Securities and Exchange Commission as they apply to our company. These non-GAAP financial measures exclude (1) depreciation and amortization and (2) compensation expenses in respect of options granted to directors, officers and employees. Non-GAAP financial measures should be evaluated in conjunction with, and are not a substitute for, GAAP financial measures. The tables also present the GAAP financial measures, which are most comparable to the non-GAAP financial measures as well as reconciliation between the non-GAAP financial measures and the most comparable GAAP financial measures. The non-GAAP financial information presented herein should not be considered in isolation from or as a substitute for operating income, net income or loss, cash flows provided by operating, investing and financing activities, per share data or other income or cash flow statement data prepared in accordance with GAAP and is not necessarily consistent to the non-GAAP data presented in previous filings.
Following the merger with Jazz, the amounts presented in this release, including the financial tables below, include Jazz’s results commencing September 19, 2008. Amounts presented for periods preceding the merger with Jazz reflect Tower’s results only. The balance sheet as of December 31, 2009, September 30, 2009 and December 31, 2008 includes Jazz’s balances as of such dates.
About TowerJazz
Tower Semiconductor Ltd. (NASDAQ: TSEM) (TASE: TSEM), the global specialty foundry leader and its fully owned U.S. subsidiary Jazz Semiconductor, operate collectively under the brand name TowerJazz, manufacturing integrated circuits with geometries ranging from 1.0 to 0.13-micron. TowerJazz provides industry leading design enablement tools to allow complex designs to be achieved quickly and more accurately and offers a broad range of customizable process technologies including SiGe, BiCMOS, Mixed-Signal and RFCMOS, CMOS Image Sensor, Power Management (BCD), and Non-Volatile Memory (NVM) as well as MEMS capabilities. To provide world-class customer service, TowerJazz maintains two manufacturing facilities in Israel and one in the U.S. with additional capacity available in China through manufacturing partnerships. For more information, please visit www.towerjazz.com.
Forward Looking Statements
This press release includes forward-looking statements, which are subject to risks and uncertainties. Actual results may vary from those projected or implied by such forward-looking statements and you should not place any undue reliance on such forward-looking statements. Potential risks and uncertainties include, without limitation, risks and uncertainties associated with: (i) maintaining existing customers and attracting additional customers, (ii) cancellation of orders, (iii) failure to receive orders currently expected (iv) the cyclical nature of the semiconductor industry and the resulting periodic overcapacity, fluctuations in operating results and future average selling price erosion, (v) the large amount of debt and liabilities and having sufficient funds to satisfy our debt obligations and other liabilities on a timely basis, (vi) operating our facilities at high utilization rates which is critical in order to defray the high level of fixed costs associated with operating a foundry and reduce our losses, (vii) our ability to satisfy the covenants stipulated in our agreements with our lenders, banks and bond holders, (viii) our ability to capitalize on potential increases in demand for foundry services, (ix) having customer demand that will exceed our manufacturing capacity, (x) meeting the conditions to receive Israeli government grants and tax benefits approved for Fab2 and obtaining the approval of the Israeli Investment Center for an expansion program, (xi) our ability to accurately forecast financial performance, which is affected by limited order backlog and lengthy sales cycles, (xii) the purchase of equipment to increase capacity, the completion of the equipment installation, technology transfer and raising the funds therefor, (xiii) our dependence on a relatively small number of products for a significant portion of our revenue, (xiv) a substantial portion of our revenues being accounted for by a small number of customers, (xv) the concentration of our business in the semiconductor industry, (xvi) product returns, (xvii) our ability to maintain and develop our technology processes and services to keep pace with new technology, evolving standards, changing customer and end-user requirements, new product introductions and short product life cycles, (xviii) competing effectively, (xix) achieving acceptable device yields, product performance and delivery times, (xx) possible production or yield problems in our wafer fabrication facilities, (xxi) our ability to manufacture products on a timely basis, (xxii) our dependence on intellectual property rights of others, our ability to operate our business without infringing others’ intellectual property rights and our ability to enforce our intellectual property against infringement, (xxiii) pending resolution of patent infringement claim against the Company, (xxiv) retention of key employees and retention and recruitment of skilled qualified personnel, (xxv) exposure to inflation, currency exchange and interest rate fluctuations and risks associated with doing business internationally and in Israel, and (xxvi) business interruption due to fire, the security situation in Israel and other events beyond our control.
A more complete discussion of risks and uncertainties that may affect the accuracy of forward-looking statements included in this press release or which may otherwise affect our business is included under the heading “Risk Factors” in Tower’s most recent filings on Forms 20-F, F-3, F-4, S-8 and 6-K, as were filed with the Securities and Exchange Commission (the “SEC”) and the Israel Securities Authority and Jazz’s most recent filings on Forms 10-K and 10-Q, as were filed with the SEC. Future results may differ materially from those previously reported. The Company does not intend to update, and expressly disclaims any obligation to update, the information contained in this release.
|
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES |
CONSOLIDATED BALANCE SHEETS |
(dollars in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
|
September 30, |
|
|
|
|
December 31, |
|
|
|
|
|
|
|
2009 |
|
|
|
|
2009 |
|
|
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
unaudited |
|
|
|
|
|
A S S E T S |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
81,795 |
|
|
|
$ |
51,708 |
|
|
|
$ |
34,905 |
|
|
Trade accounts receivable |
|
|
40,604 |
|
|
|
|
42,121 |
|
|
|
|
45,860 |
|
|
Other receivables |
|
|
2,520 |
|
|
|
|
3,418 |
|
|
|
|
2,320 |
|
|
Inventories |
|
|
32,250 |
|
|
|
|
28,746 |
|
|
|
|
40,899 |
|
|
Other current assets |
|
|
11,184 |
|
|
|
|
7,519 |
|
|
|
|
7,657 |
|
|
|
Total current assets |
|
|
168,353 |
|
|
|
|
133,512 |
|
|
|
|
131,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM INVESTMENTS |
|
|
29,361 |
|
|
|
|
29,579 |
|
|
|
|
29,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROPERTY AND EQUIPMENT, NET |
|
|
371,400 |
|
|
|
|
388,234 |
|
|
|
|
449,697 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTANGIBLE ASSETS, NET |
|
|
67,601 |
|
|
|
|
70,983 |
|
|
|
|
81,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GOODWILL |
|
|
7,000 |
|
|
|
|
7,000 |
|
|
|
|
7,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER ASSETS, NET |
|
|
8,002 |
|
|
|
|
8,282 |
|
|
|
|
8,802 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
651,717 |
|
|
|
$ |
637,590 |
|
|
|
$ |
707,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of convertible debenture |
|
$ |
— |
|
|
|
$ |
— |
|
|
|
$ |
8,330 |
|
|
Short term bank loan |
|
|
7,000 |
|
|
|
|
4,440 |
|
|
|
|
7,000 |
|
|
Trade accounts payable |
|
|
42,012 |
|
|
|
|
39,180 |
|
|
|
|
49,462 |
|
|
Deferred revenue |
|
|
24,696 |
|
|
|
|
4,100 |
|
|
|
|
6,634 |
|
|
Other current liabilities |
|
|
23,652 |
|
|
|
|
32,228 |
|
|
|
|
35,202 |
|
|
|
|
Total current liabilities |
|
|
97,360 |
|
|
|
|
79,948 |
|
|
|
|
106,628 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM DEBT |
|
|
428,813 |
|
|
|
|
416,555 |
|
|
|
|
431,501 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM CUSTOMERS’ ADVANCES |
|
|
8,262 |
|
|
|
|
12,412 |
|
|
|
|
11,138 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER LONG-TERM LIABILITIES |
|
|
60,388 |
|
|
|
|
55,020 |
|
|
|
|
45,959 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
594,823 |
|
|
|
|
563,935 |
|
|
|
|
595,226 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS’ EQUITY |
|
|
56,894 |
|
|
|
|
73,655 |
|
|
|
|
112,447 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
$ |
651,717 |
|
|
|
$ |
637,590 |
|
|
|
$ |
707,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES |
RECONCILIATION OF REPORTED GAAP TO NON-GAAP CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
(dollars in thousands, except per share data) |
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Three months ended |
|
|
Three months ended |
|
|
|
|
|
December 31, |
|
|
December 31, |
|
|
December 31, |
|
|
December 31, |
|
|
December 31, |
|
|
December 31, |
|
|
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
|
|
non-GAAP |
|
|
Adjustments (see a, b, c below) |
|
|
GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REVENUES |
|
$ |
100,616 |
|
|
$ |
77,453 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
100,616 |
|
|
$ |
77,453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COST OF REVENUES |
|
|
61,868 |
|
|
|
61,894 |
|
|
|
32,194 |
|
(a) |
|
26,346 |
|
(a) |
|
94,062 |
|
|
|
88,240 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GROSS PROFIT (LOSS) |
|
|
38,748 |
|
|
|
15,559 |
|
|
|
(32,194 |
) |
|
|
(26,346 |
) |
|
|
6,554 |
|
|
|
(10,787 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING COSTS AND EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
6,694 |
|
|
|
4,625 |
|
|
|
317 |
|
(b) |
|
654 |
|
(b) |
|
7,011 |
|
|
|
5,279 |
|
|
Marketing, general and administrative |
|
|
8,711 |
|
|
|
9,186 |
|
|
|
1,319 |
|
(c) |
|
1,352 |
|
(c) |
|
10,030 |
|
|
|
10,538 |
|
|
Write-off of in-process research and development |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(500 |
) |
|
|
— |
|
|
|
(500 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,405 |
|
|
|
13,811 |
|
|
|
1,636 |
|
|
|
1,506 |
|
|
|
17,041 |
|
|
|
15,317 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING PROFIT (LOSS) |
|
$ |
23,343 |
|
|
$ |
1,748 |
|
|
$ |
(33,830 |
) |
|
$ |
(27,852 |
) |
|
$ |
(10,487 |
) |
|
$ |
(26,104 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC OPERATING PROFIT (LOSS) PER ORDINARY SHARE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit (loss) per share |
|
$ |
0.12 |
|
|
$ |
0.01 |
|
|
$ |
(0.17 |
) |
|
$ |
(0.17 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.16 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares outstanding – in thousands |
|
|
194,236 |
|
|
|
159,747 |
|
|
|
— |
|
|
|
— |
|
|
|
194,236 |
|
|
|
159,747 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-GAAP GROSS MARGINS |
|
|
39 |
% |
|
|
20 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-GAAP OPERATING MARGINS |
|
|
23 |
% |
|
|
2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Includes depreciation and amortization expenses in the amounts of $32,046 and $26,150 and stock based compensation expenses in the amounts of $148 and $196 for the three months ended December 31, 2009 and December 31, 2008, respectively. |
|
(b) |
Includes depreciation and amortization expenses in the amounts of $148 and $532 and stock based compensation expenses in the amounts of $169 and $122 for the three months ended December 31, 2009 and December 31, 2008, respectively. |
|
(c) |
Includes depreciation and amortization expenses in the amounts of $340 and $325 and stock based compensation expenses in the amounts of $979 and $1,027 for the three months ended December 31, 2009 and December 31, 2008, respectively. |
|
(d) |
2008 data are similar to those previously presented, prior to any adjustments following the inventory change method occurred in 2009. |
|
|
|
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES |
RECONCILIATION OF REPORTED GAAP TO NON-GAAP CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
(dollars in thousands, except per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Three months ended |
|
|
Three months ended |
|
|
|
|
|
December 31, |
|
|
September 30, |
|
|
December 31, |
|
|
September 30, |
|
|
December 31, |
|
|
September 30, |
|
|
|
|
|
2009 |
|
|
2009 |
|
|
2009 |
|
|
2009 |
|
|
2009 |
|
|
2009 |
|
|
|
|
|
non-GAAP |
|
|
Adjustments (see a, b, c below) |
|
|
GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REVENUES |
|
$ |
100,616 |
|
|
$ |
79,570 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
100,616 |
|
|
$ |
79,570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COST OF REVENUES |
|
|
61,868 |
|
|
|
53,710 |
|
|
|
32,194 |
|
(a) |
|
31,205 |
|
(a) |
|
94,062 |
|
|
|
84,915 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GROSS PROFIT (LOSS) |
|
|
38,748 |
|
|
|
25,860 |
|
|
|
(32,194 |
) |
|
|
(31,205 |
) |
|
|
6,554 |
|
|
|
(5,345 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING COSTS AND EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
6,694 |
|
|
|
5,769 |
|
|
|
317 |
|
(b) |
|
288 |
|
(b) |
|
7,011 |
|
|
|
6,057 |
|
|
Marketing, general and administrative |
|
|
8,711 |
|
|
|
7,060 |
|
|
|
1,319 |
|
(c) |
|
965 |
|
(c) |
|
10,030 |
|
|
|
8,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,405 |
|
|
|
12,829 |
|
|
|
1,636 |
|
|
|
1,253 |
|
|
|
17,041 |
|
|
|
14,082 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING PROFIT (LOSS) |
|
$ |
23,343 |
|
|
$ |
13,031 |
|
|
$ |
(33,830 |
) |
|
$ |
(32,458 |
) |
|
$ |
(10,487 |
) |
|
$ |
(19,427 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC OPERATING PROFIT (LOSS) PER ORDINARY SHARE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit (loss) per share |
|
$ |
0.12 |
|
|
$ |
0.08 |
|
|
$ |
(0.17 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares outstanding – in thousands |
|
|
194,236 |
|
|
|
167,200 |
|
|
|
— |
|
|
|
— |
|
|
|
194,236 |
|
|
|
167,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-GAAP GROSS MARGINS |
|
|
39 |
% |
|
|
32 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-GAAP OPERATING MARGINS |
|
|
23 |
% |
|
|
16 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Includes depreciation and amortization expenses in the amounts of $32,046 and $31,067 and stock based compensation expenses in the amounts of $148 and $138 for the three months ended December 31, 2009 and September 30, 2009, respectively. |
|
(b) |
Includes depreciation and amortization expenses in the amounts of $148 and $154 and stock based compensation expenses in the amounts of $169 and $134 for the three months ended December 31, 2009 and September 30, 2009, respectively. |
|
(c) |
Includes depreciation and amortization expenses in the amounts of $340 and $357 and stock based compensation expenses in the amounts of $979 and $608 for the three months ended December 31, 2009 and September 30, 2009, respectively. |
|
|
|
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES |
CONSOLIDATED STATEMENTS OF OPERATIONS |
(dollars in thousands, except per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Year ended |
|
|
|
|
|
December 31, |
|
|
December 31, |
|
|
|
|
|
2009 |
|
|
2009 |
|
|
|
|
|
GAAP |
|
|
GAAP |
|
|
|
|
|
(UNAUDITED) |
|
|
|
|
|
|
|
|
|
|
|
|
REVENUES |
|
$ |
100,616 |
|
|
$ |
298,812 |
|
|
|
|
|
|
|
|
|
|
COST OF REVENUES |
|
|
94,062 |
|
|
|
325,310 |
|
|
|
|
|
|
|
|
|
|
|
|
GROSS PROFIT (LOSS) |
|
|
6,554 |
|
|
|
(26,498 |
) |
|
|
|
|
|
|
|
|
|
OPERATING COSTS AND EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
7,011 |
|
|
|
23,375 |
|
|
Marketing, general and administrative |
|
|
10,030 |
|
|
|
31,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,041 |
|
|
|
55,318 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING LOSS |
|
|
(10,487 |
) |
|
|
(81,816 |
) |
|
|
|
|
|
|
|
|
|
FINANCING EXPENSE, NET |
|
|
(18,678 |
) |
|
|
(45,710 |
) |
|
|
|
|
|
|
|
|
|
OTHER INCOME (EXPENSE), NET |
|
|
(118 |
) |
|
|
2,045 |
|
|
|
|
|
|
|
|
|
|
|
|
LOSS BEFORE INCOME TAX |
|
|
(29,283 |
) |
|
|
(125,481 |
) |
|
|
|
|
|
|
|
|
|
INCOME TAX BENEFIT (PROVISION) |
|
|
(2,128 |
) |
|
|
5,022 |
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS FOR THE PERIOD |
|
$ |
(31,411 |
) |
|
$ |
(120,459 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC LOSS PER ORDINARY SHARE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
loss per share |
|
$ |
(0.16 |
) |
|
$ |
(0.71 |
) |
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares outstanding – in thousands |
|
|
194,236 |
|
|
|
170,460 |
Feb. 24, 2010 (PR Newswire) — FARO Reports Fourth Quarter 2009 Sales of $46 million;
LAKE MARY, Fla. — FARO Technologies, Inc. (Nasdaq: FARO) today announced results for the fourth quarter and year ended December 31, 2009. Sales in the fourth quarter of 2009 increased 28.9%, to $46.0 million, from $35.7 million in the third quarter of 2009. The Company returned to operating profitability in the fourth quarter of 2009, with operating income of $2.5 million compared to an operating loss of $2.3 million in the third quarter of 2009.
Net loss for the fourth quarter of 2009 was $0.6 million, or $(0.04) per diluted share, a decrease of $2.8 million, compared to net income of $2.2 million, or $0.13 per diluted share, in the fourth quarter of 2008. The net loss for the fourth quarter of 2009 included a tax settlement with the Internal Revenue Service of $2.6 million, or $.16 per share. Net loss for fiscal 2009 was $10.6 million, or $(0.66) per diluted share, compared to net income of $14.0 million, or $0.83 per diluted share during 2008.
Sales for the fourth quarter of 2009 decreased $10.3 million, or 18.3%, to $46.0 million from $56.3 million in the fourth quarter of 2008. New order bookings for the fourth quarter of 2009 were $53.1 million, a decrease of $3.3 million, or 5.9%, compared to $56.4 million in the fourth quarter of 2008. Fiscal 2009 sales were $147.7 million, a decrease of 29.4% compared to fiscal 2008 sales of $209.2 million. New order bookings for fiscal 2009 were $151.7 million, a decrease of 28.2% from $211.3 million in fiscal 2008.
“Sales increased 29% quarter over quarter and, as expected, the target markets for our products continued to show improvement. The cost reductions we made during the first three quarters of 2009 created a leaner, more efficient operation without sacrificing R&D programs. Ultimately, those moves position us well to execute in 2010,” stated Jay Freeland, FARO’s President and CEO.
Gross margin for the fourth quarter of 2009 was 55.4%, compared to 57.3% in the fourth quarter of 2008. Gross margin decreased primarily due to a change in the sales mix between higher margin product sales and lower margin service revenue. Gross margin for fiscal 2009 was 54.6% compared to 59.8% in fiscal 2008.
Selling expenses as a percentage of sales decreased to 26.4% in the fourth quarter of 2009 from 28.6% in the fourth quarter of 2008, primarily as a result of lower marketing expenses. Selling expenses in the fourth quarter of 2009 decreased by $3.9 million from the fourth quarter of 2008 to $12.2 million. Selling expenses as a percentage of sales for fiscal 2009 were 32.9%, compared to 30.1% in fiscal 2008.
General and administrative expenses increased to 13.8% of sales in the fourth quarter of 2009 from 12.2% in the fourth quarter of 2008. General and administrative expenses in the fourth quarter of 2009 decreased by $0.5 million to $6.4 million from $6.9 million in the fourth quarter of 2008. General and administrative expenses were 16.9% of sales for fiscal 2009 compared to 12.5% in fiscal 2008.
R&D expenses were $3.0 million in the fourth quarter of 2009, a decrease of $0.5 million from $3.5 million in the fourth quarter of 2008. R&D expenses were 6.6% of sales in the fourth quarter of 2009 compared to 6.2% of sales in the fourth quarter of 2008. R&D expenses for both fiscal 2009 and 2008 were $12.6 million.
Operating income for the fourth quarter of 2009 was $2.5 million, a decrease of $2.1 million from $4.6 million in the fourth quarter of 2008. Operating margin for the fourth quarter of 2009 was 5.4% compared to 8.1% in the fourth quarter of 2008. The operating loss for fiscal 2009 was $11.0 million compared to an operating profit of $18.9 million in fiscal 2008.
Income tax expense increased by $1.9 million to $3.3 million for the fourth quarter of 2009 from $1.4 million in the fourth quarter of 2008 due to a $2.6 million tax settlement with the Internal Revenue Service. The tax settlement will not impact the Company’s tax rate going forward.
“We feel good about the Company’s prospects in 2010 and believe we are a stronger organization now than we were at the beginning of last year. We continue to have a strong balance sheet with over $100 million in cash and zero debt and have created a streamlined operating structure from which to execute. Assuming economic conditions continue to improve, we believe our prospects for 2010 are good,” Freeland concluded.
This press release contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995) that are subject to risks and uncertainties, such as statements about the future state of the economy, FARO’s focus, plans and strategies, , and its future operating results and financial condition. Statements that are not historical facts or that describe the Company’s plans, objectives, projections, expectations, assumptions, strategies, or goals are forward-looking statements. In addition, words such as “intend,” “believe,” “will,” “expect” and similar expressions or discussions of our strategy or other intentions identify forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to various known and unknown risks, uncertainties, and other factors that may cause actual results, performances, or achievements to differ materially from future results, performances, or achievements expressed or implied by such forward-looking statements. Consequently, undue reliance should not be placed on these forward-looking statements.
Factors that could cause actual results to differ materially from what is expressed or forecasted in such forward-looking statements include, but are not limited to:
- development by others of new or improved products, processes or technologies that make the Company’s products obsolete or less competitive;
- the cyclical nature of the industries of the Company’s customers and material adverse changes in customers’ access to liquidity and capital;
- further declines or other adverse changes, or lack of improvement, in industries that the Company serves or the domestic and international economies in the regions of the world where the Company operates and other general economic, business, and financing conditions;
- fluctuations in the Company’s annual and quarterly operating results and the inability to achieve its financial operating targets;
- risks associated with expanding international operations, such as fluctuations in currency exchange rates, difficulties in staffing and managing foreign operations, political and economic instability, compliance with import and export regulations, and the burdens and potential exposure of complying with a wide variety of U.S. and foreign laws and labor practices;
- other risks detailed in Part I, Item 1A. Risk Factors in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 and in Part II, Item 1A. Risk Factors in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009.
Forward-looking statements in this release represent the Company’s judgment as of the date of this release. The Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
About FARO
With approximately 20,000 installations and 10,000 customers globally, FARO Technologies, Inc. designs, develops, and markets portable, computerized measurement and imaging devices and software used to create digital models — or to perform evaluations against an existing model — for anything requiring highly detailed 3-D measurements, including part and assembly inspection, factory planning and asset documentation, as well as specialized applications ranging from surveying, recreating accident sites and crime scenes to digitally preserving historical sites.
FARO’s technology increases productivity by dramatically reducing the amount of on-site measuring time, and the various industry-specific software packages enable users to process and present their results quickly and more effectively.
Principal products include the world’s best-selling portable measurement arm — the FaroArm; the world’s best-selling laser tracker — the FARO Laser Tracker X and Xi; the FARO Laser ScanArm; FARO Photon Laser Scanners; the FARO Gage, Gage-PLUS and PowerGAGE; and the CAM2 Q family of advanced CAD-based measurement and reporting software. FARO Technologies is ISO-9001 certified and ISO-17025 laboratory registered.
FARO TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended Twelve Months Ended
------------------ -------------------
(in thousands, except
share and per share Dec 31, Dec 31, Dec 31, Dec 31,
data) 2009 2008 2009 2008
------------------- -------- -------- -------- -------
SALES
Product $38,422 $48,190 $117,714 $179,209
Service 7,604 8,125 29,989 30,040
------- ------- -------- --------
Total Sales 46,026 56,315 147,703 209,249
------- ------- -------- --------
COST OF SALES
Product 15,646 16,931 46,293 60,736
Service 4,897 7,112 20,702 23,287
------ ------ ------ ------
Total Cost of Sales
(exclusive of
depreciation and
amortization, shown
separately below) 20,543 24,043 66,995 84,023
------ ------ ------ ------
GROSS PROFIT 25,483 32,272 80,708 125,226
OPERATING EXPENSES:
Selling 12,164 16,130 48,598 63,015
General and
administrative 6,365 6,870 24,956 26,144
Depreciation and
amortization 1,440 1,212 5,530 4,505
Research and
development 3,047 3,502 12,613 12,625
------ ------ ------ ------
Total operating
expenses 23,016 27,714 91,697 106,289
------ ------ ------ -------
(LOSS) INCOME FROM
OPERATIONS 2,467 4,558 (10,989) 18,937
------ ------ -------- ------
OTHER (INCOME) EXPENSE
Interest income (28) (546) (253) (2,170)
Other (income)
expense, net (233) 1,460 (592) 2,295
Interest expense 5 2 14 452
----- ----- ----- -----
(LOSS) INCOME BEFORE
INCOME TAX EXPENSE 2,723 3,642 (10,158) 18,360
INCOME TAX EXPENSE 3,343 1,443 424 4,408
----- ----- --- -----
NET (LOSS) INCOME $(620) $2,199 $(10,582) $13,952
------ ------ -------- -------
NET (LOSS) INCOME PER
SHARE - BASIC $(0.04) $0.13 $(0.66) $0.84
------- ----- ------ -----
NET (LOSS) INCOME PER
SHARE - DILUTED $(0.04) $0.13 $(0.66) $0.83
------- ----- ------ -----
Weighted average
shares - Basic 16,101,412 16,654,910 16,125,449 16,632,608
---------- ---------- ---------- ----------
Weighted average
shares - Diluted 16,101,412 16,702,090 16,125,449 16,734,403
---------- ---------- ---------- ----------
FARO TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31, December 31,
(in thousands, except share data) 2009 2008
--------------------------------- ----------- -----------
ASSETS
Current Assets:
Cash and cash equivalents $35,078 $23,494
Short-term investments 64,986 81,965
Accounts receivable, net 42,944 49,713
Inventories 26,582 33,444
Deferred income taxes, net 4,473 5,581
Prepaid expenses and other current assets 6,016 7,879
------- -------
Total current assets 180,079 202,076
------- -------
Property and Equipment:
Machinery and equipment 19,867 16,748
Furniture and fixtures 5,225 4,099
Leasehold improvements 9,434 9,893
------ ------
Property and equipment at cost 34,526 30,740
Less: accumulated depreciation and
amortization (20,788) (16,604)
------- -------
Property and equipment, net 13,738 14,136
------- -------
Goodwill 19,934 18,951
Intangible assets, net 7,985 8,580
Service inventory 12,079 12,843
Deferred income taxes, net 1,895 2,728
-------- --------
Total Assets $235,710 $259,314
-------- --------
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $8,985 $10,813
Accrued liabilities 8,173 14,032
Income taxes payable 229 1,988
Current portion of unearned service
revenues 12,226 11,501
Customer deposits 2,173 425
Current portion of obligations under
capital leases 80 87
------ ------
Total current liabilities 31,866 38,846
Unearned service revenues - less current
portion 5,910 6,772
Deferred tax liability, net 1,143 1,107
Obligations under capital leases - less
current portion 193 281
------ ------
Total Liabilities 39,112 47,006
------ ------
Commitments and contingencies
Shareholders' Equity:
Common stock - par value $.001, 50,000,000
shares authorized; 16,795,289 and 16,741,488
issued; 16,115,054 and 16,658,552
outstanding, respectively 17 17
Additional paid-in-capital 152,380 149,298
Retained earnings 46,915 57,497
Accumulated other comprehensive income 6,361 5,742
Common stock in treasury, at cost -
680,235 and 55,808 shares, respectively (9,075) (246)
-------- --------
Total Shareholders' Equity 196,598 212,308
-------- --------
Total Liabilities and Shareholders' Equity $235,710 $259,314
-------- --------
FARO TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended December 31,
------------------------------
(in thousands) 2009 2008 2007
------------------------------ --------- ------- -------
CASH FLOWS FROM:
OPERATING ACTIVITIES:
Net (loss) income $(10,582) $13,952 $18,093
Adjustments to reconcile
net (loss) income to net
cash provided by operating
activities:
Depreciation and amortization 5,530 4,505 4,034
Compensation for stock
options and restricted
stock units 2,449 2,237 1,216
Provision for bad debts 1,852 1,092 373
Deferred income tax
expense (benefit) 1,986 (1,972) (464)
Change in operating
assets and liabilities:
Decrease (increase) in:
Accounts receivable 5,769 2,993 (9,121)
Inventories, net 8,301 (6,429) (7,265)
Prepaid expenses and
other current assets 1,964 (1,187) (3,208)
Income tax benefit from
exercise of stock
options (4) (45) (963)
Increase (decrease) in:
Accounts payable and
accrued liabilities (7,891) (5,317) 9,884
Income taxes payable (1,749) (355) 1,278
Customer deposits 1,736 82 (269)
Unearned service
revenues (396) 3,710 8,007
----- ------ ------
Net cash provided by
operating activities 8,965 13,266 21,595
----- ------ ------
INVESTING ACTIVITIES:
Purchases of property
and equipment (3,387) (9,705) (2,930)
Payments for intangible
assets (670) (3,766) (359)
Purchases of short-term
investments (64,986) (81,965) (77,375)
Proceeds from sales of
short-term investments 81,965 77,375 15,790
------ -------- --------
Net cash provided by
(used in) investing
activities 12,922 (18,061) (64,874)
------ -------- --------
FINANCING ACTIVITIES:
Payments on capital leases (88) (11) (92)
Income tax benefit from
exercise of stock options 4 45 963
Purchases of treasury stock (8,829) (95) -
Proceeds from issuance of stock,
net 83 92 58,421
------ ----- ------
Net cash (used in)
provided by financing
activities (8,830) 31 59,292
------ ----- ------
EFFECT OF EXCHANGE RATE CHANGES
ON CASH AND CASH EQUIVALENTS (1,473) 2,460 (5,904)
------- ----- -------
INCREASE (DECREASE) IN
CASH AND CASH EQUIVALENTS 11,584 (2,304) 10,109
CASH AND CASH EQUIVALENTS,
BEGINNING OF PERIOD 23,494 25,798 15,689
------- ------- -------
CASH AND CASH EQUIVALENTS,
END OF PERIOD $35,078 $23,494 $25,798
======= ======= =======
Feb. 24, 2010 (Business Wire) — True Religion Apparel, Inc. (Nasdaq: TRLG) today announced financial results for the quarter and year ended December 31, 2009.
Fourth Quarter 2009 Financial Results
- Total net sales were $92.8 million, an increase of 27.2% as compared to $73.0 million in the fourth quarter of 2008.
- Net sales for the Company’s consumer direct segment, which includes the Company’s branded retail stores and e-commerce site, increased 84.8% to $45.1 million as compared to $24.4 million in the prior year period. Fourth quarter same-store sales for 36 stores open at least 12 months increased 22.3%. The Company operated 70 branded stores as of December 31, 2009, compared to 42 as of December 31, 2008.
- Net sales for the Company’s U.S. wholesale segment totaled $31.6 million as compared to $36.4 million in the prior year period; the 13.1% decline was due to lower sales to Majors and boutiques.
- Net sales for the Company’s international segment increased 24.3% to $14.6 million as compared to $11.8 million in the prior year period.
- Net sales included $1.5 million of licensing revenue as compared to $0.5 million in the same period last year.
- Gross profit was $58.7 million, or 63.2% of net sales, compared to $43.3 million, or 59.3% of net sales, in the fourth quarter of 2008. The overall improvement in gross margin was primarily due to the ongoing sales mix shift toward the Company’s higher-margin consumer direct segment, with a higher international segment gross margin offset by a reduction in the U.S. wholesale gross margin.
- Selling, general and administrative (“SG&A”) expense increased 48.6% to $34.8 million as compared to $23.4 million in the prior year period. As a percentage of net sales, SG&A increased 540 basis points to 37.5% from 32.1% in the same period a year ago. The year-over-year growth in SG&A expenses was driven by the costs associated with the opening of 28 new stores since December 31, 2008 and additional in-house resources.
- Operating income increased 20.4% to $23.9 million as compared to $19.8 million in the prior year period. Operating income was 25.7% of sales in Q4 2009 versus 27.2% in Q4 2008.
- The effective tax rate for the quarter was 38.9% as compared to 36.5% in the fourth quarter of 2008.
- Net income increased 15.2% to $14.6 million, or $0.59 per diluted share based on weighted average shares outstanding of 24.8 million, as compared to $12.7 million, or $0.53 per diluted share based on weighted average shares outstanding of 24.1 million in the 2008 fourth quarter.
Management Comments
Jeffrey Lubell, Chairman, Chief Executive Officer and Chief Merchant of True Religion Apparel, commented: “The introduction of new jeans and related sportswear and licensed merchandise was both the foundation and catalyst for another year of record sales and profitability for True Religion. The growth of our U.S. consumer direct platform as well as the ongoing development of the True Religion brand in international markets provided incremental sales and earnings over the past year and should continue to offer our company future growth opportunities. We were also pleased to have exceeded our 2009 sales and earnings goals and delivered against our strategic and financial objectives despite the tremendous changes in the global macro-economy that occurred throughout last year.”
Mr. Lubell continued, “We recognize the importance of always looking to evolve the organization in a manner that will best position the True Religion brand for healthy long-term growth. We believe our performance in 2009 reinforces our strategy: to continually design and introduce trend-setting jeans and related sportswear; to balance our distribution between wholesale and consumer direct; and to increase our presence in the international market, which we believe has the potential of being larger than the domestic market. We also believe the strategic investments in our personnel, systems and infrastructure that we made over the past year will position our organization to take advantage of the many growth opportunities we have in front of us.”
2009 Financial Results
- Total net sales were $311.0 million, an increase of 15.2% as compared to $270.0 million in the year ended December 31, 2008.
- Net sales for the Company’s consumer direct segment increased 71.3% to $129.0 million as compared to $75.3 million in the prior year.
- Net sales for the Company’s U.S. wholesale segment decreased 19.6% to $123.2 million as compared to $153.2 million in the prior year.
- Net sales for the Company’s international segment increased 36.0% to $54.5 million as compared to $40.0 million in the prior year.
- Net sales included $4.3 million of licensing revenue as compared to $1.4 million in the prior year.
- Gross profit increased 24.6% to $195.6 million, or 62.9% of net sales, compared to $157.0 million, or 58.1% of net sales, in 2008. The overall improvement in gross margin was primarily due to the ongoing sales mix shift toward the Company’s higher-margin consumer direct segment.
- Selling, general and administrative (“SG&A”) expense increased 33.9% to $118.0 million from $88.1 million in the prior year, and as a percentage of net sales, increased 530 basis points to 37.9% from 32.6% in the prior year. The year-over-year growth in SG&A expenses was driven by the costs associated with the significant expansion of the Company’s consumer direct segment and other in-house resources.
- Operating income increased 12.7% to $77.6 million, or 25.0% of net sales, from $68.9 million, or 25.5% of net sales, in the prior year.
- The effective tax rate for the year ended December 31, 2009 was 39.1% compared to 36.6% in the prior year.
- Net income increased 6.7% to $47.3 million, or $1.92 per diluted share based on weighted average shares outstanding of 24.7 million, from $44.4 million, or $1.83 per diluted share based on weighted average shares outstanding of 24.3 million, in the prior year.
Balance Sheet and Liquidity
As of December 31, 2009, the Company had $105.5 million of cash and cash equivalents as compared to $57.2 million as of December 31, 2008. The Company also ended the year with no long-term borrowings. Inventory increased to $34.5 million, or by $8.7 million, from the same time a year ago, to support the expansion of the Company’s branded retail stores. Net cash provided by operating activities during 2009 was $66.5 million compared to $49.1 million in the prior year.
Store Openings
During the 2009 fourth quarter, True Religion opened four new stores, bringing its total store count at December 31, 2009, to 70 stores, compared to 42 stores at December 31, 2008. The Company anticipates opening 30 new retail stores in 2010, including 27 stores in the U.S. and its first three international full-price stores: Tokyo, London, and Toronto.
2010 Guidance
The Company is initiating its guidance for the fiscal year ended December 31, 2010, as follows:
- Total net sales are expected to be approximately $360 million.
- EPS is expected to be in the range of $2.00 to $2.10.
The Company’s net sales guidance relies on the following assumptions:
- Net sales growth within the Company’s consumer direct segment are forecasted to grow between 40% and 45% compared to 2009. This growth assumes 28 new retail stores (27 in the U.S. plus one store in Toronto) and the full year impact of the 28 stores opened in 2009.
- Net sales in the Company’s U.S. wholesale segment are expected to decrease in the mid-teens on a percentage basis as compared to 2009, mostly driven by management’s decision to reduce sales to the off-price channel by $10 million and instead place a greater emphasis on regular-price wholesale sales.
- The international segment’s net sales are forecasted to increase by approximately 20% as compared to 2009.
- The Company’s licensing revenues are expected to increase by approximately 15% as compared to 2009.
The Company’s 2010 EPS guidance reflects fully diluted weighted average shares outstanding of approximately 25.1 million and an effective tax rate of 37.6%, which will be down 150 bps from 2009 due to an increased federal credit rate available to domestic manufacturers in 2010.
Investor Conference Call
True Religion management will host a conference call to discuss the financial results and answer questions today at 4:30 p.m. ET. The conference call will be available to all interested parties through a live webcast at www.truereligionbrandjeans.com and www.earnings.com. Please visit the Web site at least 15 minutes prior to the start of the call to register and download any necessary software. For those unable to listen to the live broadcast, the call will be archived and available online at both sites. A telephone replay of the call will be available for approximately one month following the conclusion of the call by dialing (877) 660-6853 (domestic) or (201) 612-7415 (international) and entering account: 3055 and conference identification: 342908. Please note participants must enter both the account and Conference identification numbers in order to access the replay.
About True Religion Apparel, Inc.
True Religion Apparel, Inc. is a growing, design-based jeans and jean-related sportswear brand. The company designs, manufactures and markets True Religion Apparel products, including its premium True Religion Brand Jeans. Its expanding product line, which includes high-quality, distinctive styling and fit in denim, sportswear, and licensed products, may be found in contemporary department stores and boutiques in 50 countries around the world, including the United States, Canada, Germany, United Kingdom, Japan, Korea, France, Spain, Sweden, Greece, Italy, Mexico, Australia, South Africa and China. For more information, please visit www.truereligionbrandjeans.com.
|
|
|
|
|
|
Q4 & FY 2009 Segment Results
(Dollar amounts in thousands) |
|
|
|
|
|
|
|
|
|
Quarters Ended December 31, |
|
Years Ended December 31, |
|
|
|
|
|
|
|
|
|
% Increase/ |
|
|
|
|
|
|
% Increase/ |
Net sales: |
|
|
2009 |
|
|
2008 |
|
Decrease |
|
|
2009 |
|
|
2008 |
|
Decrease |
|
Consumer Direct |
|
$ |
45,145 |
|
$ |
24,424 |
|
84.8 |
% |
|
$ |
129,029 |
|
$ |
75,314 |
|
71.3 |
% |
|
U.S. Wholesale |
|
|
31,582 |
|
|
36,358 |
|
(13.1 |
)% |
|
|
123,203 |
|
|
153,235 |
|
(19.6 |
)% |
|
International |
|
|
14,617 |
|
|
11,755 |
|
24.3 |
% |
|
|
54,479 |
|
|
40,044 |
|
36.0 |
% |
|
Other |
|
|
1,494 |
|
|
453 |
|
229.8 |
% |
|
|
4,289 |
|
|
1,407 |
|
204.8 |
% |
|
Total net sales |
|
$ |
92,838 |
|
$ |
72,990 |
|
27.2 |
% |
|
$ |
311,001 |
|
$ |
270,000 |
|
15.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended December 31, |
|
Years Ended December 31, |
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
|
|
|
|
|
Gross |
|
|
|
Gross |
|
|
|
Gross |
|
|
|
Gross |
|
|
|
|
|
|
Margin |
|
|
|
Margin |
|
|
|
Margin |
|
|
|
Margin |
Gross Profit: |
|
Amount |
|
% |
|
Amount |
% |
|
Amount |
% |
|
Amount |
% |
|
Consumer Direct |
|
$ |
33,147 |
|
|
73.4 |
% |
|
$ |
18,273 |
|
74.8 |
% |
|
$ |
95,276 |
|
73.8 |
% |
|
$ |
57,669 |
|
76.6 |
% |
|
U.S. Wholesale |
|
|
16,021 |
|
|
50.7 |
% |
|
|
18,740 |
|
51.5 |
% |
|
|
65,882 |
|
53.5 |
% |
|
|
78,670 |
|
51.3 |
% |
|
International |
|
|
8,047 |
|
|
55.1 |
% |
|
|
5,798 |
|
49.3 |
% |
|
|
30,115 |
|
55.3 |
% |
|
|
19,255 |
|
48.1 |
% |
|
Other |
|
|
1,494 |
|
|
100.0 |
% |
|
|
453 |
|
100.0 |
% |
|
|
4,289 |
|
100.0 |
% |
|
|
1,407 |
|
100.0 |
% |
|
Total gross profit |
|
$ |
58,709 |
|
|
63.2 |
% |
|
$ |
43,264 |
|
59.3 |
% |
|
$ |
195,562 |
|
62.9 |
% |
|
$ |
157,001 |
|
58.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended December 31, |
|
Years Ended December 31, |
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
|
|
|
|
|
Operating |
|
|
Operating |
|
|
|
Operating |
|
|
Operating |
|
|
|
|
|
|
Margin |
|
|
|
Margin |
|
|
|
Margin |
|
|
|
Margin |
Operating Income: |
|
Amount |
|
% |
|
Amount |
% |
|
Amount |
% |
|
Amount |
% |
|
Consumer Direct |
|
$ |
17,413 |
|
|
38.6 |
% |
|
$ |
8,540 |
|
35.0 |
% |
|
$ |
44,766 |
|
34.7 |
% |
|
$ |
27,810 |
|
36.9 |
% |
|
U.S. Wholesale |
|
|
6,253 |
|
|
19.8 |
% |
|
|
11,270 |
|
31.0 |
% |
|
|
30,763 |
|
25.0 |
% |
|
|
47,452 |
|
31.0 |
% |
|
International |
|
|
6,374 |
|
|
43.6 |
% |
|
|
4,652 |
|
39.6 |
% |
|
|
25,167 |
|
46.2 |
% |
|
|
16,761 |
|
41.9 |
% |
|
Other |
|
|
(6,157 |
) |
|
NM |
|
|
|
(4,627 |
) |
NM |
|
|
|
(23,099 |
) |
NM |
|
|
|
(23,147 |
) |
NM |
|
|
Total operating Income |
|
$ |
23,883 |
|
|
25.7 |
% |
|
$ |
19,835 |
|
27.2 |
% |
|
$ |
77,597 |
|
25.0 |
% |
|
$ |
68,876 |
|
25.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Among these forward looking statements are our 2010 Guidance, Segment Guidance, Store Opening Guidance and the other statements contained in this press release addressing our plans, expectations, future financial condition and results of operations. These forward-looking statements are not historical facts and are inherently uncertain and outside of our control. Any or all of our forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Actual future results may vary materially. Factors that may cause our plans, expectations, future financial condition and results to change are described in our Annual Report on Form 10-K, Reports on Form 10-Q and our other filings with the SEC, and include: the current downturn in the global economy and in particular, the decline in consumer spending generally and in the apparel industry more specifically; the Company’s ability to predict fashion trends; the Company’s ability to continue to maintain its brand image and reputation; competition from companies with significantly greater resources than ours; and the Company’s ability to continue and control its expansion plans.
|
TRUE RELIGION APPAREL, INC. AND SUBSIDIARIES |
CONSOLIDATED STATEMENTS OF INCOME |
(Amounts in thousands, expect per share data) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended |
|
Years Ended |
|
|
|
|
December 31, |
|
December 31, |
|
|
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
Net sales |
|
$ |
92,838 |
|
|
$ |
72,990 |
|
|
$ |
311,001 |
|
|
$ |
270,000 |
|
Cost of sales |
|
|
34,129 |
|
|
|
29,726 |
|
|
|
115,439 |
|
|
|
112,999 |
|
Gross profit |
|
|
58,709 |
|
|
|
43,264 |
|
|
|
195,562 |
|
|
|
157,001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
34,826 |
|
|
|
23,429 |
|
|
|
117,965 |
|
|
|
88,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
23,883 |
|
|
|
19,835 |
|
|
|
77,597 |
|
|
|
68,876 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income, net |
|
|
(75 |
) |
|
|
(177 |
) |
|
|
(169 |
) |
|
|
(1,065 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
|
|
23,958 |
|
|
|
20,012 |
|
|
|
77,766 |
|
|
|
69,941 |
|
Provision for income taxes |
|
|
9,323 |
|
|
|
7,305 |
|
|
|
30,434 |
|
|
|
25,570 |
|
Net income |
|
$ |
14,635 |
|
|
$ |
12,707 |
|
|
$ |
47,332 |
|
|
$ |
44,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.61 |
|
|
$ |
0.54 |
|
|
$ |
1.97 |
|
|
$ |
1.89 |
|
|
Diluted |
|
$ |
0.59 |
|
|
$ |
0.53 |
|
|
$ |
1.92 |
|
|
$ |
1.83 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
24,051 |
|
|
|
23,686 |
|
|
|
23,993 |
|
|
|
23,511 |
|
|
Diluted |
|
|
24,847 |
|
|
|
24,050 |
|
|
|
24,659 |
|
|
|
24,270 |
|
|
TRUE RELIGION APPAREL, INC. AND SUBSIDIARIES |
CONSOLIDATED BALANCE SHEETS |
(Amounts in thousands, except par value amounts) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
December 31, |
|
|
|
|
2009 |
|
|
2008 |
ASSETS |
|
|
|
|
|
|
|
Current Assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
105,531 |
|
|
$ |
57,245 |
|
Short-term investments |
|
|
4,948 |
|
|
|
4,850 |
|
Accounts receivable, net of allowances: |
|
|
|
|
|
|
|
|
|
From customers |
|
|
27,214 |
|
|
|
10,043 |
|
|
From factor |
|
|
3 |
|
|
|
23,060 |
|
Inventory |
|
|
34,502 |
|
|
|
25,828 |
|
Deferred income tax assets |
|
|
8,753 |
|
|
|
6,498 |
|
Prepaid expenses and other current assets |
|
|
7,000 |
|
|
|
4,148 |
|
|
Total current assets |
|
|
187,951 |
|
|
|
131,672 |
Property and equipment, net |
|
|
39,693 |
|
|
|
28,006 |
Long-term investments |
|
|
– |
|
|
|
4,990 |
Other assets |
|
|
2,162 |
|
|
|
1,784 |
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
229,806 |
|
|
$ |
166,452 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
Current Liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
$ |
11,717 |
|
|
$ |
10,633 |
|
Accrued salaries, wages and benefits |
|
|
8,843 |
|
|
|
6,889 |
|
Income taxes payable |
|
|
826 |
|
|
|
1,042 |
|
|
Total current liabilities |
|
|
21,386 |
|
|
|
18,564 |
Long-Term Liabilities: |
|
|
|
|
|
|
|
|
Long-term deferred rent |
|
|
7,851 |
|
|
|
4,536 |
|
Long-term deferred income tax liabilities |
|
|
2,715 |
|
|
|
1,102 |
|
|
Total long-term liabilities |
|
|
10,566 |
|
|
|
5,638 |
Total liabilities |
|
|
31,952 |
|
|
|
24,202 |
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity: |
|
|
|
|
|
|
|
|
Preferred stock, $0.0001 par value, 20,000, shares authorized, |
|
|
|
|
|
|
|
|
no shares issued and outstanding |
|
|
– |
|
|
|
– |
|
Common stock, $0.0001 par value, 80,000 shares authorized, |
|
|
|
|
|
|
|
|
25,250 and 24,450 issued and outstanding, respectively |
|
|
3 |
|
|
|
2 |
|
Additional paid-in capital |
|
|
49,840 |
|
|
|
38,554 |
|
Retained earnings |
|
|
147,809 |
|
|
|
103,508 |
|
Accumulated other comprehensive income, net |
|
|
202 |
|
|
|
186 |
Total stockholders’ equity |
|
|
197,854 |
|
|
|
142,250 |
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
$ |
229,806 |
|
|
$ |
166,452 |
|
TRUE RELIGION APPAREL, INC. AND SUBSIDIARIES |
CONSOLIDATED STATEMENTS OF CASH FLOWS |
(Amounts in thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2009 |
|
|
2008 |
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
Net income |
$ |
47,332 |
|
|
|
$ |
44,371 |
|
Adjustments to reconcile net income to net cash provided |
|
|
|
|
|
|
|
by operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
6,492 |
|
|
|
|
3,427 |
|
|
Provision for bad debts |
|
99 |
|
|
|
|
577 |
|
|
Stock-based compensation |
|
11,899 |
|
|
|
|
10,297 |
|
|
Tax benefit from stock-based compensation |
|
55 |
|
|
|
|
229 |
|
|
Excess tax benefit from stock-based compensation |
|
(55 |
) |
|
|
|
(229 |
) |
|
Deferred income tax benefit |
|
(642 |
) |
|
|
|
(128 |
) |
|
Other |
|
206 |
|
|
|
|
305 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable from factor |
|
23,057 |
|
|
|
|
(8,271 |
) |
|
|
Accounts receivable from customers |
|
(17,278 |
) |
|
|
|
1,914 |
|
|
|
Inventory |
|
(8,719 |
) |
|
|
|
(4,377 |
) |
|
|
Prepaid expenses and other current assets |
|
(2,861 |
) |
|
|
|
(1,834 |
) |
|
|
Other assets |
|
(280 |
) |
|
|
|
(448 |
) |
|
|
Accounts payable and accrued expenses |
|
2,800 |
|
|
|
|
(825 |
) |
|
|
Accrued salaries, wages and benefits |
|
1,954 |
|
|
|
|
2,831 |
|
|
|
Income taxes payable |
|
(884 |
) |
|
|
|
(2,168 |
) |
|
|
Long-term deferred rent |
|
3,315 |
|
|
|
|
3,391 |
|
Net cash provided by operating activities |
|
66,490 |
|
|
|
|
49,062 |
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
Purchases of property and equipment |
|
(20,082 |
) |
|
|
|
(18,187 |
) |
|
Sales of investments |
|
4,900 |
|
|
|
|
5,550 |
|
|
Expenditures to establish trademarks |
|
(128 |
) |
|
|
|
(81 |
) |
Net cash used in investing activities |
|
(15,310 |
) |
|
|
|
(12,718 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
Statutory tax withholding payment for stock-based compensation |
|
(3,032 |
) |
|
|
|
(8,110 |
) |
|
Excess tax benefit from stock-based compensation |
|
55 |
|
|
|
|
229 |
|
|
Proceeds from exercise of stock options |
|
– |
|
|
|
|
25 |
|
Net cash used in financing activities |
|
(2,977 |
) |
|
|
|
(7,856 |
) |
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes in cash |
|
83 |
|
|
|
|
71 |
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents |
|
48,286 |
|
|
|
|
28,559 |
|
Cash and cash equivalents, beginning of period |
|
57,245 |
|
|
|
|
28,686 |
|
Cash and cash equivalents, end of period |
$ |
105,531 |
|
|
|
$ |
57,245 |
Feb. 25, 2010 (Business Wire) — Smith Micro Software, Inc. (NASDAQ: SMSI), a leading developer and marketer of mobility solutions and services for the wireless market, today announced that William W. Smith, Jr., President and CEO will be presenting at the Jefferies 4th Annual Global Technology Conference on Tuesday, March 9th at 8:00 am ET. The conference is being held at the Mandarin Oriental Hotel in New York City, New York.
Smith Micro will offer a live audio webcast of its presentation at 8:00 am ET on March 9, 2010 at http://www.wsw.com/webcast/jeff42/smsi/, as well as an archived replay, which may be accessed in the investor relations section of Smith Micro’s website at www.smithmicro.com.
Conference Details:
Jefferies 4th Annual Global Technology Conference |
March 8-10, 2010 |
Mandarin Oriental Hotel in New York City, NY |
More information can be found at: http://www.jefferies.com/ |
|
About Smith Micro Software, Inc.:
Smith Micro Software, Inc., headquartered in Aliso Viejo, California, with offices in Europe and Asia, develops mobility solutions that enable seamless broadband connectivity and next generation media and mobile convergence products over wireless networks. Smith Micro’s complete lines of products are available through its sales groups, direct from its websites, retail distributors, and value-added resellers. Smith Micro’s common stock trades on the NASDAQ Global Market under the symbol SMSI. For more information, please visit: http://www.smithmicro.com.
Safe Harbor Statement:
This release may contain forward-looking statements that involve risks and uncertainties, including without limitation forward-looking statements relating to the company’s net revenues guidance for fiscal 2010, its financial prospects and other projections of its performance, the company’s ability to increase its business and the anticipated timing and financial performance of its new products and potential acquisitions. Among the important factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements are changes in demand for the company’s products from its customers and their end-users, new and changing technologies, customer acceptance of those technologies, new and continuing adverse economic conditions, and the company’s ability to compete effectively with other software companies. These and other factors discussed in the company’s filings with the Securities and Exchange Commission, including its filings on Forms 10-K and 10-Q, could cause actual results to differ materially from those expressed or implied in any forward-looking statements. The forward-looking statements contained in this release are made on the basis of the views and assumptions of management regarding future events and business performance as of the date of this release, and the company does not undertake any obligation to update these statements to reflect events or circumstances occurring after the date of this release.
Smith Micro and the Smith Micro logo are registered trademarks or trademarks of Smith Micro Software, Inc. All other trademarks and product names are the property of their respective companies.
Feb. 24, 2010 (Business Wire) — VocalTec Communications Ltd. (NasdaqCM: VOCL) (the “Company” or “VocalTec”), a global provider of VoIP and convergence solutions for communication service providers, today reported results for the fourth quarter and full year ended December 31, 2009.
Revenues for the fourth quarter of 2009 were $2.0 million, an increase of 4% over the $1.9 million reported in the third quarter of 2009, resulting from continued growth in product sales.
Gross margin for the fourth quarter of 2009 was 60% compared with 64% for the prior quarter, in line with the Company’s normal expected level of around 60%.
On a non-GAAP basis, excluding the amortization of intangible assets and share based compensation expenses, the operating expenses in the fourth quarter were $1.1 million compared with $1.6 in the prior quarter. Operating expenses were lower in the quarter primarily due to the recording of a R&D grant for 2009 from the Office of the Chief Scientist of the Israeli Ministry of Trade, Industry and Labor amounting to $0.4 million.
The Company reported a non-GAAP operating income in the fourth quarter of 2009 of $0.1 million compared to an operating loss of $0.4 million in the prior quarter.
On a non-GAAP basis, net income for the fourth quarter was $0.7 million or $0.12 per share, compared with a net loss of $0.4 million, or $0.07 per share, in the third quarter of 2009. Net income on a GAAP basis for the fourth quarter of 2009 was also $0.7 million or $0.12 per share, compared with a net loss of $0.7 million, or $0.12 per share, in the third quarter of 2009. Both GAAP and non-GAAP net income for the fourth quarter of 2009 included a tax benefit of $0.6 million.
For the full year, 2009 revenues were $6.4 million compared with $6.1 million in 2008. Non-GAAP gross margin was 64% for 2009 compared with 58% in 2008. Non-GAAP operating loss for 2009 was $2.2 million, compared with an operating loss of $5.5 million in 2008 which excludes a one-time income from the sale of patents and an impairment of intangible assets. The improvement in 2009 was due to a higher gross profit and a significant reduction in operating expenses.
As of December 31, 2009, the Company had net cash and cash equivalents, short-term bank deposits and restricted cash, in the amount of $10.6 million, or $1.82 per share.
Commenting on the results, Ido Gur, VocalTec’s President and CEO, said, “We are pleased with our results, especially since despite a tough year in the Telecom industry, we showed continued growth in revenue and a reduction in costs. This demonstrates that we are very much on the right track to achieving sustained profitability. We also saw a high level of bookings in 2009 and our year-end backlog going into 2010 is strong, providing us with an increased level of visibility.”
Mr. Gur continued, “Our fourth quarter was also eventful from an M&A standpoint. We purchased substantially all of the assets of Outsmart, and we are happy to already report a first order. The acquired technology enables us to capitalize on the convergence between mobile and VoIP – a trend that is becoming increasingly prevalent, with global mobile VoIP users expected to exceed 280 million by 2013.”
Mr. Gur concluded, “For 2010, we expect to continue growing our revenues organically compared to 2009, and also capitalize on sales into the convergence and mobile VoIP markets. While we expect the first quarter to show the normal seasonal decline in revenues, we believe that our 2010 revenues will show accelerated annual growth. At the same time, we continue exploring M&A opportunities that will provide us with additional growth engines for the long-term.”
Conference Call
Mr. Ido Gur, President and CEO of VocalTec, invites investors to participate in a conference call scheduled for later today, Wednesday, February 24, 2010. The conference call will be held at 9:00am ET. On the call, VocalTec’s management will review and discuss the fourth quarter and full year results of operations and will be available to answer questions.
To participate, please call one of the following teleconferencing numbers, 5 minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.
US Dial-in Number: 1 888 281 1167
ISRAEL Dial-in Number: 03 918 0644
INTERNATIONAL Dial-in Number: +972 3 918 0664
For those unable to listen to the live call, a replay of the call will be available from a link in the investor relations section of VocalTec’s website, at: www.vocaltec.com
About VocalTec
VocalTec Communications (NasdaqCM: VOCL) is a global provider of carrier-class Voice-over-IP and Convergence solutions for fixed and wireless service providers. A pioneer in VoIP technology since 1994, VocalTec develops and markets an extensive VoIP offering enabling the flexible deployment of next-generation networks (NGNs). Partnering with prominent system integrators and equipment manufacturers, VocalTec serves an installed base of dozens of leading carriers worldwide. VocalTec is led by a management team comprised of respected industry veterans.
www.vocaltec.com
Forward Looking Statements
This press release contains historical information and forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 with respect to the business, financial condition and results of operations of VocalTec. The words “believe,” “expect,” “intend,” “plan,” “should” and similar expressions are intended to identify forward-looking statements. Such statements reflect the current views, assumptions and expectations of the Company with respect to future events and are subject to risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, changes in the telecommunications and VoIP markets and in general economic and business conditions, loss of key customers and unpredictable sales cycles, competitive pressures, market acceptance of new products, inability to meet efficiency and cost reduction objectives, changes in business strategy and various other factors, both referenced and not referenced in this press release. Various risks and uncertainties may affect the Company and its results of operations, as described in reports filed by the Company with the Securities and Exchange Commission from time to time. Should one or more of these or other risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended, planned or projected. The Company does not intend or assume any obligation to update these forward-looking statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENT OF OPERATIONS |
|
|
|
|
|
|
|
|
Reconciliation of GAAP to non GAAP results * |
|
|
|
|
|
|
|
|
All data in thousands of U.S. dollars |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Twelve months ended |
|
|
|
|
|
|
December 31, |
|
September 30, |
|
December 31, |
|
|
|
|
|
|
2009 |
|
2009 |
|
2009 |
|
2008 |
|
|
|
|
|
|
GAAP results(as reported) |
|
GAAP results(as reported) |
|
GAAP results(as reported) |
|
GAAP results(as reported) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
Products |
|
|
|
1,573 |
|
|
1,270 |
|
|
4,218 |
|
|
|
3,980 |
|
|
|
Services |
|
|
|
415 |
|
|
644 |
|
|
2,189 |
|
|
|
2,134 |
|
|
|
|
|
|
|
1,988 |
|
|
1,914 |
|
|
6,407 |
|
|
|
6,114 |
|
|
Cost of sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
Products |
|
|
|
655 |
|
|
552 |
|
|
1,768 |
|
|
|
2,027 |
|
|
|
Services |
|
|
|
137 |
|
|
142 |
|
|
569 |
|
|
|
580 |
|
|
|
|
|
|
|
792 |
|
|
694 |
|
|
2,337 |
|
|
|
2,607 |
|
|
|
Amortization of intangible assets |
|
|
|
– |
|
|
– |
|
|
– |
|
|
|
328 |
|
|
|
|
|
|
|
792 |
|
|
694 |
|
|
2,337 |
|
|
|
2,935 |
|
|
Gross profit |
|
|
|
1,196 |
|
|
1,220 |
|
|
4,070 |
|
|
|
3,179 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development, net. |
|
|
|
(22 |
) |
|
624 |
|
|
2,056 |
|
|
|
4,154 |
|
|
|
Selling and marketing |
|
|
|
610 |
|
|
778 |
|
|
3,020 |
|
|
|
3,374 |
|
|
|
General and administrative |
|
|
|
498 |
|
|
535 |
|
|
2,147 |
|
|
|
2,704 |
|
|
|
Income from sale of Patents, net |
|
|
|
– |
|
|
– |
|
|
– |
|
|
|
(14,913 |
) |
|
|
Impairment of goodwill and intangible assets |
|
|
|
– |
|
|
– |
|
|
– |
|
|
|
3,993 |
|
|
|
Amortization of intangible assets |
|
|
|
6 |
|
|
6 |
|
|
24 |
|
|
|
180 |
|
|
|
Total Operating Expenses |
|
|
|
1,092 |
|
|
1,943 |
|
|
7,247 |
|
|
|
(508 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
|
104 |
|
|
(723 |
) |
|
(3,177 |
) |
|
|
3,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Income, net |
|
|
|
2 |
|
|
27 |
|
|
132 |
|
|
|
90 |
|
|
Net income (loss) before income taxes |
|
|
|
106 |
|
|
(696 |
) |
|
(3,045 |
) |
|
|
3,777 |
|
|
Income taxes (tax benefit) |
|
|
|
(590 |
) |
|
– |
|
|
(590 |
) |
|
|
69 |
|
|
Net income (loss) |
|
|
|
696 |
|
|
(696 |
) |
|
(2,455 |
) |
|
|
3,708 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) |
|
|
|
696 |
|
|
(696 |
) |
|
(2,455 |
) |
|
|
3,708 |
|
|
Adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of goodwill |
|
|
|
– |
|
|
– |
|
|
– |
|
|
|
3,993 |
|
|
Amortization of intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
included in cost of sales |
|
|
|
– |
|
|
– |
|
|
– |
|
|
|
328 |
|
|
|
included in operating expenses |
|
|
|
6 |
|
|
6 |
|
|
24 |
|
|
|
180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity based compensation expense (income) |
|
|
|
|
|
|
|
|
|
|
|
|
|
included in cost of sales |
|
|
|
(6 |
) |
|
5 |
|
|
9 |
|
|
|
17 |
|
|
|
included in research and development |
|
|
|
(160 |
) |
|
94 |
|
|
120 |
|
|
|
357 |
|
|
|
included in sales and marketing |
|
|
|
(58 |
) |
|
62 |
|
|
127 |
|
|
|
263 |
|
|
|
included in general and administrative |
|
|
|
189 |
|
|
158 |
|
|
680 |
|
|
|
532 |
|
|
Non-GAAP net income (loss) |
|
|
|
667 |
|
|
(371 |
) |
|
(1,495 |
) |
|
|
9,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*To supplement our consolidated financial statement presented in accordance with generally accepted accounting principles (GAAP), we use NON-GAAP measures of operating results, net income, which are adjusted from results based on GAAP to exclude the expense we recorded for share-based compensation and amortization of intangible assets. These NON-GAAP financial measures are provided to enhance overall understanding of our current financial performance and our prospects for the future. Specifically, we believe the NON-GAAP results provide useful information to both management and investors as these NON- GAAP results exclude matters that we believe are not indicative of our core operating results. Further, these NON-GAAP results are one of the primary indicators management uses for assessing our performance, allocating resources and planning and forecasting future periods. These measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP results. These NON-GAAP measures may be different than the NON-GAAP measures used by other companies.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VOCALTEC COMMUNICATIONS LTD. |
|
|
|
|
|
|
CONSOLIDATED BALANCE SHEETS |
|
|
|
|
|
|
(In thousands of U.S. dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31 |
|
December 31 |
|
|
|
|
|
|
2009 |
|
2008 |
|
Current Assets |
|
|
|
|
|
|
|
|
Cash and Cash equivalents |
|
|
7,510 |
|
5,090 |
|
|
Short term deposits |
|
|
3,049 |
|
9,900 |
|
|
Restricted cash |
|
|
23 |
|
554 |
|
|
Trade receivables, net |
|
|
199 |
|
214 |
|
|
Other receivables |
|
|
459 |
|
483 |
|
|
Severance pay funds |
|
|
3 |
|
489 |
|
|
Inventories |
|
|
|
63 |
|
38 |
|
|
Work in progress |
|
|
762 |
|
– |
|
|
|
Total Current Assets |
|
|
12,068 |
|
16,768 |
|
|
|
|
|
|
|
|
|
|
Severance pay funds |
|
|
823 |
|
618 |
|
Equipment, net |
|
|
|
487 |
|
614 |
|
Intangible assets, net |
|
|
480 |
|
160 |
|
|
|
Total Assets |
|
|
13,858 |
|
18,160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
|
|
Trade payable |
|
|
851 |
|
1,707 |
|
|
Accrued expenses |
|
|
2,053 |
|
3,300 |
|
|
Accrued severance pay |
|
|
3 |
|
756 |
|
|
Deferred revenues |
|
|
1,313 |
|
885 |
|
|
|
Total Current Liabilities |
|
|
4,220 |
|
6,648 |
|
Long Term Liabilities |
|
|
|
|
|
|
|
Accrued severance pay |
|
|
1,027 |
|
870 |
|
|
Other long term liabilities |
|
|
107 |
|
– |
|
|
|
Total Long Term |
|
|
1,134 |
|
870 |
|
Total Liabilities |
|
|
|
5,354 |
|
7,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity |
|
|
|
|
|
|
|
Share capital |
|
|
|
216 |
|
213 |
|
|
Other comprehensive income |
|
|
– |
|
76 |
|
|
Additional paid-in capital |
|
|
95,820 |
|
94,761 |
|
|
Treasury stock |
|
|
(669) |
|
– |
|
|
Accumulated deficit |
|
|
(86,863) |
|
(84,408) |
|
|
|
Total Shareholders Equity |
|
|
8,504 |
|
10,642 |
|
Total Liabilities and Shareholders Equity |
|
|
13,858 |
|
18,160 |
Feb. 23, 2010 (Business Wire) — Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today reported that the Gastrointestinal Drugs Advisory Committee of the FDA has recommended by a vote of 14 to 4 in favor of the approval of XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy (HE).
“We are very pleased with the advisory committee’s support for the approval of XIFAXAN 550 mg tablets. If approved, XIFAXAN 550 mg will be the first new option for the management of hepatic encephalopathy in over 30 years,” stated Bill Forbes, Pharm.D., Senior Vice President Research and Development and Chief Development Officer, Salix. “We believe the availability of XIFAXAN 550 mg has the potential to change the treatment paradigm for HE. Today’s independent recommendation from the outside experts comprising the advisory committee reinforces the Company’s confidence in the potential for XIFAXAN 550 mg to provide a solution for patients suffering from this serious condition.”
The committee reviewed data from the Company’s 299-subject, double-blind, placebo-controlled, multinational, Phase 3 study. This study demonstrated a statistically significant and clinically meaningful reduction in the risk of recurrent overt HE.1 The primary endpoint – the risk of experiencing a breakthrough overt HE episode – was reduced by 58 percent in XIFAXAN 550 mg-treated subjects compared with placebo (p<0.0001). The key secondary endpoint – risk of experiencing HE-related hospitalization – was reduced by 50 percent in XIFAXAN 550 mg-treated subjects compared with placebo (p=0.0129). The committee also reviewed supporting evidence from the Company’s long-term, open-label, Phase 3 study, as well as evidence derived from clinical studies in acute HE, three-month and six-month studies from the published literature and meta-analyses.
The FDA convenes the Gastrointestinal Drugs Advisory Committee to obtain independent expert advice on a broad scope of issues relating to gastrointestinal drug products. The committee provides non-binding recommendations which will be considered by the FDA in its final review; however, the final decision on approval of the drug is made by the FDA.
The FDA has issued an action date of March 24, 2010 under the Prescription Drug User Fee Act for the XIFAXAN 550 mg HE NDA. XIFAXAN has been granted Orphan Drug designation by the FDA for use in hepatic encephalopathy. Salix believes this designation will provide seven years of marketing exclusivity in the United States if XIFAXAN 550 mg gains approval from the FDA for HE.
Hepatic encephalopathy occurs frequently in patients with cirrhosis as a result of their end-stage liver disease. Typically the cirrhosis is caused by a number of factors, such as alcohol and/or drug abuse, chronic viral hepatitis and autoimmune disease. There are more than 600,000 cases of cirrhosis in the United States and it is a leading cause of death in the United States.2 The number of cases of liver disease in the United States and around the world is rapidly increasing, with the estimated prevalence of chronic liver disease in the United States believed to be between 6 and 7 million cases. There are reported to be approximately 200,000 patients in the United States with overt HE.
About Hepatic Encephalopathy
Hepatic encephalopathy (HE) is a neurological disorder caused by chronic liver failure resulting in cognitive, psychiatric and motor impairments. The condition encompasses a wide spectrum of often reversible neuropsychiatric abnormalities caused by the inability of the liver to remove toxic products in the gut, most notably ammonia produced by bacteria in the GI tract. When toxins reach the central nervous system, this condition can result in symptoms ranging in severity from mild cerebral function deficits to coma and characterized by disruption in sleep patterns, changes in personality and intellectual capacity, high blood ammonia levels, altered neuromuscular activity and electroencephalogram (EEG) abnormalities.
About XIFAXAN® (rifaximin)
Rifaximin is a gut-selective antibiotic with negligible systemic absorption (<0.4%) and broad-spectrum activity in vitro against both gram-positive and gram-negative pathogens. Rifaximin has a similar tolerability profile to that of placebo.
Rifaximin tablets 200 mg, which Salix markets in the United States under the trade name XIFAXAN® (rifaximin) tablets 200 mg, currently is approved for the treatment of patients, 12 years of age or older, with travelers’ diarrhea (TD) caused by non–invasive strains of Escherichia coli. XIFAXAN (rifaximin) is a gut–selective antibiotic with negligible systemic absorption (<0.4%) and broad–spectrum activity in vitro against both gram–positive and gram–negative pathogens. Rifaximin has a similar tolerability profile to that of placebo and has activity against the most common TD pathogens. XIFAXAN should not be used in patients with diarrhea complicated by fever or blood in the stool or diarrhea due to pathogens other than Escherichia coli. XIFAXAN should be discontinued if diarrhea symptoms get worse or persist more than 24–48 hours and alternative antibiotic therapy should be considered. In clinical trials, XIFAXAN was generally well tolerated. The most common side effects (vs. placebo) were flatulence 11.3% (versus 19.7%), headache 9.7% (versus 9.2%), abdominal pain 7.2% (versus 10.1 %) and rectal tenesmus 7.2% (versus 8.8%).
Rifaximin has been used in Italy for 24 years and is approved in 33 countries. Salix acquired rights to market rifaximin in North America from Alfa Wassermann S.p.A. in Bologna, Italy. Alfa Wassermann markets rifaximin in Italy under the trade name Normix®.
About Salix Pharmaceuticals
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, NC, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete with any required development and regulatory submission of these products, and market them through the Company’s gastroenterology specialty sales and marketing team.
Salix also markets MOVIPREP® (PEG 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate and Ascorbic Acid for Oral Solution), VISICOL® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets, OSMOPREP® (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets, APRISO™ (mesalamine) extended-release capsules 0.375 g., METOZOLVTM ODT (metoclopramide HCl), PEPCID® (famotidine) for Oral Suspension, Oral Suspension DIURIL® (Chlorothiazide), AZASAN® Azathioprine Tablets, USP, 75/100 mg, ANUSOL-HC® 2.5% (Hydrocortisone Cream, USP), ANUSOL-HC® 25 mg Suppository (Hydrocortisone Acetate), PROCTOCORT® Cream (Hydrocortisone Cream, USP) 1% and PROCTOCORT® Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 mg. Crofelemer, budesonide foam and rifaximin for additional indications are under development.
For full prescribing information and important safety information, including BOXED WARNINGS for VISICOL, OSMOPREP and METOZOLV, on Salix products, please visit www.salix.com where the Company promptly posts press releases, SEC filings and other important information or contact the Company at 919 862-1000.
For more information, please visit our Web site at www.salix.com or contact the Company at 919-862-1000. Information on our Web site is not incorporated into our SEC filings.
Please Note: The materials provided herein contain projections and other forward-looking statements regarding future events. Such statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: the unpredictable nature of the duration and results of regulatory review of new drug applications; market acceptance for approved products; generic and other competition; the possible impairment of, or inability to obtain, intellectual property rights and the costs of obtaining such rights from third parties; our need to return to profitability; and the need to acquire new products. The reader is referred to the documents that the Company files from time to time with the Securities and Exchange Commission.
1. Barbaro. In: Hepatology: Flumazenil for Hepatic Encephalopathy Grade III and IVa in Patients With Cirrhosis: An Italian Multicenter Double-Blind, Placebo-Controlled, Cross-Over Study 1998: 374-378. AASLD publication Vol. 28, No. 2.
2. DuFour. In: Everhart, ed. Digestive Diseases in the United States: Epidemiology and Impact. 1994: 613-646. NIH publication No. 94-1447.
Feb. 24, 2010 (Business Wire) — FedFirst Financial Corporation (the “Company”) (Nasdaq Capital: FFCO), holding company for First Federal Savings Bank (the “Bank”), announced today that the Board of Directors of the Company has unanimously adopted a Plan of Conversion and Reorganization pursuant to which the Bank will reorganize from the two-tier mutual holding company structure to the stock holding company structure and will undertake a “second-step” stock offering of shares of common stock of a new state chartered corporation formed in connection with the conversion. The Bank converted from a mutual savings bank to the two-tier mutual holding company structure in 1999 and completed a public offering of shares of the mid-tier stock holding company in 2005.
FedFirst Financial Mutual Holding Company (the “MHC”), which owns approximately 57.5% of the outstanding common stock of the Company, will be merged with and into the Bank as part of the reorganization and its shares in the Company will be retired. The new holding company will offer and sell shares of common stock in an amount representing the percentage ownership interest currently held by the MHC, to be based on an appraisal of the Bank, as converted, which will be performed by an independent appraiser. The new holding company will offer shares of its common stock for sale to the Bank’s eligible account holders and borrows and to members of the general public in a subscription and community offering in the manner and subject to the priorities set forth in the Plan of Conversion and Reorganization. The highest priority will be depositors with qualifying deposits as of January 31, 2009. In addition, existing shareholders of the Company, other than the MHC, will receive shares of common stock of the new holding company pursuant to an “exchange ratio” designed to preserve their aggregate percentage ownership interest. The exchange ratio will be determined based upon the appraisal and the results of the offering.
The conversion and reorganization will be subject to approval of the Bank’s depositors and certain borrowers, the Company’s shareholders (including the approval of a majority of the shares held by persons other than the MHC), and the Office of Thrift Supervision.
Information, including the details of the offering and business and financial information about the Company and the Bank, will be provided in proxy materials and a prospectus when the offering commences, which is expected to be during the second quarter of 2010.
FedFirst Financial Corporation is the parent company of First Federal Savings Bank, a community-oriented financial institution operating nine full-service branch locations in southwestern Pennsylvania. First Federal offers a broad array of retail and commercial lending and deposit services and provides commercial and personal insurance services through Exchange Underwriters, Inc., its 80% owned subsidiary.
This release is neither an offer to sell nor a solicitation of an offer to buy common stock. The offer is made only by the prospectus when accompanied by a stock order form. The shares of common stock of the new holding company are not savings accounts or savings deposits, may lose value, and are not insured by the Federal Deposit Insurance Corporation or any other government agency.
This press release contains certain forward-looking statements about the conversion and reorganization. Forward-looking statements include statements regarding anticipated future events and can be identified by the fact that they do not relate strictly to historical or current facts. They often include words such as “believe,” “expect,” “anticipate,” “estimate,” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could,” or “may.” Forward-looking statements, by their nature, are subject to risks and uncertainties. Certain factors that could cause actual results to differ materially from expected results include delays in consummation of the Plan of Conversion and Reorganization, difficulties in selling the conversion stock or in selling the conversion stock within the expected time frame, increased competitive pressures, changes in the interest rate environment, general economic conditions or conditions within the securities markets, and legislative and regulatory changes that could adversely affect the business in which the Company and Bank are engaged.
Feb. 24, 2010 (Business Wire) — PositiveID Corporation (“PositiveID” or the “Company”) (NASDAQ:PSID) announced today that it has entered into a partnership with FIS™ (NYSE:FIS), one of the world’s largest providers of banking and payments technology, to launch the Company’s next generation Health Link personal health record (“Health Link”). The new Health Link, which is now live, will be interoperable with Microsoft HealthVault and Google Health, as well as numerous electronic medical records systems in use throughout the country.
To launch the next generation of Health Link, PositiveID partnered with FIS and their HealthManager product to build a robust, interoperable personal health record to offer patients the best of breed for storing and accessing their vital data. Health Link connects patients to a multitude of customized material such as personalized health education and online connectivity to caregivers. Through reminders and alerts that can be tailored to suit an individual’s unique circumstances, members are reminded of important actions and receive suggestions to better manage their health. This includes everything from refilling prescriptions on time, appointment reminders, drug interaction warnings, and tips for preventative actions.
Scott R. Silverman, Chairman and CEO of PositiveID, said, “The next generation of our Health Link personal health record will put consumers in charge of their health information, enabling them to manage all of their health data from one centralized, interoperable location. Health Link’s partnership with FIS will give patients the ability to connect to their healthcare providers, pharmacies, caretakers, and even their medical devices.”
About FIS
FIS delivers banking and payments technologies to more than 14,000 financial institutions and businesses in over 100 countries worldwide. FIS provides financial institution core processing, and card issuer and transaction processing services, including the NYCE® Network. FIS maintains processing and technology relationships with 40 of the top 50 global banks, including nine of the top 10. FIS is a member of Standard and Poor’s (S&P) 500® Index and consistently holds a leading ranking in the annual FinTech 100 rankings. Headquartered in Jacksonville, Fla., FIS employs more than 30,000 on a global basis. FIS is listed on the New York Stock Exchange under the “FIS” ticker symbol. For more information about FIS see www.fisglobal.com.
About PositiveID Corporation
PositiveID Corporation develops and markets healthcare and information management products through its RFID-based diagnostic devices and identification technologies, and its proprietary disease management tools. PositiveID operates in two main divisions: HealthID and ID Security. For more information on PositiveID, please visit www.PositiveIDCorp.com.
Statements about PositiveID’s future expectations, including the ability of Health Link to be interoperable with Microsoft Health Vault and Google Health and numerous electronic medical records systems in use throughout the country, the capabilities of Health Link, the ability of Health Link to put consumers in charge of their health information, enabling them to manage all of their health data from one centralized, interoperable location, the ability of the Company’s partnership with FIS to give patients the ability to connect to their healthcare providers, pharmacies, caretakers and medical devices, and all other statements in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include the capabilities of Health Link and Health Link’s interoperability; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on February 12, 2009, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Feb. 23, 2010 (Business Wire) — Iteris, Inc. (NYSE Amex:ITI), a leader in the traffic management market that focuses on the application and development of advanced technologies, today announced that Scania, one of the world’s leading manufacturers of trucks and buses for heavy transport applications, has signed a three-year contract extension to continue to offer Iteris’ AutoVue® Lane Departure Warning (LDW) Systems as a factory-installed option on its heavy trucks. The contract period began at end of 2009 and extends through 2012.
The LDW system that Iteris provides to Scania is an active safety system that has been specially developed to take into account driver behavior as well as adverse weather conditions. This intelligent system warns the driver if the vehicle unintentionally crosses lane markings on the road. By monitoring steering wheel movement the system can also discern between intentional lane positioning as opposed to drifting caused by inattention.
“I am pleased that Scania has chosen to extend its contract to continue to provide Iteris’ AutoVue LDW Systems,” said Mr. Abbas Mohaddes, president and chief executive officer of Iteris. “Since the initial agreement in 2006, Scania has made the Iteris AutoVue LDW System a part of its safety offering for heavy commercial trucks. I believe this contract extension is another important step in solidifying our European LDW heavy truck business as we now have agreements with two of the largest European heavy truck OEM’s, Scania and MAN, through 2012.”
AutoVue LDW System
Iteris’ AutoVue LDW system is a small, integrated unit consisting of a camera, onboard computer, and sophisticated image processing algorithms. The system’s camera tracks visible lane markings and its algorithms detect when a vehicle drifts toward an unintended lane change. If this occurs, the system automatically emits a distinctive rumble strip or other audible warning, alerting the driver to make a correction. LDW is a proven, reliable technology that is well positioned to become an integral part of any comprehensive vehicle safety solution. A pioneer in vehicle safety technology, Iteris developed the world’s first production Lane Departure Warning System and is available as an OEM option in passenger cars and as an OEM and aftermarket option on heavy trucks worldwide.
About Scania
Scania is one of the world’s leading manufacturers of trucks and buses for heavy transport applications, and of industrial and marine engines. A growing proportion of the company’s operations consist of products and services in the financial and service sectors, assuring Scania customers of cost-effective transport solutions and maximum uptime. Employing 32,000 people, Scania operates in about 100 countries. Research and development activities are concentrated in Sweden, while production takes place in Europe and South America, with facilities for global interchange of both components and complete vehicles. In 2009, invoiced sales totalled SEK 62 billion and net income amounted to SEK 1.1 billion. Scania press releases are available on www.scania.com.
About Iteris, Inc.
Iteris, Inc. is a leader in the traffic management market focused on the development and application of advanced technologies that reduce traffic congestion, minimize the environmental impact of traffic congestion, and improve the safety of surface transportation systems infrastructure. Combining outdoor image processing, traffic engineering, and information technology, Iteris offers a broad range of Intelligent Transportation Systems and driver safety solutions to customers worldwide. Iteris is headquartered in Santa Ana, California, with offices throughout North America and in Europe and Asia. Investors are encouraged to contact us at 888-329-4483, or at www.iteris.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release may contain forward-looking statements, which speak only as of the date hereof and are based upon our current expectations and the information available to us at this time. Words such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “seeks,” “estimates,” “may,” “will,” “can,” and variations of these words or similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements about the performance, acceptance and expected benefits of our technology including our AutoVue Lane Departure Warning Systems, our market opportunities both domestically and abroad and our strategies and our future prospects. These statements are subject to change and we undertake no obligation to revise or update publicly any forward-looking statements for any reason. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors.
Important factors that may cause such a difference include, but are not limited to the market acceptance of our technologies and of the products that incorporate our technologies; commercial vehicle and automotive production schedules and agendas; the timing and successful completion of customer qualification of our products and the risks of non-qualification; market acceptance of our LDW system and the vehicles that incorporate our systems; our ability to specify, develop, complete, introduce, market, and transition our products and technologies to volume production in a timely manner; the potential unforeseen impact of product offerings from competitors and other competitive pressures; and the general economic and political conditions and specific conditions in the markets we address, including the general economic slowdown and volatility in the automotive and commercial vehicle sector. Further information on Iteris, Inc., including additional risk factors that may affect our forward-looking statements, is contained in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K, and our other SEC filings that are available through the SEC’s website (www.sec.gov).
Feb. 23, 2010 (PR Newswire) — NIVS Announces Preliminary Results of Operations for 2009
HUIZHOU, Guangdong, China — NIVS IntelliMedia Technology Group, Inc. (“NIVS” or the “Company”) (NYSE Amex: NIV), a consumer electronics company that designs, manufactures and sells intelligent audio and visual products, today announced preliminary results of operations for its fiscal 2009 year end.
Preliminary results from the Company’s 2009 fiscal year ended December 31, 2009 include:
-- Estimated revenue of $184 million to $186 million for the year
ended December 31, 2009 as compared to $143.6 million for the year
ended December 31, 2008.
-- Estimated net income for the year ended December 31, 2009 of $23.5
million to $25.5 million as compared to $13 million for the year
ended December 31, 2008 - of note is that net income for 2009 was
positively affected by the reversal in 2009 of $2.7 million of bad
debt allowance. This reversal in 2009, combined with $2.5 million of
bad debt expense recorded in 2008 resulted in $5.2 million of the
estimated $10.5 to $12.5 million increase in estimated net income
for 2009. The Company believes the reversal of its bad debt allowance
was justified due to an improvement in the Chinese economy in late
2009, stable collection of accounts receivable in 2009 and the
Company's efforts to collect outstanding old accounts receivables
in 2009.
-- General and administrative expense for the year ended December 31, 2009
are estimated to be $1.5 million to $1.7 million as compared to $8.7
million for the year ended December 31, 2008 - of note is that the
substantial portion of such decrease relates to the above-referenced
$5.2 million decrease in general and administrative expense resulting
from the $2.7 million reversal of bad debt allowance in 2009 and the
$2.5 million bad debt expense recorded in 2008.
-- Cash and cash equivalents at December 31, 2009 were approximately $6.0
million with a working capital deficit of $4.6 million as compared to
$0.5 million of cash and cash equivalents and an $18.6 working capital
deficit for the period ended December 31, 2008
“We are encouraged to report strong estimated revenue and net income growth for fiscal 2009. The improvement in our working capital position at year-end as compared to the previous year-end period is also encouraging,” commented Mr. Tianfu Li, NIVS’ Chairman and Chief Executive Officer.
About NIVS IntelliMedia Technology Group, Inc.
NIVS IntelliMedia Technology Group is an integrated consumer electronics company that designs, manufactures, markets and sells intelligent audio and video products in China, Greater Asia, Europe, and North America. The NIVS brand has received “Most Popular Brand” distinction in China’s acoustic industry for three consecutive years, among numerous other awards. NIVS has developed leading Chinese speech interactive technology, which forms a foundation for the Company’s intelligent audio and visual systems, including digital audio, LCD televisions, digital video broadcasting (“DVB”) set-top boxes, peripherals and more.
Safe Harbor Statement
This release contains certain “forward-looking statements” relating to the business of the Company and its subsidiary companies. These forward looking statements are often identified by the use of forward looking terminology such as “believes, expects” or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties, including, but not limited to completion and audit of the Company’s financial statements for the fourth quarter and year end 2009; the Company’s ability to remediate the significant deficiencies and/or material weakness(es) in its internal controls; the Company’s ability to effectively integrate the operations and management of acquisition targets; the Company’s ability to timely deliver products; the Company’s ability to timely develop and market new products; the Company’s ability to continue to borrow and raise additional capital to fund its operations; the Company’s ability to accurately forecast amounts of supplies needed to meet customer demand; exposure to market risk through sales in international markets; the market acceptance of the Company’s products; exposure to product liability and defect claims; fluctuations in the availability of raw materials and components needed for the Company’s products; protection of the Company’s intellectual property rights; and changes in the laws of the PRC that affect the Company’s operations. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the discussed above and in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume an obligation to update these forward-looking statements.
Feb. 23, 2010 (PR Newswire) — PharmAthene Awarded up to Additional $78.4 Million Under Existing Contract for Advanced Development of SparVax(TM) Anthrax Vaccine
ANNAPOLIS, Md. — PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA) has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile (SNS).
“We are pleased to be awarded additional development funding for our SparVax™ anthrax vaccine program, which may offer a promising improved alternative to existing anthrax vaccine options,” commented David P. Wright, President and Chief Executive Officer. “There is widespread acknowledgement among various government agencies that the United States must develop and stockpile a second generation anthrax vaccine employing modern vaccine technology that offers the potential for improved safety, convenience and enhanced cost effectiveness. New and improved anthrax vaccines, based on modern state-of-the-art recombinant vaccine technology, incorporate significant product development and technological advancements and ultimately may provide meaningful health and economic advantages.”
In addition to the funding announced today, on February 1, 2010 PharmAthene also submitted a White Paper seeking further development funding for SparVax™, in response to a Broad Agency Announcement (Solicitation Number: BAA-BARDA-09-34).
“We believe that, if awarded, funding provided under the BAA, along with the additional funding announced today, could be sufficient to advance SparVax™ to a stage where it will be eligible for consideration for a Project BioShield procurement contract,” said Mr. Wright.
SparVax™ is a highly purified recombinant protective antigen vaccine being developed for pre and post exposure protection against anthrax infection. Phase I and Phase II clinical trials involving 770 healthy human subjects have been completed and demonstrated that SparVax™ appears to be well tolerated and immunogenic in humans. These studies suggest that three doses of SparVax™, administered over a 56 day period, are sufficient to induce protective immunity. The vaccination regimen for the currently licensed anthrax vaccine, BioThrax®, requires five doses over a period of eighteen months.
The contract modification, which is effective February 22, 2010 and extends until December 31, 2012, provides for up to $61 million during a “base period” of performance with options for an additional $17 million on a cost reimbursement plus fixed fee basis in additional advanced development funding for SparVax™. Provided that certain milestones are achieved, and that all contract options and extensions are exercised by the government, the contract has a total potential value of $78.4 million. The activities outlined under the contract modification are designed to continue existing development activities already under contract (HHSO100200900103C). The modification will include non-clinical safety and efficacy studies, assay development and qualification, and process scale up and validation.
“PharmAthene has a strong track record of successfully collaborating with a number of U.S. government agencies, including, the National Institutes of Health (NIH), BARDA, the United States Army Medical Research Institute for Infectious Diseases, and the Department of Defense, to advance the development of our biodefense product portfolio to address biological and chemical threats and preserve the security and well-being of our military personnel and citizens. We are deeply committed to providing improved medical countermeasures for anthrax, which is considered to be the number one biological threat facing the Nation. We applaud President Obama’s renewed commitment to protecting our Nation against the threat of bioterrorism and look forward to continuing our work with the government. It is our shared goal to develop the medical countermeasures necessary to successfully deter or quickly respond to a biologic attack and save American lives,” said Mr. Wright.
Including the additional funding announced today, PharmAthene’s SparVax™ program has been awarded funding commitments from the U.S. government totaling up to $213.2 million.
The rPA contract modification was announced via a Special Notice (Solicitation Number: HHSO100200900103C) rPA Anthrax Vaccine Advance Development, issued by HHS on December 29, 2009. The original development contract for rPA vaccine (N01-Al-30052) was issued in 2003 and transferred to BARDA on April 1, 2009.
About SparVax™
SparVax™ is a novel second generation recombinant protective (rPA) anthrax vaccine being developed for pre and post exposure protection against anthrax infection. SparVax™ is a highly purified, well characterized, sub unit vaccine comprised of a single protein (recombinant PA) manufactured in E.coli. Phase I and Phase II clinical trials involving 770 healthy human subjects have been completed and showed that SparVax™ appears to be well tolerated and immunogenic in humans. These studies suggest that three doses of SparVax™, administered several weeks apart, should be sufficient to induce protective immunity. In non-clinical studies SparVax™ has also demonstrated the capability to protect rabbits and non-human primates against a lethal aerosol spore challenge of the anthrax Ames strain.
About PharmAthene, Inc.
PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene’s lead product development programs include:
- SparVax™ – a second generation recombinant protective antigen (rPA) anthrax vaccine
- Third generation rPA anthrax vaccine
- Valortim® – a fully human monoclonal antibody for the prevention and treatment of anthrax infection
- Protexia® – a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents
For more information about PharmAthene, please visit www.PharmAthene.com.
Statement on Cautionary Factors
Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words “potential”; “believe”; “anticipate”; “intend”; “plan”; “expect”; “estimate”; “could”; “may”; “should”; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risks associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company’s product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company’s development programs, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products as well as risks detailed from time to time in PharmAthene’s Form 10-K and 10-Q under the caption “Risk Factors” and in its other reports filed with the U.S. Securities and Exchange Commission (the “SEC”). In particular, the funding provided for under this contract modification is not sufficient to complete the development work needed for SparVax™ to meet the criteria for procurement into the Strategic National Stockpile or to achieve FDA licensure. There can be no assurance that the government will provided additional funding to support the further advanced development of this product candidate to achieve these objectives. Furthermore, significant additional non-clinical animal studies, human clinical trials, and manufacturing development work remain to be completed for SparVax™. At this point there can be no assurance that this product candidate will be shown to be safe and effective and approved by regulatory authorities for use in humans. Copies of PharmAthene’s public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com.
Feb. 22, 2010 (PR Newswire) — Cimatron Reports Non-GAAP Net Profit of $1 Million in the Fourth Quarter of 2009
GIVAT SHMUEL, Israel, February 22, 2010 /PRNewswire-FirstCall/ — Cimatron Limited (NASDAQ: CIMT) (“Cimatron” or the “Company”), a leading provider of integrated CAD/CAM solutions for the toolmaking and manufacturing industries, today announced financial results for the fourth quarter and full year 2009.
The following provides details on Cimatron’s GAAP and non-GAAP results for the fourth quarter and full year 2009:
GAAP:
Revenues for the fourth quarter of 2009 were $9.8 million, compared to $10.4 million recorded in the fourth quarter of 2008. In the full year ended December 31, 2009, revenues were $33 million, compared to $41 million in 2008.
Gross Profit for the fourth quarter of 2009 was $8 million as compared to $8.3 million for the same period in 2008. Gross margin in the fourth quarter of 2009 was 82% of revenues, compared to a gross margin of 79% in the fourth quarter of 2008. In 2009, gross profit was $26.8 million, compared to $33.2 million in 2008. Gross margin in 2009 constituted 81% of revenues, reflecting no change relative to 2008.
Operating Profit in the fourth quarter of 2009 was $773 thousand, compared to an operating profit of $652 thousand in the fourth quarter of 2008. In 2009, Cimatron recorded an operating loss of $(957) thousand, compared to an operating profit of $526 thousand in 2008.
Net Profit for the fourth quarter of 2009 was $1.4 million, or $0.15 per diluted share, compared to a net profit of $706 thousand, or $0.08 per diluted share recorded for the same quarter of 2008.
In 2009, net profit was $14 thousand, or $0.00 per diluted share, compared to a net profit of $724 thousand, or $0.08 per diluted share, in 2008.
Non-GAAP:
Revenues on a non-GAAP basis for the fourth quarter of 2009 were $9.8 million, compared to $10.5 million recorded for the fourth quarter of 2008. In the full year ended December 31, 2009, revenues were $33 million, compared to $41.8 million in 2008.
Gross Profit on a non-GAAP basis for the fourth quarter of 2009 was $8.2 million as compared to $8.5 million for the same period in 2008. Gross margin in the fourth quarter of 2009 was 84% of revenues, compared to 81% in the fourth quarter of 2008. In 2009, gross profit on a non-GAAP basis was $27.4 million, compared to $34.6 million in 2008. Gross margin on a non-GAAP basis in 2009 constituted 83% of revenues, reflecting no change relative to 2008.
Operating Profit on a non-GAAP basis in the fourth quarter of 2009 was $1 million, compared to an operating profit of $977 thousand in the fourth quarter of 2008. In 2009, Cimatron recorded an operating profit of $31 thousand, compared to operating profit of $2.3 million in 2008.
Net Profit on a non-GAAP basis for the fourth quarter of 2009 was $955 thousand, or $0.10 per diluted share, compared to net profit of $553 thousand, or $0.06 per diluted share recorded in the same quarter of 2008. In 2009, net profit was $46 thousand, or $0.01 per diluted share, compared to net profit of $2.2 million, or $0.23 per diluted share, in 2008.
Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, said “We are very pleased with the fourth quarter results. The combination of higher revenues (relative to previous quarters in 2009) and continued tight budget control has resulted in a strong bottom line in the fourth quarter, and positive cash flow for the entire year. 2009 was one of the toughest years for our industry, ever. In spite of a steep drop in global demand, we were able to generate a significant amount of cash in 2009, and even show small non-GAAP operating and net profits for the year. We are confident that our strong market position, strong balance sheet, and healthy cash reserves, together with continued investment in marketing and product development, will help us take advantage of new business opportunities. We are witnessing some signs of market recovery, and look forward to a hopefully less turbulent 2010”, concluded Mr. Haran.
Conference Call
Cimatron’s management will host a conference call tomorrow, February 23rd, 2010 at 9:00 EST, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.
To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.
USA: +1-800-994-4498
International: +972-3-9180644
Israel: 03-9180644
For those unable to listen to the live call, a replay of the call will be available from the day after the call at the investor relations section of Cimatron’s website, at: http://www.cimatron.com
Reconciliation between results on a GAAP and Non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets and deferred income tax, as well as certain business combination accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-GAAP charges and other items that are considered by management to be outside our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.
Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance, especially as our two most recent acquisitions have resulted in amortization and non-cash items that have had a material impact on our GAAP results. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.
About Cimatron
With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers, as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.
The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron’s subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company web site at: http://www.cimatron.com.
Safe Harbor Statement
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act Of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the Company’s plans, objectives and expected financial and operating results. The words “may,” “could,” “would,” “will,” “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties of the business, refer to the Company’s filings with the Securities and Exchanges Commission. The Company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
CIMATRON LIMITED
CONSOLIDATED STATEMENTS OF INCOME
(US Dollars in thousands, except for per share data)
Three months ended Twelve months ended
December 31, December 31,
2009 2008 2009 2008
Total revenue 9,762 10,404 32,957 40,975
Total cost of revenue 1,719 2,142 6,186 7,769
Gross profit 8,043 8,262 26,771 33,206
Research and development
expenses, net 1,347 1,657 5,736 6,930
Selling, general and
administrative expenses 5,923 5,953 21,992 25,750
Operating income (loss) 773 652 (957) 526
Financial income
(expenses), net. 38 (207) 19 (80)
Taxes on Income 639 263 949 237
Other (41) 5 (41) -
Net income (loss) 1,409 713 (30) 683
Less: Net loss (gain)
attributable to the
noncontrolling interest (18) (*)(7) 44 (*)41
Net income attributable to
Cimatron's shareholders $ 1,391 $ 706 $ 14 $ 724
Net income per share -
basic and diluted $ 0.15 $ 0.08 $ 0.00 $ 0.08
Weighted average number of
shares outstanding
Basic EPS
(in thousands) 9,128 9,274 9,156 9,341
Diluted EPS
(in thousands) 9,128 9,274 9,156 9,360
(*) Reclassification due to the adoption of SFAS 160
CIMATRON LIMITED
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
(US Dollars in thousands, except for per share data)
Three months ended
December 31,
2009 2008
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total revenue (1) 9,762 - 9,762 10,404 77 10,481
Total cost of
revenue (2) 1,719 (147) 1,572 2,142 (148) 1,994
Gross profit 8,043 147 8,190 8,262 225 8,487
Research and
development expenses,
net 1,347 - 1,347 1,657 - 1,657
Selling, general and
administrative
expenses (2) 5,923 (100) 5,823 5,953 (100) 5,853
Operating income
(loss) 773 247 1,020 652 325 977
Financial income
(expenses), net. 38 - 38 (207) - (207)
Taxes on Income (3) 639 (726) (87) 263 (478) (215)
Other (4) (41) 43 2 5 - 5
Net income (loss) 1,409 (436) 973 713 (153) 560
Less: Net loss
(gain) attributable
to the noncontrolling
interest (18) - (18) (*)(7) - (*) (7)
Net income (loss)
attributable to
Cimatron's
shareholders $ 1,391 $ (436) $ 955 $ 706 $(153) $ 553
Net income per share
- basic and diluted $ 0.15 $ 0.10 $ 0.08 $ 0.06
Weighted average
number of shares
outstanding
Basic EPS
(in thousands) 9,128 9,128 9,274 9,274
Diluted EPS
(in thousands) 9,128 9,128 9,274 9,274
Twelve months ended
December 31,
2009 2008
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total revenue (1) 32,957 - 32,957 40,975 821 41,796
Total cost of
revenue (2) 6,186 (588) 5,598 7,769 (588) 7,181
Gross profit 26,771 588 27,359 33,206 1,409 34,615
Research and
development
expenses, net 5,736 - 5,736 6,930 - 6,930
Selling, general
and administrative
expenses (2) 21,992 (400) 21,592 25,750 (400) 25,350
Operating income
(loss) (957) 988 31 526 1,809 2,335
Financial income
(expenses), net. 19 - 19 (80) - (80)
Taxes on Income (3) 949 (999) (50) 237 (358) (121)
Other (4) (41) 43 2 - - -
Net income (loss) (30) 32 2 683 1,451 2,134
Less: Net loss (gain)
attributable to the
noncontrolling interest 44 - 44 (*)41 - (*)41
Net income (loss)
attributable to
Cimatron's
shareholders $ 14 $ 32 $ 46 $ 724 $1,451 $ 2,175
Net income per share
- basic and diluted $ 0.00 $ 0.01 $ 0.08 $ 0.23
Weighted average
number of shares
outstanding
Basic EPS
(in thousands) 9,156 9,156 9,341 9,341
Diluted EPS
(in thousands) 9,156 9,156 9,360 9,360
(*) Reclassification due to the adoption of SFAS 160
(1) Non-GAAP adjustment related to Gibbs' assumed support contracts
that were not recognized on a GAAP basis in fiscal 2008 or thereafter
due to business combination accounting rules.
(2) Non-GAAP adjustment to exclude non-cash amortization of acquired
intangible assets.
(3) Non-GAAP adjustment to exclude the effect of deferred taxes.
(4) Non-GAAP adjustment to exclude loss from discontinued operations.
CIMATRON LIMITED
CONSOLIDATED BALANCE SHEETS
(US Dollars in thousands)
December 31, December 31,
2009 2008
ASSETS
CURRENT ASSETS:
Total cash, cash equivalents and
short-term investments $ 6,684 $ 5,727
Trade receivables 5,422 7,108
Other current assets 3,308 2,697
Total current assets 15,414 15,532
Deposits with insurance companies
and severance pay fund 2,935 2,719
Net property and equipment 1,046 1,312
Total other assets 13,285 14,307
Total assets $ 32,680 $ 33,870
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Short-term bank credit $ 456 $ 155
Trade payables 1,064 1,865
Accrued expenses and other liabilities 6,991 7,348
Deferred revenues 2,397 2,348
Total current liabilities 10,908 11,716
LONG-TERM LIABILITIES:
Accrued severance pay 4,104 3,933
Long-term loan 204 293
Deferred tax liability 1,365 1,729
Total long-term liabilities 5,673 5,955
Total shareholders' equity 16,099 (*)16,199
Total liabilities and shareholders' equity $ 32,680 $ 33,870
(*) Reclassification due to the adoption of SFAS 160
CIMATRON LIMITED
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(US Dollars in thousands)
Accumulated
Additional other
Non-controlling Share paid-in comprehensive
Interest capital capital income (loss)
Balance at
December 31, 2008 $ (4) $ 304 $ 18,131 $ 65
Changes during the
twelve months ended
December 31, 2009:
Net gain (loss) (44)
Unrealized loss on
derivative instruments (81)
Stock option
compensation 73
Investment in treasury
stock
Foreign currency
translation adjustment 91
Total comprehensive loss
Balance at
December 31, 2009 $ (48) $ 304 $ 18,204 $ 75
Retained
earnings Comprehensive Total
(accumulated Treasury income shareholders'
deficit) stock (loss) equity
Balance at
December 31, 2008 $ (1,908) $ (389) $ 16,199
Changes during the
twelve months ended
December 31, 2009:
Net gain (loss) 14 (30) (30)
Unrealized loss on
derivative instruments (81) (81)
Stock option
compensation 73
Investment in
treasury stock (153) (153)
Foreign currency
translation adjustment 91 91
Total comprehensive
loss (20)
Balance at
December 31, 2009 $ (1,894) $ (542) $ 16,099
CIMATRON LIMITED
STATEMENTS OF CASH FLOWS
(US Dollars in thousands)
Twelve months ended
December 31,
2009 2008
Cash flows from operating activities:
Net (loss) gain $ (30) (*)$ 683
Adjustments to reconcile net loss
to net cash provided by operating
activities:
Depreciation and amortization 1,575 1,584
Increase in accrued severance pay 138 4
Gain from sale of property and
equipment, net - (3)
Stock option compensation 73 115
Loss on disposal of businesses -
discontinued operations 43 -
Deferred taxes, net (984) (359)
Changes in assets and liabilities:
Increase in accounts receivable and
prepaid expenses 1,854 2,475
Decrease (increase) in inventory (15) 26
Increase in deposits with insurance
companies and severance pay fund (216) (16)
Decrease in trade payables, accrued
expenses and other liabilities (1,164) (1,739)
Net cash provided by operating
activities 1,274 2,770
Cash flows from investing activities:
Proceeds from sale of property and
equipment - 2
Proceeds from sale and redemption of bonds - 1,245
Purchase of property and equipment (262) (438)
Cash and cash equivalents disposed of
discontinued operations (46) -
Additional payment for acquisition of
subsidiary - (1,268)
Acquisition of newly-consolidated
subsidiaries (Appendix A) - (4,761)
Net cash used in investing activities (308) (5,220)
Cash flows from financing activities:
Short-term bank credit 301 (637)
Long-term bank credit (104) 4
Proceeds from issuance of shares upon
exercise of options - 14
Investment in treasury stock (153) (230)
Net cash provided (used) in financing
activities 44 (849)
Net increase (decrease) in cash and cash
equivalents 1,010 (3,299)
Effect of exchange rate changes on cash (53) -
Cash and cash equivalents at beginning of
period 5,727 9,026
Cash and cash equivalents at end of
period $ 6,684 $ 5,727
Appendix A - Acquisition of subsidiary, net of cash acquired
Working capital - excluding cash (879)
Goodwill 4,035
Other intangible assets 5,432
Property and equipment 158
Tax Asset 302
9,048
Issuance of shares (4,287)
$ 4,761
Appendix B - Non-cash transactions
Purchase of property on credit $ 10 $ 5
(*) Reclassification due to the adoption of SFAS 160
NEW YORK, NY — (Marketwire) — 02/19/10 — Man Sang International (B.V.I.) Limited (NYSE Amex: MHJ) (“MSBVI”) today announced that it and Creative Gains Limited, its wholly owned subsidiary, have entered into a definitive merger agreement with China Metro-Rural Limited (“China Metro”) to combine the companies in an all stock transaction. The transaction is expected to be completed by March 31, 2010. This strategic transaction, unanimously approved by the independent members of the Board of Directors of MSBVI and unanimously approved by the Board of Directors of China Metro, will expand MSBVI’s commercial and real estate portfolio to include properties in New District, Tieling, Liaoning Province in the People’s Republic of China, where China Metro is currently devoted to the development and completion of an integrated, agricultural logistics and multi-functional project, known as China Northeast Logistics City, that will facilitate exhibition, trading, logistics, warehousing, commercial and residential housing in Tieling.
“The combination of MSBVI’s subsidiary and China Metro will further enhance MSBVI’s real estate portfolio and give MSBVI the opportunity to become an integral part of the exciting development that is already in progress in Tieling,” said Cheng Chung Hing, Ricky, President and Chairman of the Board of Directors and Chief Executive Officer of MSBVI. “We believe that China Metro has identified a key niche market and that China Northeast Logistics City is an excellent opportunity to actively expand MSBVI’s overall business in growing North East China while simultaneously popularizing to a worldwide market.”
Under the terms of the merger agreement, China Metro shareholders will receive approximately 574,432 ordinary shares of MSBVI for each ordinary share of China Metro they own. MSBVI will issue up to 57,443,238 ordinary shares at $5 per share (representing a premium of approximately 150% of the closing share price of MSBVI ordinary shares at $2 each on February 18, 2010) to the China Metro shareholders in order to acquire China Metro. This represents a total consideration of approximately $287 million. MSBVI shareholders will retain their shares. Upon completion of the transaction, China Metro shareholders will own approximately 90% of the ordinary shares of MSBVI and MSBVI shareholders will own approximately 10% of the ordinary shares of MSBVI. The $5 per share imputed price is not intended to serve as a projection by MSBVI of the trading price of MSBVI’s ordinary shares upon or immediately following completion of the merger.
MSBVI will maintain its corporate headquarters in Hong Kong and offices and subsidiary operations in the PRC. China Metro will operate as a wholly owned subsidiary of MSBVI and maintain its offices in Hong Kong, as well as its subsidiary operations in the PRC.
Following the close of the transaction, Mr. Cheng Chung Hing, Ricky, MSBVI’s current Chairman, President and Chief Executive Officer, will be the Chairman and President of MSBVI and Mr. Sio Kam Seng, China Metro’s current Chairman and Director, will become Vice Chairman and Chief Executive Officer of MSBVI. In addition, Ms. Leung Wai Yan will join the board of directors of MSBVI. The remaining members of the management team for MSBVI will be comprised of executives from each organization.
The transaction is subject to approval by each of MSBVI’s and China Metro’s shareholders, the approval of the listing of the shares to be issued in the transaction by the NYSE Amex, as well as customary closing conditions. The transaction is expected to be completed by March 31, 2010.
ABOUT MAN SANG INTERNATIONAL (B.V.I.) LIMITED
Man Sang International (B.V.I.) Limited, formerly Man Sang Holdings, Inc., is principally engaged through subsidiaries in the purchasing, processing, assembling, merchandising and wholesale distribution of pearls, pearl jewelry products and jewelry products. In addition, Man Sang International (B.V.I.) Limited, through its subsidiaries, owns and operates commercial real estate for lease and sale in Hong Kong and the People’s Republic of China.
IMPORTANT ADDITIONAL INFORMATION WILL BE FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION
In connection with the proposed Merger of Creative Gains Limited, a wholly owned subsidiary of MSBVI, and China Metro (the “Merger”) pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), MSBVI will file with the U.S. Securities and Exchange Commission (the “SEC”) a current report on Form 6-K, which will include a notice of a special meeting at which MSBVI’s shareholders will be asked to, among other things, adopt the Merger Agreement and approve the Merger, and a proxy statement of MSBVI and other relevant materials in connection with the proposed transactions. MSBVI expects to file the Form 6-K with the SEC on or about February 26, 2010 and mail the notice of a special meeting and proxy statement to its shareholders on or about March 2, 2010. The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which will be included in the proxy statement. MSBVI’s shareholders are urged to read the proxy statement, when it becomes available, because it will contain important information about MSBVI, China Metro and the proposed transactions. The proxy statement and other relevant materials (when they become available), and any and all documents filed with the SEC, may be obtained free of charge at the SEC’s website at www.sec.gov. Free copies of the documents filed with the SEC by MSBVI will be available on the investor relations portion of MSBVI’s website at http://www.man-sang.com.
INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE OTHER RELEVANT MATERIALS WHEN THEY BECOME AVAILABLE BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE PROPOSED TRANSACTIONS.
Forward-Looking Statements
The information above includes forward-looking statements about Man Sang International (B.V.I.) Limited. Such forward-looking statements are subject to certain risks and uncertainties, as disclosed by Man Sang International (B.V.I.) Limited from time to time in its filings with the U.S. Securities and Exchange Commission. As a result of these factors, Man Sang International (B.V.I.) Limited’s actual results may differ materially from those indicated or implied by such forward-looking statements. Man Sang International (B.V.I.) Limited disclaims any intent or obligation to update these forward-looking statements.
Feb. 22, 2010 (PR Newswire) — Deer Consumer Products, Inc. Announces Sales Expansion in the China Domestic Markets
NEW YORK — Deer Consumer Products, Inc. (“Deer”) (Nasdaq: DEER) (website: www.deerinc.com), one of the world’s largest designers and OEM/ODM manufacturers of home and kitchen electronics marketing to both global and Chinese domestic consumers, announced today that Deer has initiated product sales to Wal-Mart Stores in China.
“Deer” branded kitchen electronic products will be immediately available at local Chinese Wal-Mart stores located in the Guangdong province, China’s most economically developed region.
Bill He, Chairman & Chief Executive Officer of Deer commented: “While Deer continues to maintain healthy profit margins across all product lines, we anticipate significant revenue increases through various expanding distribution channels in the China domestic markets. Deer’s fully integrated model of aligning product design, internal manufacturing and quality control, supply chain and customers has helped establish Deer as an effective distribution platform for expanded product offerings in China’s fast growing small household appliance industry. We look forward to reporting our 2009 annual results by mid March of 2010.”
About Deer Consumer Products, Inc.
Deer Consumer Products, Inc. (www.deerinc.com) is a NASDAQ Global Market listed U.S. public company headquartered in China. Deer has a 15-year operating business. Supported by more than 103 patents, trademarks, copyrights and approximately 2,000 company-trained seasonal and full-time staff, Deer is a leading designer, ODM/OEM manufacturer and global marketer of quality small home and kitchen electric appliances. Deer’s product lines include blenders, juicers, soy milk makers and a large variety of other home appliances designed to make today’s lifestyles simpler and healthier. With more than 100 global clients/branded products such as Black & Decker, Ariete, Disney, Toastmaster, Magic Bullet, Back to Basics and Wal-Mart, Deer has enjoyed rapid sales and earnings growth in recent years.
Safe Harbor Statement
All statements in this press release that are not historical are forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ from the company’s expectations. You are cautioned not to place undue reliance on any forward-looking statements in this press release as they reflect Deer’s current expectations with respect to future events and are subject to risks and uncertainties that may cause actual results to differ materially from those contemplated. Potential risks and uncertainties include, but are not limited to, the risks described in Deer’s filings with the Securities and Exchange Commission.
Feb. 22, 2010 (Business Wire) — TowerJazz, the global specialty foundry leader, today announced its full library of Y-Flash Non-Volatile Memory (NVM) building blocks at the Applied Power Electronics Conference (APEC), Booth #413, in Palm Springs, Calif., Feb. 22-24, 2010. This patented Y-Flash technology, not available from any other foundry in the industry, is designed to give customers flexibility on memory size, allowing optimization of performance/cost for any given application. TowerJazz invented its Y-Flash building blocks to meet the ever expanding customer needs for NVM in today’s power supplies for consumer, medical, industrial and automotive applications. VDC Research forecasts worldwide shipment of power management ICs to grow more than 10% annually through 2012.
Y-Flash is the leading solution for NVM in the market today due to its small cell size, zero mask adder and flexibility to implement various memory sizes. Current competing NVM solutions for medium density memories add 11 or more masks to the process flow, over the standard ~20 masks, making it impossible to have a one-chip solution for digital power management. Y-Flash can support a variety of memory densities from a few bits for trimming and chip ID applications up to 256Kb and more for code storage. NVM blocks that utilize this proprietary technology include array sizes that are up to five times smaller than other competitive solutions and can be built using only one gate oxide allowing for ultra low cost designs. Y-Flash is well-suited for applications such as digital controlled power, portable products and products requiring very tight and well matched IOs.
TowerJazz’s Y-Flash module was recently integrated into Exar Corporation’s latest digital power management design, and Richard Randlett, Division Vice President, Advanced Analog Design, commented, “TowerJazz has long experience and expertise in NVM technology and is well known in the industry and highly appreciated by Exar. We will definitely gain a great deal by using this technology in our new line of digital power products.”
“Our new Y-Flash memory blocks are an industry leading solution for NVM technology and further validate our business strategy and commitment to providing the most complete power management platform in the industry,” said Dr. Avi Strum, Vice President and General Manager, Specialty Business Unit at TowerJazz. “We developed this proprietary technology to further enhance our power management offerings, allowing for faster design cycles and lower cost designs for the emerging digital power applications.”
Availability
The Y-Flash IP is available in the TS35PM/TS18PM design kits. This IP combined with TowerJazz’s continuously customizable LDMOS from 20V to 80V process provides design flexibility and optimization demanded by today’s power management ICs.
About TowerJazz
Tower Semiconductor Ltd. (NASDAQ: TSEM) (TASE: TSEM), the global specialty foundry leader, and its fully owned U.S. subsidiary Jazz Semiconductor, operate collectively under the brand name TowerJazz, manufacturing integrated circuits with geometries ranging from 1.0 to 0.13-micron. TowerJazz provides industry leading design enablement tools to allow complex designs to be achieved quickly and more accurately and offers a broad range of customizable process technologies including SiGe, BiCMOS, Mixed-Signal and RFCMOS, CMOS Image Sensor, Power Management (BCD), and Non-Volatile Memory (NVM) as well as MEMS capabilities. To provide world-class customer service, TowerJazz maintains two manufacturing facilities in Israel and one in the U.S. with additional capacity available in China through manufacturing partnerships. For more information, please visit www.towerjazz.com.
Safe Harbor Regarding Forward-Looking Statements
This press release includes forward-looking statements, which are subject to risks and uncertainties. Actual results may vary from those projected or implied by such forward-looking statements. A complete discussion of risks and uncertainties that may affect the accuracy of forward-looking statements included in this press release or which may otherwise affect Tower and/or Jazz’s business is included under the heading “Risk Factors” in Tower’s most recent filings on Forms 20-F, F-3, F-4 and 6-K, as were filed with the Securities and Exchange Commission (the “SEC”) and the Israel Securities Authority and Jazz’s most recent filings on Forms 10-K and 10-Q, as were filed with the SEC, respectively. Tower and Jazz do not intend to update, and expressly disclaim any obligation to update, the information contained in this release.
Feb. 22, 2010 (GlobeNewswire) —
Results for the Fourth Quarter of 2009
- Net income of $23.1 million
- Diluted earnings per share of $0.91
Results for the Full Year of 2009
- Net income of $19.8 million
- Diluted earnings per share of $0.79
OMAHA, Neb., Feb. 22, 2010 (GLOBE NEWSWIRE) — Green Plains Renewable Energy, Inc. (Nasdaq:GPRE) announced today its financial results for the fourth quarter and full-year ended December 31, 2009. Net income attributable to Green Plains was $23.1 million, or $0.91 per diluted share, for the quarter ended December 31, 2009, compared to a net loss attributable to Green Plains of $1.8 million, or $0.08 per share, for the same period of 2008. Revenues were $436.7 million for the fourth quarter of 2009, compared to revenues of $183.2 million for the same period in 2008. For the twelve months ended December 31, 2009, revenues were $1.3 billion, with net income attributable to Green Plains of $19.8 million, or $0.79 per diluted share.
“All of our businesses performed well in the fourth quarter,” said Todd Becker, President and Chief Executive Officer. “We generated significantly higher operating income during the quarter primarily due to a strong performance from our ethanol production segment. In the fourth quarter, we produced 122 million gallons of ethanol which exceeds our expected capacity. The combination of higher production volumes, a stronger margin environment, and harvest activities for agribusiness resulted in a record quarter.”
“During 2009 and more recently, we have continued to see demand for ethanol increase driven by expanded mandates and positive blend margins. This combined with a record corn harvest resulted in an improved margin environment in late 2009 and early 2010. While we are pleased with these trends, our focus remains on risk management, operational excellence, safety and expanding our platform in the coming year as opportunities present themselves,” commented Becker.
“I am proud of the many accomplishments our team achieved during 2009. We fortified our operating, administrative and commercial activities while at the same time demonstrated our ability to significantly grow our operating segments. Our business model has been tested through one of the most challenging environments the ethanol industry has seen and continues to prove itself. As a result, we were able to reach profitability for the full year. We believe our industry, and more importantly, our company is on solid footing for the coming years,” said Becker.
EBITDA, which is defined as earnings before interest, income taxes, noncontrolling interests, depreciation and amortization, was $37.8 million for the quarter ended December 31, 2009, compared with $6.5 million for the same period in 2008. Green Plains had available liquidity of $138.7 million, including $102.3 million total cash and equivalents, and $36.4 million available under committed loan agreements (subject to satisfaction of specified lending conditions and covenants) at December 31, 2009. EBITDA for the twelve months ended December 31, 2009 was $67.7 million.
2009 Business Highlights
- On October 14, 2009, Green Plains unveiled BioProcessAlgae, LLC’s Phase I Grower Harvester TM pilot project. BioProcessAlgae has completed the installation of Phase I of the multi-phase pilot project and algae production has commenced at the company’s Shenandoah ethanol plant.
- Green Plains Trade Group LLC, a wholly-owned subsidiary, entered into an agreement to provide third-party ethanol marketing services to Lincolnway Energy, LLC at the end of the third quarter. The addition of Lincolnway, located near Nevada, Iowa, increased our third-party marketing services to four plants with annual expected ethanol production totaling 360 million gallons.
- On July 2, 2009, Green Plains completed the acquisition of two Nebraska ethanol plants located near Central City and Ord. The addition of these plants increased the company’s expected ethanol production capacity by 45%. Green Plains acquired the ethanol plants from a lender group for $121.0 million which provided debt financing to fund the purchases.
- On January 15, 2009, Green Plains Trade entered into an agreement to provide third-party ethanol marketing services to Bushmills Ethanol, Inc. of Atwater, Minnesota.
- Green Plains acquired majority interest in Houston-based biofuel terminal operator Blendstar, LLC as of January 1, 2009. The transaction involved a membership interest purchase whereby Green Plains acquired 51% of Blendstar for $8.9 million. Blendstar currently operates nine blending and terminaling facilities in the south central United States.
Conference Call
On February 22, 2010, Green Plains will hold a conference call to discuss its financial results for the fourth quarter and full-year ended December 31, 2009. Green Plains’ participants will include Todd Becker, President and Chief Executive Officer, Jerry Peters, Chief Financial Officer and Steve Bleyl, Executive Vice President – Ethanol Marketing. The time of the call is 11:00 a.m. ET / 10:00 a.m. CT. To participate by telephone, the domestic dial-in number is 877-868-1833 and the international dial-in number is 914-495-8604. The conference call will be webcast and accessible at www.gpreinc.com. Listeners are advised to go to the website at least 10 minutes prior to the call to register, download and install any necessary audio software. The conference call will also be archived and available for replay through March 8, 2010.
About Green Plains Renewable Energy, Inc.
Green Plains Renewable Energy, Inc. (Nasdaq:GPRE) is North America’s fourth largest ethanol producer, operating a total of six ethanol plants in Indiana, Iowa, Nebraska and Tennessee with annual expected operating capacity totaling approximately 480 million gallons. Green Plains also markets and distributes ethanol for four third-party ethanol producers with annual expected operating capacity totaling approximately 360 million gallons. Green Plains owns 51% of Blendstar, LLC, a biofuel terminal operator which operates nine blending or terminaling facilities with approximately 495 million gallons per year of total throughput capacity in seven states in the south central United States. Green Plains operates grain storage facilities and complementary agronomy and petroleum businesses in northern Iowa and southern Minnesota.
Safe Harbor
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such statements are identified by the use of words such as “anticipates,” “estimates,” “expects,” “will,” “predicts,” “intends,” “plans,” “believes,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Such statements are based on management’s current expectations and are subject to various factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such forward-looking statements. Green Plains may experience significant fluctuations in future operating results due to a number of economic conditions, including, but not limited to, competition in the ethanol and other industries in which the company competes; commodity market risks, financial market risks, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in the company’s reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-KT/A and any amendments thereto for the nine-month transition period ended December 31, 2008 and in the company’s subsequent filings with the SEC. Green Plains assumes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The cautionary statements in this report expressly qualify all of our forward-looking statements. In addition, the company is not obligated, and does not intend, to update any of its forward-looking statements at any time unless an update is required by applicable securities laws.
Consolidated Financial Results
The following are our consolidated statements of operations (in thousands, except per share amounts):
|
|
|
|
|
|
Three Months Ended
December 31, |
Year Ended
December 31, |
Nine-Month
Transition Period
Ended December 31, |
|
2009 |
2008 |
2009 |
2008 |
|
|
|
|
|
Revenues |
$436,714 |
$183,221 |
$1,304,174 |
$188,758 |
Cost of goods sold |
392,449 |
167,898 |
1,221,745 |
175,444 |
Gross profit |
44,265 |
15,323 |
82,429 |
13,314 |
Selling, general and administrative expenses |
14,501 |
14,444 |
44,923 |
18,467 |
Operating income (loss) |
29,763 |
879 |
37,506 |
(5,153) |
|
|
|
|
|
Other income (expense) |
|
|
|
|
Interest income |
80 |
121 |
225 |
150 |
Interest expense, net of |
|
|
|
|
amounts capitalized |
(6,048) |
(3,871) |
(18,049) |
(3,933) |
Other, net |
(197) |
783 |
563 |
887 |
Total other income (expense) |
(6,165) |
(2,967) |
(17,261) |
(2,896) |
|
|
|
|
|
Income (loss) before income taxes |
23,598 |
(2,088) |
20,245 |
(8,049) |
Income tax provision |
280 |
— |
91 |
— |
Net income (loss) |
23,318 |
(2,088) |
20,154 |
(8,049) |
Net (income) loss attributable to |
|
|
|
|
noncontrolling interests |
(268) |
239 |
(364) |
1,152 |
|
|
|
|
|
Net income (loss) attributable to Green Plains |
$23,050 |
$(1,849) |
$19,790 |
$ (6,897) |
|
|
|
|
|
Earnings (loss) per share: |
|
|
|
|
Basic |
$0.92 |
$(0.08) |
$0.79 |
$(0.56) |
Diluted |
$0.91 |
$(0.08) |
$0.79 |
$(0.56) |
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
Basic |
24,930 |
22,048 |
24,895 |
12,366 |
Diluted |
25,313 |
22,048 |
25,069 |
12,366 |
The merger with VBV, the startup of our Bluffton and Obion plants, the acquisition of Blendstar and the acquisitions of our Central City and Ord ethanol plants affected comparability of results for the periods presented. The nine-month transition period reflects only the activity for VBV prior to the merger on October 15, 2008, and the results of the combined entity for the period following the merger through December 31, 2008. As a result, the nine-month transition period includes less than four months of activity at our Bluffton ethanol plant, along with the results of our Shenandoah and Superior ethanol plants and Green Plains Grain from October 15, 2008 to the end of the year, and less than two months of activity at our Obion ethanol plant. The year ended December 31, 2009 includes a full year of activity at our Bluffton, Obion, Shenandoah and Superior ethanol plants, as well as at Green Plains Grain and Blendstar, and approximately five months of activity at our Central City and Ord ethanol plants. Similarly, the comparison of the fourth quarter of 2009 to the fourth quarter of 2008 are affected by the timing of the above mentioned plant startups and acquisitions.
The events described above account for most of the overall increase in revenues of $253.5 million, the increase in gross profit of $28.9 million and the increase in operating income of $28.9 million when the fourth quarter of 2009 is compared with the same period of 2008. Interest expense increased $2.2 million for the fourth quarter of 2009 as compared to the same quarterly period in 2008, due to interest expense relating to businesses developed or acquired. Income tax expense was $0.3 million during the quarter ended December 31, 2009. Current period income tax expense reflected a tax benefit for the reversal of a valuation allowance for deferred tax assets established in prior periods due to the uncertainty of realizing these assets. At December 31, 2009, Green Plains had approximately $5.1 million in valuation allowances remaining for federal deferred tax assets which may be available to reduce future income tax expense.
Operating Segment Information
Green Plains’ operating segments are as follows: (1) production of ethanol and related co-products (collectively referred to as “ethanol production”); (2) grain warehousing and marketing, as well as sales and related services of agronomy and petroleum products (collectively referred to as “agribusiness”); and (3) marketing and distribution of company-produced and third-party ethanol and distillers grains (collectively referred to as “marketing and distribution”). Corporate operating expenses not directly related to a specific operating segment are reflected in the table below as “corporate activities.”
The following are revenues, gross profit and operating income by segment for the periods indicated (in thousands):
|
Three Months Ended |
Three Months Ended |
Year Ended |
|
December 31, 2009 |
December 31, 2008 |
December 31, 2009 |
|
|
|
|
Revenues |
|
|
|
Ethanol production |
$235,888 |
$131,114 |
$731,253 |
Agribusiness |
71,068 |
68,785 |
220,615 |
Marketing and distribution |
368,615 |
71,408 |
1,096,091 |
Intersegment eliminations |
(238,857) |
(88,086) |
(743,785) |
Total revenues |
$436,714 |
$183,221 |
$1,304,174 |
|
|
|
|
Gross profit |
|
|
|
Ethanol production |
31,121 |
6,674 |
49,155 |
Agribusiness |
9,245 |
8,554 |
21,210 |
Marketing and distribution |
3,904 |
192 |
11,975 |
Intersegment eliminations |
(5) |
(97) |
89 |
Total gross profit |
$44,265 |
$15,323 |
$82,429 |
|
|
|
|
Operating income (loss) |
|
|
|
Ethanol production |
$28,653 |
$11 |
$40,435 |
Agribusiness |
4,592 |
5,310 |
7,654 |
Marketing and distribution |
1,524 |
(48) |
2,761 |
Intersegment eliminations |
(9) |
(97) |
85 |
Segment operating income |
34,760 |
5,176 |
50,935 |
Corporate activities |
(4,996) |
(4,297) |
(13,429) |
Total operating income |
$29,763 |
$879 |
$37,506 |
Intersegment revenues and corresponding costs were eliminated in consolidation. Certain amounts previously reported have been reclassified to conform to the current presentation.
Ethanol Production Segment
The chart below presents key operating data within our ethanol production segment for the periods indicated:
|
Three Months Ended |
Three Months Ended |
Year Ended |
|
December 31, 2009 |
December 31, 2008 |
December 31, 2009 |
|
|
|
|
Ethanol sold |
121,794 |
61,547 |
379,393 |
(thousands of gallons) |
|
|
|
|
|
|
|
Distillers grains sold |
353 |
174 |
1,098 |
(thousands of equivalent dried tons) |
|
|
|
|
|
|
|
Corn consumed |
43,930 |
23,169 |
136,569 |
(thousands of bushels) |
|
|
|
Revenues for the ethanol production segment increased $104.8 million to $235.9 million for the quarter ended December 31, 2009. The company sold 121.8 million gallons of ethanol within the ethanol production segment during the quarter, an increase of 60.2 million gallons over the same period of 2008. This increase is primarily due to the commencement of production at certain ethanol plants and several acquisitions summarized above. Ethanol production during the fourth quarter of 2009 represented 101% of the company’s average daily operating capacity.
Cost of goods sold in the ethanol production segment during the quarter ended December 31, 2009 increased $80.3 million to $204.8 million. This increase was primarily due to the consumption of 20.8 million more bushels of corn during the fourth quarter of 2009 when compared to the same period in 2008. Operating income for the quarter ended December 31, 2009 increased by $28.6 million from breakeven during the same quarter of 2008. The improvement in operating income was a result of improved margins and higher production volumes as mentioned above. Depreciation and amortization expense for the ethanol production segment was $7.9 million during the fourth quarter of 2009 compared to $6.1 million during the same period of 2008.
The following chart summarizes the approximate percentage of forecasted production or usage, as applicable, for the next 12 months under fixed-price contracts as of December 31, 2009:
|
Portion Subject to
Fixed-Price Contracts |
Ethanol Production |
15% |
Distillers Grains Production |
19% |
Corn Usage |
16% |
Natural Gas Usage |
15% |
Agribusiness Segment
The agribusiness segment revenues increased $2.3 million to $71.1 million for the quarter ended December 31, 2009. The company sold 10.5 million bushels of grain and 22.8 thousand tons of fertilizer during the fourth quarter of 2009. Cost of goods sold in the agribusiness segment during the quarter ended December 31, 2009 was $61.9 million, an increase of $1.6 million over the same period of 2008. Operating income was $4.6 million during the quarter ended December 31, 2009, compared to operating income of $5.3 million during the same period of 2008.
Marketing and Distribution Segment
Revenues of the marketing and distribution segment increased $297.2 million to $368.6 million during the quarter ended December 31, 2009 when compared to the same period of 2008. The increase is driven by the volumes marketed from our ethanol production segment as well as production from the third-party plants. The company sold 186.8 million gallons of ethanol within the marketing and distribution segment during the quarter ended December 31, 2009, compared to 61.6 million gallons sold during the same period of 2008. Operating income was $1.5 million during the quarter ended December 31, 2009 compared to a slight loss during the same period of 2008.
EBITDA
Management uses EBITDA to compare the financial performance of its business segments and to internally manage those segments. Management believes that EBITDA provides useful information to investors as a measure of comparison with peer and other companies. EBITDA should not be considered an alternative to, or more meaningful than, net income or cash flow as determined in accordance with generally accepted accounting principles. EBITDA calculations may vary from company to company. Accordingly, our computation of EBITDA may not be comparable with a similarly-titled measure of another company. The following sets forth the reconciliation of net income attributable to Green Plains to EBITDA for the periods indicated (in thousands):
|
Three Months Ended |
Three Months Ended |
Year Ended |
|
December 31, 2009 |
December 31, 2008 |
December 31, 2009 |
|
|
|
|
Net income (loss) attributable |
|
|
|
to Green Plains |
$23,050 |
$(1,849) |
$19,790 |
Net (income) loss attributable |
|
|
|
to noncontrolling interests |
268 |
(239) |
364 |
Interest expense |
6,048 |
3,871 |
18,049 |
Income taxes |
280 |
— |
91 |
Depreciation and amortization |
8,151 |
4,675 |
29,414 |
EBITDA |
$37,797 |
$6,458 |
$67,708 |
Summary Balance Sheets
The following is condensed consolidated balance sheet information (in thousands):
|
December 31, |
December 31, |
|
2009 |
2008 |
ASSETS |
|
|
|
|
|
Current assets |
$252,446 |
$190,655 |
Property and equipment, net |
596,235 |
495,772 |
Other assets |
29,400 |
6,694 |
Total assets |
$878,081 |
$693,121 |
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
Current liabilities |
$174,332 |
$108,304 |
Long-term debt |
388,573 |
299,011 |
Other liabilities |
4,468 |
5,821 |
Total liabilities |
567,373 |
413,136 |
|
|
|
Total stockholders’ equity |
310,708 |
279,985 |
Total liabilities and stockholders’ equity |
$878,081 |
$693,121 |
At December 31, 2009, Green Plains had $102.3 million in total cash and equivalents and $36.4 million available under committed loan agreements (subject to satisfaction of specified lending conditions and covenants). Green Plains had total assets of approximately $878.1 million and total stockholders’ equity of approximately $310.7 million. As of December 31, 2009, Green Plains had approximately 25.0 million common shares outstanding.
Feb. 19, 2010 (Business Wire) — SinoCoking Coal and Coke Chemical Industries, Inc. (NASDAQ:SCOK) (the “Company” or “SinoCoking”) today announced its plans to consolidate local area coal mines as a part of the government-directed consolidation of the coal mining industry in the Pindingshan region of Henan Province, China.
According to government sources, Henan province in central China is in the process of consolidating coal mines with a production capacity below 300,000 tons per year, and will only approve new mines with an output capacity of at least 450,000 tons per year. The Henan plan is a part of a general policy in China to consolidate its coal industry in order to improve production efficiency and reduce coal mine accidents. The plan is modeled after a pilot consolidation program in Shanxi province that was conducted last year. In 2009, Shanxi province, one of the nation’s key coal-producing regions, reduced the total number of its coal mines to 1,053 from 2,600 after consolidating all coal mines with a production capacity below 300,000 tons per year. The consolidation also caused coal output in Shanxi to decline by 6% in 2009. Smaller coal mines reportedly make up approximately one-third of China’s total coal output.
SinoCoking is a supplier of the vital commodities of thermal and metallurgical coal and coke to industrial users such as power plants, steel mills, plant and factory operators and manufacturers in China. The Company is a vertically-integrated processor that uses coal from both its own mines and that of third-party mines to provide basic and value-added coal products to its customer base. Excluding any of its planned acquisitions, SinoCoking currently holds mining rights to extract 300,000 tons of coal per year from mines located in the Henan Province in central China. SinoCoking began producing metallurgical coke in 2002, and since then has expanded its production to become an important supplier to regional steel producers in central China.
“The coking coal produced in the Pingdingshan region has particularly high agglutinating value combined with low levels of ash, sulfur and phosphor, which sets our region’s coal resources apart from other coal-producing provinces in China,” said Jianhua Lv, the Chief Executive Officer of SinoCoking. “In order to increase our annual coke production and ensure a steady supply of raw material for our coke chemical projects, SinoCoking intends to make acquisitions of local mining operations that will increase the total reserves directly available to the company. While we have engaged in preliminary dialogues with acquisition targets over the past couple of years, we believe the government’s imperative for consolidation of the coal mining sector this year has now come to fruition, and this creates acquisition opportunities for us that are strategically and financially compelling.”
SinoCoking has entered into discussions with ten distinct private companies in the region, and intends to acquire a majority interest in each of these companies, or their mining assets, within the next six months. The target companies are:
- Baofeng Yuxiang Coal Ltd., based in Qingliangsi Village of Daying town in Baofeng County;
- Baofeng Xingsheng Coal Ltd., based in Zhaozhuang Village of Daying town in Baofeng County;
- Pingdingshan Shilong Zhaoling Industries Coal Ltd., based in Zhaoling Village in the Shilong area of Pingdingshan;
- Pingdingshan Shilong Yuantong Coal Ltd., based in Dazhuang Village in the Shilong area of Pingdingshan;
- Pingdingshan Shilong Tianyuan Coal Ltd., based in Nanzhangzhuang Village in the Shilong area of Pingdingshan;
- Ruzhou Changsheng Coal Ltd., based in Fangwan Village of Xiaotun Town of Ruzhou;
- Baofeng Hongjiu Coal Ltd., based in Yudong Village of Zhouzhuang Town in Baofeng County;
- Baofeng Zhouzhuang Dinglou Dongfang Coal Ltd., based in Dazhuang Village in the Shilong area of Pingdingshan;
- Ruzhou Xiaotun Jialingnan Coal Ltd., based in Jialing Village of Xiaotun Town of Ruzhou; and
- Baofeng Shuangrui Coal Ltd., based in Liping Village of Daying Town in Baofeng County.
The aggregate licensed production capacity of the mines operated by these target companies is 1.5 million metric tons per year. In addition, the aggregate coal reserves of these companies is estimated to be 25 million metric tons, based on Chinese geological standards. The Company is conducting its own due diligence investigation of each prospective target.
“The opportunities presented to SinoCoking by these potential acquisitions extend beyond their licensed production capacity or reserves,” Mr. Lv added. “Assuming we can complete most if not all of the acquisitions we described in today’s announcement, SinoCoking would then directly control all of the feedstock that is necessary for both our current and planned coke manufacturing facilities. As a result, this vertical integration is expected to enable us to achieve significantly higher profit margins than previously anticipated. In the past, we relied heavily on washed coal produced by third parties for our coking feedstock.”
SinoCoking believes it can acquire each of these targets at an attractive purchase price and without the need for significant outside capital, using internally-generated cash flow and its own common stock, noting that the target companies are required to either agree to consolidate or face government-mandated closure. SinoCoking also noted that its acquisition opportunities are only one element of its expansion plan, and that SinoCoking remains focused on the financing and construction of its newly planned state-of-the-art coking plant with an expected production capacity of 900,000 metric tons per year.
“The moment has now arrived for the inevitable consolidation of the coal mining sector in Henan province, and we believe SinoCoking is very well-positioned to benefit from this consolidation,” Mr. Lv stated. “Our company is a profitable, efficient operator, with a strong record in worker safety, and a vertically-integrated business model that produces important coal products in an environmentally-conscious manner. Our common stock is listed on NASDAQ in the U.S., offering our shareholders access to liquidity while providing us an important source of currency to pursue our acquisition program. While we cannot predict with certainty the outcome of these negotiations, we are committed to prudently pursuing any opportunity that enables SinoCoking to better serve our customers, reduce our production costs and fortify our business model while creating incremental value for our shareholders. I look forward to providing updates to our shareholders of tangible progress towards these goals.”
About SinoCoking
SinoCoking Coal and Coke Chemical Industries, Inc., a Florida corporation (NASDAQ: SCOK) is a vertically-integrated coal and coke processor that uses coal from both its own mines and that of third-party mines to produce basic and value-added coal products for steel manufacturers, power generators, and various industrial users. SinoCoking currently holds mining rights to extract 300,000 tons of coal per year from mines located in the Henan Province in central China. SinoCoking has been producing metallurgical coke since 2002, and acts as a key supplier to regional steel producers in central China. SinoCoking, a Florida corporation, owns its assets and conducts its operations through its subsidiaries, Top Favour Limited, a British Virgin Islands holding company, Pingdingshan Hongyuan Energy Science and Technology Development Co., Ltd. (“Hongyuan”), Henan Province Pingdingshan Hongli Coal & Coke Co., Ltd. (“Hongli”), Baofeng Coking Factory, Baofeng Hongchang Coal Co., Ltd. and Baofeng Hongguang Environment Protection Electricity Generating Co., Ltd.
For further information about SinoCoking, please refer to the Definitive Proxy Statement of the Company (previously named Ableauctions.com, Inc.) filed on Schedule 14A with the Securities and Exchange Commission on November 27, 2009.
This press release contains forward-looking statements, particularly as related to, among other things, the business plans of the Company, statements relating to goals, plans and projections regarding the Company’s financial position and business strategy. The words or phrases “plans”, “would be,” “will allow,” “intends to,” “may result,” “are expected to,” “will continue,” “anticipates,” “expects,” “estimate,” “project,” “indicate,” “could,” “potentially,” “should,” “believe,” “think”, “considers” or similar expressions are intended to identify “forward-looking statements.” These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of local, regional, and global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports and on documents we file from time to time with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place undue reliance on such statements. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from the Company’s expectations and estimates. The Company provides no assurances that any potential acquisitions will actually be consummated, or if consummated that such acquisitions will be on terms and conditions anticipated on the date of this press release, and the Company makes no assurances with regard to any results of any such acquisitions.
Feb. 19, 2010 (PR Newswire) — InfoLogix Joins Industry Leaders Presenting at SAP Insider’s Logistics and Supply Chain Management Conference in Orlando, Feb 22-26, 2010
HATBORO, Pa. — InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it will be presenting and exhibiting at the SAP Insider Logistics and Supply Chain Conference in Orlando, Florida on February 22-26, 2010.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO )
As a rapidly rising leader in SAP® supply chain execution and mobility solutions, InfoLogix will be delivering a three-hour “jumpstart” session on Monday, February 22 from 9:00-12:00 EST, placing InfoLogix among an elite group of thought leaders from SAP, eBay, IBM Global Business Services and PricewaterhouseCoopers that will be kicking off the conference. InfoLogix will present “A Comprehensive Guide to Warehouse Management Functionality from SAP” from 9:00-12:00 on Monday, February 22. More information on the conference session is available at: http://www.scm2010.com/session.cfm?id=3893.
“In a very short span, InfoLogix has become a specialized leader in SAP supply chain execution and implementation services that deliver increased supply chain velocity and efficiencies across the enterprise,” says Brian Thorn, Senior Vice President of Enterprise Solutions at InfoLogix. “It’s an honor to be recognized among the key organizations in the space, as we continue to help customers boost the performance of their external and internal supply chain operations.”
InfoLogix’s SAP consultants will also be available for discussion at Booth #210 during regular show hours from Tuesday, February 23rd through Thursday, February 25th.
Discounted registration for InfoLogix customers is available at http://www.sapinsidervendors.com/eventRegistration.aspx?vendorId=Infologix2010. For more information on InfoLogix’s solutions, or to reserve a meeting with one of our SAP consultants, please visit www.infologix.com/enterprise.
About InfoLogix, Inc.
InfoLogix is a leading provider of enterprise mobility solutions for the healthcare and commercial industries. InfoLogix uses the industry’s most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company (Nasdaq: IFLG). For more information visit www.infologix.com.
Press Release Source: Neuralstem, Inc. On Thursday February 18, 2010, 1:40 pm EST
ROCKVILLE, Md., Feb. 18 /PRNewswire-FirstCall/ — Neuralstem, Inc. (NYSE AMEX: CUR) announced today that it has raised a total of $5,228,000 since the beginning of the year, comprised of a previously disclosed $1.5 million private placement of 646,551 common shares at $2.32, priced at a 30 percent premium over the market on the closing, and approximately $3.7 million from warrant exercises.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )
Neuralstem also is pleased to announce that it received notice from the NYSE Amex that the Company is now in compliance with its listing requirements.
“These funds will help to support the development of our stem cell technology, including our ongoing clinical trial at Emory University,” stated Richard Garr, President and CEO of Neuralstem. “We are also pleased that the NYSE Amex has recognized the improvement in Neuralstem’s financial position.”
About Neuralstem, Inc.
Neuralstem’s patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The company is targeting major central nervous system diseases including: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington‘s disease and Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig‘s disease. ALS is a progressive fatal neurodegenerative disease that affects nerve cells in the brain, leading to the degeneration and death of the motor neurons in the spinal cord that control muscle movement. Pre-clinical work has shown that Neuralstem’s cells extended the life of rats with ALS (as reported in the journal TRANSPLANTATION, October 16, 2006, in collaboration with Johns Hopkins University researchers), and also reversed paralysis in rats with Ischemic Spastic Paraplegia (as reported in NEUROSCIENCE, June 29, 2007, in collaboration with researchers at University of California San Diego).
Cautionary Statement Regarding Forward Looking Information
This news release may contain forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem’s technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward- looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem’s periodic reports, including the annual report on Form 10-K for the year ended December 31, 2008 and the quarterly report on form 10-Q for the period ended September 30, 2009.
Press Release Source: GFI Group On Thursday February 18, 2010, 4:15 pm EST
NEW YORK, NY–(Marketwire – 02/18/10) – GFI Group Inc. (NASDAQ:GFIG – News), a leading provider of wholesale brokerage, electronic execution and trading support products for global financial markets, today announced financial results for the fourth quarter and year ended December 31, 2009.
Highlights
�
-- Total revenues for the fourth quarter of 2009 were $185.6 million
compared with $196.2 million in the fourth quarter of 2008, a decrease
of 5%. On a non-GAAP basis, total revenues declined 13% to $184.1
million in the fourth quarter of 2009 from $210.9 million in the fourth
quarter of 2008. This excludes the effects of a $1.4 million mark-to-
market unrealized gain on forward hedges of future foreign currency
revenues in the fourth quarter of 2009 and a $14.6 million mark-to-
market unrealized loss on such forward hedges in the fourth quarter of
2008.
-- Brokerage revenues for the fourth quarter of 2009 were $168.7 million
compared with $193.8 million in the fourth quarter of 2008.
-- To align its cost structure with the current performance of its
brokerage operations, GFI renegotiated certain employment agreements
and initiated a front office restructuring in the fourth quarter of
2009 resulting in a pre-tax charge of $30.6 million. Total
restructuring charges of $31.4 million for the fourth quarter of 2009
also included non-compensation charges of $0.8 million.
-- Compensation and employee benefits expense in the fourth quarter of
2009 was 84.1% of total revenues on a GAAP basis, but 68.2% on a non-
GAAP basis. This compares with 70.1% of total revenues on a GAAP basis
and 65.2% of total revenues on a non-GAAP basis in the fourth quarter
of 2008.
-- Non-compensation expenses were 29.7% of total revenues on a GAAP basis
and 28.7% on a non-GAAP basis in the fourth quarter of 2009. This
compares with 30.1% of total revenues on a GAAP basis and 27.3% on a
non-GAAP basis in the fourth quarter of 2008.
-- The net loss for the fourth quarter of 2009 was $14.5 million, or $0.12
per diluted share, compared with net income of $0.2 million, or $0.00
per diluted share, in the fourth quarter of 2008. On a non-GAAP basis,
the Company reported net income of $4.5 million, or $0.04 per diluted
share, for the fourth quarter of 2009, compared with non-GAAP net
income of $10.7 million, or $0.09 per diluted share in the fourth
quarter of 2008.
-- For the full year 2009, total GAAP revenues were $818.7 million
compared with $1.02 billion for 2008. Net income for 2009 was $16.3
million or $0.13 per diluted share compared to $53.1 million or $0.44
per diluted share for 2008. On a non-GAAP basis, total revenues for
full year 2009 were $814.4 million compared with $1.04 billion in 2008,
while net income was $39.0 million or $0.32 per diluted share compared
with $94.7 million or $0.79 per diluted share for the full year 2008.
Michael Gooch, Chairman and Chief Executive Officer of GFI, commented: “The fourth quarter of 2009 continued to be challenging on the heels of an equally challenging year, even as we moved farther away from the height of the financial crisis in the second half of 2008. In addition, we believe some customers closed their books earlier than usual, thereby reducing trading activity in the fourth quarter. However, although our revenues were lower, the general business environment was more stable overall than it was in the fourth quarter of 2008 and the diversity of our business enabled us to take advantage of areas of market strength.
“Credit product revenues decreased 8% from the fourth quarter of 2008 and were down 23% sequentially. Within the credit category, our revenues from credit derivatives were 46% lower year over year, offsetting a 66% increase in revenues from cash fixed income products. In spite of the ongoing challenges in the credit markets, we were again ranked the #1 credit derivatives inter-dealer broker by Risk magazine in 2009.
“Lower market volatility directly affected our equity product revenues, which were down 37% from the fourth quarter of 2008, but up 3% from the third quarter of 2009.
“Our financial product revenues rose 12% year over year but were 5% lower sequentially. The year-over-year growth was due to higher emerging market product revenues in Asia-Pacific and the Americas.
“Strength in electricity brokerage in the Americas and Europe was the main contributor to improvement in our commodity product revenues, which rose 9% year over year and 1% sequentially. In total, electricity-related revenues increased 27% from the fourth quarter of 2008. I am pleased to report that we were recently named the No.1 Energy & Commodity Broker for 2010 by Energy Risk magazine.
“Compensation and employee benefits expense is the largest component of our costs. Controlling that expense category has posed a significant challenge. This was especially the case in the years of rapid growth in the derivatives market. However, with volumes and revenues at a lower base than in prior years, we renegotiated certain employment agreements in the fourth quarter of 2009 to better reflect the current market environment. While the restructuring of the contracts led to a substantial, predominantly non-cash charge to fourth quarter results, our compensation expense level going forward will better reflect the run-rate of our brokerage operations.
“It is clear from the varied performance of our product categories during the fourth quarter and full year 2009 that market participants were actively looking for opportunistic places to deploy capital. As we enter 2010, we are still experiencing a similarly opportunistic investing environment, but we are also seeing an overall improvement in performance.
“Looking at the first quarter of 2010, with seven weeks already behind us, we currently expect total non-GAAP revenues to increase by 4% to 7% compared with non-GAAP total revenues in the first quarter of 2009.
“Despite the challenging conditions in the financial markets that we have faced over the past two years, we have not wavered in our ongoing investment in technology to support our hybrid brokerage model. This includes the continuing development of our own electronic execution platforms, as well as acquiring Trayport and its GlobalVision(SM) electronic trading platform. In the fourth quarter alone, Trayport software revenues rose 24% over the fourth quarter of 2008 and 13% sequentially, reflecting growth in the Trading Gateway(SM) product. In the first quarter of 2010, we are seeing noteworthy traction in electronic trading in key credit and commodity products on our CreditMatch� and EnergyMatch� hybrid brokerage platforms in North America. This pick-up in electronic trading is consistent with the goals of proposed legislation in the U.S. and in Europe.
“Thus far in 2010 we are experiencing a positive start to the year. We anticipate further volatility in the global credit, financial, equity and commodity markets this year and we welcome and applaud thoughtful efforts to regulate derivatives and increase market transparency. At this point, we feel that our business is well-prepared and increasingly diversified to manage through the evolving market landscape. Our technology is playing an increasingly crucial role in our markets, particularly in light of coming regulations and the market’s direction towards increased automation and transparency. Therefore, we are confident that our business prospects will continue to improve as the year unfolds.”
Mr. Gooch concluded: “Despite the recent global financial crisis, over the past two years, GFI generated in excess of $290 million in positive cash flow from operations and paid $54 million in dividends to its shareholders. In addition, we reduced our bank debt by $50 million in 2009 alone.”
Revenues
For the fourth quarter of 2009, total revenues were $185.6 million on a GAAP basis and $184.1 million on a non-GAAP basis. This compares with total revenues of $196.2 million on a GAAP basis and $210.9 million on a non-GAAP basis in the fourth quarter of 2008.
Brokerage revenues in the fourth quarter of 2009 were $168.7 million compared with $193.8 million in the fourth quarter of 2008. Revenues from financial products increased 12% and commodity product revenues increased 9% from the fourth quarter of 2008, while credit product and equity product revenues decreased 8% and 37%, respectively, from the prior year period. By geographic region, fourth quarter 2009 brokerage revenues increased 8% in Asia-Pacific while decreasing 18% in the Americas and 11% in EMEA compared with the fourth quarter of 2008.
Revenues from trading software, analytics and market data products for the fourth quarter of 2009 were $14.6 million, up 14% from the same period of 2008. Included in the 2009 fourth quarter was a $9.1 million contribution to software revenue from Trayport Limited. Trayport’s software revenues increased 24% from the fourth quarter of 2008.
Expenses
For the fourth quarter of 2009, compensation and employee benefits expense was $156.1 million on a GAAP basis. Excluding a $30.6 million pre-tax charge related to the renegotiation of certain employment agreements and a front-office restructuring initiative, non-GAAP compensation and employee benefits expense was $125.5 million. This compares with $137.6 million on both a GAAP and non-GAAP basis in the fourth quarter of 2008. Compensation and employee benefits expense was 84.1% of total revenues on a GAAP basis and 68.2% on a non-GAAP basis in the fourth quarter of 2009 compared with 70.1% of total revenues on a GAAP basis and 65.2% on a non-GAAP basis, in the fourth quarter of 2008.
Non-compensation expenses for the fourth quarter of 2009 on a GAAP basis were $55.0 million or 29.7% of total revenues compared with $59.0 million or 30.1% of total revenues in the fourth quarter of 2008. On a non-GAAP basis, non-compensation expenses for the fourth quarter of 2009, excluding $0.8 million in restructuring charges and $1.4 million in intangible asset amortization, were $52.8 million or 28.7% of total revenues compared with $57.6 million or 27.3% of total revenues in the fourth quarter of 2008.
The effective tax rate for 2009 was 30.0% on a GAAP basis and 35.5% on a non-GAAP basis, compared to 36.0% for 2008 for both GAAP and non-GAAP.
Earnings
The net loss for the fourth quarter of 2009 was $14.5 million, or $0.12 per diluted share, compared with net income of $0.2 million, or $0.00 per diluted share, in the fourth quarter of 2008. On a non-GAAP basis, net income for the fourth quarter of 2009 was $4.5 million, or $0.04 per diluted share, compared with $10.7 million or $0.09 per diluted share for the fourth quarter of 2008.
Full Year Results
Total revenues for the year ended December 31, 2009 were $818.7 million and net income was $16.3 million or $0.13 per diluted share, compared with revenues of $1.02 billion and net income of $53.1 million or $0.44 per diluted share for 2008. On a non-GAAP basis, total revenues for the full year 2009 were $814.4 million and net income was $39.0 million or $0.32 per diluted share, compared with non-GAAP revenues of $1.04 billion and net income of $94.7 million or $0.79 per diluted share for 2008.
Non-GAAP Financial Measures
To supplement GFI’s unaudited financial statements presented in accordance with GAAP, the Company uses certain non-GAAP measures of financial performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from, as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP. The non-GAAP financial measures used by GFI include non-GAAP revenues, non-GAAP net income and non-GAAP diluted earnings per share. These non-GAAP financial measures currently exclude amortization of acquired intangibles and certain other items that management views as non-operating or non-recurring from the Company’s statement of income as detailed below.
In addition, GFI may consider whether other significant non-operating or non-recurring items that arise in the future should also be excluded in calculating the non-GAAP financial measures it uses. The non-GAAP financial measures also take into account income tax adjustments with respect to the excluded items.
GFI believes that these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provide meaningful supplemental information regarding the Company’s performance by excluding certain items that may not be indicative of the Company’s core business, operating results or future outlook. GFI’s management uses, and believes that investors benefit from referring to these non-GAAP financial measures in assessing the Company’s operating results, as well as when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate comparisons of the Company’s performance to prior periods.
In addition to the reasons stated above, which are generally applicable to each of the items GFI excludes from its non-GAAP financial measures, the Company believes it is appropriate to exclude amortization of acquired intangibles because when analyzing the operating performance of an acquired business, GFI’s management focuses on the total return provided by the investment (i.e., operating profit generated from the acquired entity as compared to the purchase price paid) without taking into consideration any charges for allocations made for accounting purposes. Further, because the purchase price for an acquisition necessarily reflects the accounting value assigned to intangible assets, when analyzing the operating performance of an acquisition in subsequent periods, the Company’s management excludes the GAAP impact of acquired intangible assets on its financial results. GFI believes that such an approach is useful in understanding the long-term return provided by an acquisition and that investors benefit from a supplemental non-GAAP financial measure that excludes the accounting expense associated with acquired intangible assets.
Set forth below is specific detail regarding items excluded in our non-GAAP financial measures. A reconciliation of the non-GAAP to GAAP figures follows this press release.
In the fourth quarter of 2009, the difference between GAAP and non-GAAP revenues was $1.4 million and the difference between the GAAP net loss and non-GAAP net income was $19.0 million and reflected for non-GAAP purposes:
�
-- The exclusion from revenues of a $1.4 million mark-to-market unrealized
gain on forward hedges of future foreign currency revenues;
-- The exclusion of a $25.5 million charge related to the renegotiation of
certain employment agreements;
-- The exclusion of $5.1 million charge related to severance and other
front office restructurings;
-- The exclusion of a $0.8 million write-off related to a terminated joint
venture and other terminated operations;
-- The exclusion of $1.4 million of amortization on all acquired
intangible assets; and
-- The effect of adjusting for these items would increase the Company's
income tax expense by $12.4 million.
For full year 2009, the difference between GAAP and non-GAAP revenue was $4.3 million and the difference between GAAP and non-GAAP net income was $22.7 million and reflected for non-GAAP purposes:
�
-- The exclusion from revenues of:
-- $3.6 million mark-to-market unrealized gains on forward hedges of
future foreign currency revenues;
-- a $0.7 million gain on the Company's exchange of its investment in
The Clearing Corporation for an investment in a holding company of
ICE Trust;
-- The exclusion of $5.5 million of amortization on all acquired
intangible assets;
-- The exclusion of $25.5 million charge related to the renegotiation of
certain employment agreements;
-- The exclusion of $8.9 million of charges related to severance and other
front office restructurings;
-- The exclusion of $1.6 million of write-offs related to a terminated
joint venture and other terminated operations; and
-- The effect of adjusting for these items would increase the Company's
income tax expense by $14.5 million.
In the fourth quarter of 2008, the difference between GAAP and non-GAAP revenue was $14.6 million and the difference between GAAP and non-GAAP net income was $10.5 million and reflected for non-GAAP purposes:
�
-- The exclusion from revenues of a $14.6 million mark-to-market
unrealized loss on forward hedges of future foreign currency revenues;
-- The exclusion of $1.4 million of amortization on all acquired
intangible assets; and
-- The effect of adjusting for these items would increase the Company's
income tax expense by $5.5 million.
For full year 2008, the difference between GAAP and non-GAAP revenues was $24.2 million and the difference between GAAP and non-GAAP net income was $41.6 million and reflected for non-GAAP purposes:
�
-- The exclusion from revenues of a $14.6 million mark-to-market
unrealized loss on forward hedges of future foreign currency revenues;
-- The exclusion from revenues of a $9.6 million charge for unsettled
trades directly related to the Lehman Brothers bankruptcy;
-- The exclusion of $5.3 million of amortization on all acquired
intangible assets;
-- The exclusion of $1.8 million in expenses related to discontinued
merger discussions;
-- The exclusion of items related to the relocation of the Company's New
York offices to larger premises completed in the third quarter of 2008,
including:
-- $2.5 million of duplicate rent expense;
-- $2.7 million of accelerated depreciation expense related to assets
to be abandoned; and
-- $7.8 million of costs related to the abandonment of and move from
our previous headquarters;
-- The exclusion of $3.5 million of reduced compensation expenses related
to the Lehman Brothers bankruptcy;
-- The exclusion of $20.9 million related to the Company's restructuring
initiatives, including:
-- $14.5 million for costs relating to desk closings and other
restructuring charges, and
-- $6.4 million adjustment related to deferred compensation expense;
-- The exclusion of a $3.1 million write-off of an investment in an
unconsolidated affiliate; and
-- The effect of adjusting for these items would increase the Company's
income tax expense by $23.4 million.
Dividend Declaration
The Board of Directors of GFI Group has declared a quarterly cash dividend of $0.05 per share payable on March 29, 2010 to shareholders of record on March 15, 2010.
Conference Call
GFI has scheduled an investor conference call to discuss the results at 8:30 a.m. (Eastern Time) on Friday, February 19. Those wishing to listen to the live conference call via telephone should dial 800-510-0219 in North America, passcode 95873108; and +1 617-614-3451 in Europe, same passcode.
A live audio web cast of the conference call will be available on the Investor Relations section of GFI’s Website. For web cast registration information, please visit: http://www.gfigroup.com. Following the conference call, an archived recording will be available at the same site.
Supplementary Financial Information
GFI Group has posted details of its historical monthly brokerage revenues on the Investor Relations page of its web site under the heading Supplementary Financial Information. The Company currently plans to post this information quarterly in conjunction with its announcement of earnings, but does not undertake a responsibility to continue to provide or update such information.
About GFI Group Inc. www.GFIgroup.com
GFI Group Inc. (NASDAQ:GFIG – News) is a leading provider of wholesale brokerage, electronic execution and trading support products for global financial markets. GFI Group Inc. provides brokerage services, market data, trading platform and analytics software products to institutional clients in markets for a range of credit, financial, equity and commodity instruments.
Headquartered in New York, GFI was founded in 1987 and employs more than 1,700 people with additional offices in London, Paris, Hong Kong, Seoul, Tokyo, Singapore, Sydney, Cape Town, Santiago, Dubai, Dublin, Tel Aviv, Calgary, Englewood (NJ) and Sugar Land (TX). GFI Group Inc. provides services and products to over 2,100 institutional clients, including leading investment and commercial banks, corporations, insurance companies and hedge funds. Its brands include GFISM, GFInet�, CreditMatch�, GFI ForexMatch�, EnergyMatch�, FENICS�, Starsupply�, Amerex�, and Trayport�.
Forward-looking statement
Certain matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “might,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of GFI Group Inc. (the “Company”) and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: economic, political and market factors affecting trading volumes; securities prices or demand for the Company’s brokerage services; competition from current and new competitors; the Company’s ability to attract and retain key personnel, including highly-qualified brokerage personnel; the Company’s ability to identify and develop new products and markets; changes in laws and regulations governing the Company’s business and operations or permissible activities; the Company’s ability to manage its international operations; financial difficulties experienced by the Company’s customers or key participants in the markets in which the Company focuses its brokerage services; the Company’s ability to keep up with technological changes; and uncertainties relating to litigation. Further information about factors that could affect the Company’s financial and other results is included in the Company’s filings with the Securities and Exchange Commission. The Company does not undertake to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
�
- FINANCIAL TABLES FOLLOW -
=IR=
GFI Group Inc. and Subsidiaries
Consolidated Statements of Income (unaudited)
(In thousands except share and per share data)
------------------------ -------------------------
Three Months Ended Twelve Months Ended
December 31, December 31,
2009 2008 2009 2008
----------- ----------- ------------ -----------
REVENUES:
Brokerage revenues:
Agency commissions $ 115,043 $ 143,556 $ 481,326 $ 757,310
Principal
transactions 53,608 50,272 270,378 206,669
----------- ----------- ------------ -----------
Total brokerage
revenues 168,651 193,828 751,704 963,979
Software, analytics
and market data 14,649 12,800 54,347 51,250
Interest income 148 1,669 1,043 8,617
Other income (loss) 2,112 (12,061) 11,613 (8,343)
----------- ----------- ------------ -----------
Total revenues 185,560 196,236 818,707 1,015,503
----------- ----------- ------------ -----------
EXPENSES:
Compensation and
employee benefits 156,053 137,583 583,315 665,973
Communications and
market data 11,864 12,245 46,263 47,810
Travel and promotion 9,509 8,897 33,819 45,756
Rent and occupancy 5,343 4,811 20,325 31,452
Depreciation and
amortization 7,959 7,827 31,493 31,390
Professional fees 4,674 6,081 18,402 26,200
Clearing fees 6,988 9,706 30,354 43,420
Interest 2,645 3,993 10,540 14,334
Other expenses 6,046 5,445 20,926 26,191
----------- ----------- ------------ -----------
Total expenses 211,081 196,588 795,437 932,526
----------- ----------- ------------ -----------
INCOME (LOSS) BEFORE
PROVISION FOR
(BENEFIT FROM) INCOME
TAXES ----------- ----------- ------------ -----------
(25,521) (352) 23,270 82,977
----------- ----------- ------------ -----------
PROVISION FOR (BENEFIT
FROM) INCOME TAXES (11,070) (544) 6,982 29,871
----------- ----------- ------------ -----------
NET INCOME (LOSS) $ (14,451) $ 192 $ 16,288 $ 53,106
=========== =========== ============ ===========
Basic earnings (loss)
per share $ (0.12) $ 0.00 $ 0.14 $ 0.45
=========== =========== ============ ===========
Diluted earnings (loss)
per share $ (0.12) $ 0.00 $ 0.13 $ 0.44
=========== =========== ============ ===========
Weighted average shares
outstanding - basic 118,359,826 118,425,796 118,178,493 117,966,596
Weighted average shares
outstanding - diluted 118,359,826 119,604,529 121,576,767 119,743,693
GFI Group Inc. and Subsidiaries
Consolidated Statements of Income (unaudited)
As a Percentage of Total Revenues
Three Months Twelve Months
Ended Ended
December 31, December 31,
2009 2008 2009 2008
------ ------ ------ ------
REVENUES:
Brokerage revenues:
Agency commissions 62.0% 73.2% 58.8% 74.6%
Principal transactions 28.9% 25.6% 33.0% 20.4%
------ ------ ------ ------
Total brokerage revenues 90.9% 98.8% 91.8% 95.0%
Software, analytics and market data 7.9% 6.5% 6.6% 5.0%
Interest income 0.1% 0.9% 0.1% 0.8%
Other income (loss) 1.1% -6.2% 1.5% -0.8%
------ ------ ------ ------
Total revenues 100.0% 100.0% 100.0% 100.0%
------ ------ ------ ------
EXPENSES:
Compensation and employee benefits 84.1% 70.1% 71.2% 65.6%
Communications and market data 6.4% 6.2% 5.7% 4.7%
Travel and promotion 5.1% 4.5% 4.1% 4.5%
Rent and occupancy 2.9% 2.5% 2.5% 3.1%
Depreciation and amortization 4.3% 4.0% 3.8% 3.1%
Professional fees 2.5% 3.1% 2.2% 2.6%
Clearing fees 3.8% 4.9% 3.7% 4.3%
Interest 1.4% 2.0% 1.3% 1.4%
Other expenses 3.3% 2.8% 2.6% 2.6%
------ ------ ------ ------
Total expenses 113.8% 100.1% 97.1% 91.9%
------ ------ ------ ------
INCOME (LOSS) BEFORE PROVISION FOR ------ ------ ------ ------
(BENEFIT FROM) INCOME TAXES -13.8% -0.1% 2.9% 8.1%
------ ------ ------ ------
PROVISION FOR (BENEFIT FROM) INCOME TAXES -6.0% -0.3% 1.0% 2.9%
------ ------ ------ ------
NET INCOME (LOSS) -7.8% 0.2% 1.9% 5.2%
====== ====== ====== ======
GFI Group Inc. and Subsidiaries
Selected Financial Data (unaudited)
(Dollars in thousands)
Three Months Ended Twelve Months Ended
December 31, December 31,
2009 2008 2009 2008
----------- ----------- ----------- -----------
Brokerage Revenues by
Product Categories:
Credit $ 52,650 $ 57,439 $ 276,377 $ 304,438
Financial 31,469 28,051 129,131 171,935
Equity 45,900 72,891 192,820 291,184
Commodity 38,632 35,447 153,376 196,422
----------- ----------- ----------- -----------
Total brokerage
revenues $ 168,651 $ 193,828 $ 751,704 $ 963,979
=========== =========== =========== ===========
Brokerage Revenues by
Geographic Region:
Americas $ 72,325 $ 88,646 $ 325,359 $ 385,854
Europe, Middle
East, and Africa 82,136 92,050 364,752 489,517
Asia-Pacific 14,190 13,132 61,593 88,608
----------- ----------- ----------- -----------
Total brokerage
revenues $ 168,651 $ 193,828 $ 751,704 $ 963,979
=========== =========== =========== ===========
December 31, December 31,
2009 2008
----------- -----------
Consolidated Statement of
Financial Condition Data:
Cash and cash
equivalents $ 342,379 $ 342,375
Total assets (1) 952,094 1,085,911
Total debt,
including current
portion 173,688 223,823
Stockholders'
equity 484,102 476,963
Selected Statistical Data:
Brokerage personnel
headcount (2) 1,082 1,037
Employees 1,768 1,740
Broker productivity
for the period (3) $ 155 $ 184
(1) Total assets include receivables from brokers, dealers and clearing
organizations of $87.7 million and $149.7 million at December 31, 2009
and December 31, 2008, respectively. These receivables primarily
represent securities transactions entered into in connection with our
matched principal business which have not settled as of their stated
settlement dates. These receivables are substantially offset by
corresponding payables to brokers, dealers and clearing organizations
for these unsettled transactions.
(2) Brokerage personnel headcount includes brokers, trainees and clerks.
(3) Broker productivity is calculated as brokerage revenues divided by
average monthly brokerage personnel headcount for the quarter.
GFI Group Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Measures (unaudited)
(In thousands except share and per share data)
Three Months Ended Twelve Months Ended
December 31, December 31,
2009 2008 2009 2008
----------- ----------- ----------- -----------
GAAP revenues $ 185,560 $ 196,236 $ 818,707 $ 1,015,503
Net charge related to
Lehman unsettled
trades (a) - - - 9,586
Gain on exchange of
cost-method
investments (a) - - (697) -
Mark-to-market
(gain)/loss on
forward hedges
of future foreign
currency revenues (a) (1,415) 14,645 (3,617) 14,645
----------- ----------- ----------- -----------
Total Non-GAAP
Revenues 184,145 210,881 814,393 1,039,734
GAAP expenses 211,081 196,588 795,437 932,526
Non-operating
adjustments:
Amortization of
intangibles (1,381) (1,373) (5,465) (5,282)
Discontinued merger
discussion costs - - - (1,832)
Severance and other
restructuring (31,393) - (36,037) (14,541)
Adjustment related to
deferred compensation
expense - - - (6,408)
Duplicate rent - - - (2,547)
Accelerated depreciation
on 100 Wall Street - - - (2,730)
Abandonment of 100
Wall Street - - - (7,830)
Reduction in
compensation related
to Lehman - - - 3,469
Write-off investment
in unconsolidated
affiliate - - - (3,071)
----------- ----------- ----------- -----------
Total Non-GAAP
adjustments (a) (32,774) (1,373) (41,502) (40,772)
----------- ----------- ----------- -----------
Non-GAAP operating
expenses 178,307 195,215 753,935 891,754
GAAP income (loss)
before provision
for income taxes (25,521) (352) 23,270 82,977
Sum of Non-GAAP
items = (a) 31,359 16,018 37,188 65,003
----------- ----------- ----------- -----------
Non-GAAP income before
tax provision 5,838 15,666 60,458 147,980
GAAP provision for
(benefit from) income
taxes (11,070) (544) 6,982 29,871
Income tax impact on
Non-GAAP items (b) 12,365 5,545 14,481 23,401
----------- ----------- ----------- -----------
Non-GAAP provision for
income taxes 1,295 5,001 21,463 53,272
GAAP net inc
Press Release Source: Luna Innovations Incorporated On Thursday February 18, 2010, 4:46 pm EST
ROANOKE, Va.–(BUSINESS WIRE)–Luna Innovations Incorporated (NASDAQ: LUNA – News) announced today that it has entered into a $5 million revolving credit facility with Silicon Valley Bank (SVB). In May 2008, Luna entered into a $10 million credit facility with SVB that included a four-year term debt of $5 million and a remaining facility available under a four-year revolving line of credit of up to $10 million. Luna paid off the original $5 million term debt and terminated the prior facility in July 2009.
“SVB has once again put forth a credit facility that shows its support of Luna and our business model in the midst of the tough economy,” said Scott Graeff, Chief Operating Officer and Treasurer. “SVB is a bank that clearly understands the importance of technology in the global marketplace. We are very pleased that it remains committed to our long relationship.”
The facility is secured by certain company assets and is subject to customary covenants, including covenants requiring the company to meet EBITDA milestones and liquidity ratios.
About Luna Innovations:
Luna Innovations Incorporated (www.lunainnovations.com) is focused on sensing and instrumentation, and pharmaceutical nanomedicines. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The company’s products are used to measure, monitor, protect and improve critical processes in the markets we serve. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in Roanoke, Virginia.
Forward Looking Statements:
This release may include information that constitutes “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Statements that describe the Company’s business strategy, goals, prospects, opportunities, outlook, plans or intentions are also forward looking statements. Actual results may differ materially from the expectations expressed in such forward-looking statements as a result of various factors, including risks and uncertainties set forth in the company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at http://www.sec.gov, and at the company’s website at http://www.lunainnovations.com. The statements made in this release are based on information available to the company as of the date of this release and Luna Innovations undertakes no obligation to update any of the forward-looking statements after the date of this release.
Press Release Source: Dataram Corporation On Friday February 19, 2010, 8:28 am EST
PRINCETON, N.J.–(BUSINESS WIRE)–Dataram Corporation (NASDAQ: DRAM – News), a worldwide leader in the manufacture of high-quality computer memory, storage products, software, and services, today announced the signing of a strategic teaming agreement with Government Acquisitions, Inc., a proven provider of IT infrastructure solutions and a trusted advisor to the federal government.
The essence of the teaming agreement provides Government Acquisitions the opportunity to exclusively market Dataram products and services to their key customers, and to work towards bringing the cost benefits of the Dataram solutions to the entire federal government. In consideration, Government Acquisitions and Dataram have developed a joint strategy to ensure the federal government, in these times of tight budgets, are exposed to the substantial cost savings which can be garnered using Dataram solutions.
“This is truly a story of two companies with tremendous synergy, both focused on delivering value by optimizing and leveraging their customer’s investment in their IT assets,” said Bruce Magath, Dataram VP of Marketing and Strategy. Mr. Magath went on to say, “our joint capabilities provide our customers with data center solutions that deliver immediate and substantial cost reductions, while at the same time enhancing the performance of their existing infrastructure.”
Government Acquisitions is a rising star in the Government VAR sector, achieving double-digit growth since its formation in 1989, with revenues exceeding $215 million. Government Acquisitions is ranked in the Government VAR 100, VAR Business 500, and Washington Technology Top 100 Federal IT Contractors.
Jay Lambke, Government Acquisitions Executive Vice President stated, “Dataram has a 43-year history of delivering quality products and innovative technologies. We intend to take advantage of that for the benefit of our customers. What caught our attention is their focus and success on delivering immediate value and providing alternative and stable computing models which reduce expenses, while at the same time enhance performance. I believe our customers will be very receptive to the alternatives we can now present to them as a result of our partnership.”
About Government Acquisitions, Inc.
Government Acquisitions, Inc. is an IT solutions provider and trusted advisor to the Federal Government, focused on Optimizing the Data Center through consolidation, virtualization, information assurance, information automation, and client services. As a top 25 hardware reseller on the GSA Schedule 70 contract with annual revenues exceeding $215 million, Government Acquisitions provides relevant and cost-effective solutions exclusively to the Federal Government, enjoying a successful reputation for implementing very intricate programs and executing large scale transactions. (513) 721-8700. www.gov-acq.com
About Dataram
Founded in 1967, Dataram is a worldwide leader in the manufacture of high-quality computer memory, storage and software products. Our products and services deliver IT infrastructure optimization, dramatically increase application performance and deliver substantial cost savings. Dataram solutions are deployed in 70 Fortune 100 companies and in mission-critical government and defense applications around the world. For more information about Dataram, visit www.dataram.com.
Press Release Source: Sino-Global Shipping America, Ltd. On Friday February 19, 2010, 5:00 am EST
BEIJING, Feb. 19 /PRNewswire-Asia/ — Sino-Global Shipping America, Ltd. (Nasdaq:SINO – News) (“Sino-Global” or the “Company”), a leading, non-state-owned provider of shipping agency services operating primarily in China, today announced that it has obtained shareholder approval for all the matters submitted for approval at its 2010 annual general meeting held on February 11, 2010.
A total of 2,769,480 shares were represented in person or by proxy at the Company’s 2010 annual general meeting, representing a quorum of approximately 91.43% of the Company’s outstanding shares. During the meeting, all proposed resolutions were duly passed including:
1. Wang Jing and Zhang Mingwei were elected as the Class III members of
the board of directors, each to serve a term expiring at the annual
meeting of shareholders in 2013 or until his successor is duly
elected and qualified. Mr. Wang received approximately 99.85% of the
votes cast at the meeting. Mr. Zhang received approximately 99.85%
of the votes cast at the meeting.
2. Friedman LLP was appointed as the Company's independent registered
public accounting firm for the fiscal year ending June 30, 2010.
Approximately 99.87% of the votes cast at the meeting were cast for
This item; approximately 0.01% were cast against this item, and
Approximately 0.12% were abstentions.
For more information on Sino-Global’s 2010 annual general meeting, please visit the investor relations section of the Company’s website at http://www.sino-global.com .
About Sino-Global Shipping America, Ltd.
Registered in the United States in 2001 and operating primarily in mainland China, Sino-Global is a leading, non-state-owned provider of high- quality shipping agency services. With local branches in most of the main Chinese ports and contractual arrangements in all those where it does not have branch offices, Sino-Global is able to offer efficient, high-quality shipping agency services to shipping companies entering Chinese ports. With a subsidiary in Perth, Australia, where it has a contractual relationship with a local shipping agency, Sino-Global provides complete shipping agent services to companies involved in trades between Chinese and Australian ports. Sino- Global also operates a subsidiary in Hong Kong, China, to provide comprehensive shipping agent services to vessels going to and from one of the world’s busiest ports.
Sino-Global provides ship owners, operators and charters with comprehensive yet customized shipping agency services including intelligence, planning, real-time analysis and on-the-ground implementation and logistics support. Sino-Global has achieved both ISO9001 and UKAS certifications.
Forward Looking Statements
No statement made in this press release should be interpreted as an offer to purchase any security. Such an offer can only be made in accordance with the Securities Act of 1933, as amended, and applicable state securities laws. Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties as identified in Sino-Global’s filings with the Securities and Exchange Commission. Actual results, events or performance may differ materially. Readers are cautioned not to place undo reliance on these forward- looking statements, which speak only as the date hereof. Sino-Global undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Press Release Source: Lannett Company, Inc. On Thursday February 18, 2010, 3:50 pm
PHILADELPHIA–(BUSINESS WIRE)–Lannett Company, Inc. (NYSE AMEX: LCI) today announced Arthur Bedrosian, president and chief executive officer, purchased 2,000 shares of the company’s common stock in the open market on February 16, 2010.
Mr. Bedrosian said he plans to purchase additional shares as permitted under Lannett’s insider trading policy.
About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit the company’s website at www.lannett.com.